RESULT_COUNT: 473,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
EXAS,EXAS:US,BBG000CWL0F5,"Zacks.com featured highlights include Nintendo Co., Exact Sciences, Tabula Rasa Healthcare, Facebook and Nova Measuring Instruments",2017-10-18 13:20:01 +0000,https://finance.yahoo.com/news/zacks-com-featured-highlights-nintendo-132001585.html?.tsrc=rss,"Zacks.com featured highlights include Nintendo Co., Exact Sciences, Tabula Rasa Healthcare, Facebook and Nova Measuring Instruments"
EXAS,EXAS:US,BBG000CWL0F5,5 Top-Ranked Profitable Stocks to Boost Your Portfolio,2017-10-17 16:54:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AVNr8AclGYE/5-top-ranked-profitable-stocks-to-boost-your-portfolio-cm860821,Profitability analysis is used to measure the company s ability to manage its revenues effectively and provide stunning returns to its investors This analysis helps to detect a profitable company over a loss making one The most successful way to identify a company s profitability is by
EXAS,EXAS:US,BBG000CWL0F5,Inovio Initiates Bladder Cancer Study With Roche's Tecentriq,2017-10-17 16:53:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OuYnPS4RTFM/inovio-initiates-bladder-cancer-study-with-roches-tecentriq-cm860802,Inovio Pharmaceuticals Inc INO announced that it has initiated a phase Ib II study to evaluate the combination of two immunotherapy candidates and Roche Holding AG s RHHBY anti PDL1 inhibitor Tecentriq in advanced bladder cancer Inovio s candidates include INO 5401 a T cell
EXAS,EXAS:US,BBG000CWL0F5,See what the IHS Markit Score report has to say about Exact Sciences Corp.,2017-10-17 12:01:52 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120152818.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
EXAS,EXAS:US,BBG000CWL0F5,"EXACT Sciences Corp. Moves Up In Market Cap Rank, Passing Mattel",2017-10-16 22:17:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E2e1MAfhsN4/exact-sciences-corp-moves-up-in-market-cap-rank-passing-mattel-cm860366,In the latest look at stocks ordered by largest market capitalization Russell 3000 component EXACT Sciences Corp Symbol EXAS was identified as having a larger market cap than the smaller end of the S amp P 500 for example Mattel Inc Symbol MAT according to The Online Investor
EXAS,EXAS:US,BBG000CWL0F5,See what the IHS Markit Score report has to say about Exact Sciences Corp.,2017-10-16 13:41:15 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-134115635.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
EXAS,EXAS:US,BBG000CWL0F5,"IWO, EXAS, CTLT, KNX: Large Inflows Detected at ETF",2017-10-13 16:10:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jU2v2GSQTYs/iwo-exas-ctlt-knx-large-inflows-detected-at-etf-cm859390,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 2000 Growth ETF Symbol IWO where we have detected an approximate 90 4 million dollar inflow that s a 1 0 increase week over week in
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Stock Just Hit an All-Time High: Here's Why It Could Go Even Higher,2017-10-13 13:16:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qsGq0c4hZgA/exact-sciences-stock-just-hit-an-all-time-high-heres-why-it-could-go-even-higher-cm859233,In May Andrew Left of Citron Research blasted Exact Sciences NASDAQ EXAS calling the stock a poster child for what goes wrong when Wall Street gets a hold of a healthcare concept with no discrimination for whether it s good or bad medicine Citron Research assigned a short
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Stock Just Hit an All-Time High: Here&apos;s Why It Could Go Even Higher,2017-10-13 11:16:00 +0000,https://finance.yahoo.com/news/exact-sciences-stock-just-hit-111600546.html?.tsrc=rss,There&apos;s still a huge untapped market for this company&apos;s DNA screening test.
EXAS,EXAS:US,BBG000CWL0F5,EXACT Sciences Corp. (EXAS) Is Losing Ground In Early Trade,2017-10-13 09:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o8rhG2RNrf0/exact-sciences-corp-exas-is-losing-ground-in-early-trade-20171013-00490,EXACT Sciences Corp. (EXAS) Is Losing Ground In Early Trade
EXAS,EXAS:US,BBG000CWL0F5,Pluristem Therapeutics Inc. (PSTI) Catches Eye: Stock Jumps 5.1%,2017-10-11 14:15:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L-QZB2m_z4c/pluristem-therapeutics-inc-psti-catches-eye-stock-jumps-51-cm858140,Pluristem Therapeutics Inc PSTI was a big mover last session as the company saw its shares rise over 5 on the day The move came on solid volume too with far more shares changing hands than in a normal session This stock which remained volatile and traded within the range of 1 23 1 56
EXAS,EXAS:US,BBG000CWL0F5,MiMedx Group (MDXG) Looks Good: Stock Adds 5.4% in Session,2017-10-11 12:52:12 +0000,https://finance.yahoo.com/news/mimedx-group-mdxg-looks-good-125212352.html?.tsrc=rss,"MiMedx Group (MDXG) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences schedules third-quarter 2017 earnings call,2017-10-10 10:00:00 +0000,https://finance.yahoo.com/news/exact-sciences-schedules-third-quarter-100000470.html?.tsrc=rss,"MADISON, Wis., Oct. 10, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that the company plans to release its third-quarter 2017 financial results after the close of the U.S. financial markets on Oct. 31.  Following the release, the company's management will host a webcast and conference call at 5 p.m. Eastern time to discuss financial results and business progress."
EXAS,EXAS:US,BBG000CWL0F5,See what the IHS Markit Score report has to say about Exact Sciences Corp.,2017-10-09 12:04:33 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120433820.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
EXAS,EXAS:US,BBG000CWL0F5,Ignore Citron Report and Use This Dip to Buy Shopify Inc (US) (SHOP) Stock,2017-10-06 09:00:32 +0000,https://finance.yahoo.com/news/ignore-citron-report-dip-buy-090032601.html?.tsrc=rss,"Timing is everything in the stock market.  On Wednesday morning, I called Shopify Inc (US) (NYSE:SHOP) the most exciting stock in the market.  SHOP stock plunged more than 11% following Citron’s report, and another 4% yesterday, to hover right around the critical $100 level."
EXAS,EXAS:US,BBG000CWL0F5,Why EXACT Sciences Corporation Jumped 13.2% in September,2017-10-06 00:47:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XvBP8eIKnW4/why-exact-sciences-corporation-jumped-132-in-september-cm856038,What happened Shares of EXACT Sciences NASDAQ EXAS a diagnostics company focused on colon cancer rose more than 13 in September according to data from S amp P Global Market Intelligence While it was a quiet month on the news front an analyst at Leerink Partners
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences: Going…Up!,2017-10-03 19:44:00 +0000,http://finance.yahoo.com/r/503559ee-2f7d-37b0-9f76-5fe4cd00dea0/exact-sciences-goingup-1507059840?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Shares of Exact Sciences (EXAS) have more than tripled so far this year this year as investors started betting that it's colorectal cancer test would go from a niche product to a mainstream one. And one ...
EXAS,EXAS:US,BBG000CWL0F5,"Atlas Genetics Appoints Life Sciences Veteran, Jeffrey Luber, as Chief Executive Officer; Founding CEO Dr John Clarkson Steps Up to Executive Chairman",2017-10-03 06:00:00 +0000,https://finance.yahoo.com/news/atlas-genetics-appoints-life-sciences-060000648.html?.tsrc=rss,"Atlas Genetics Ltd., the ultra-rapid, point-of-care (POC) testing company for women's and family health, today announced that Jeffrey R. Luber has been appointed Chief Executive Officer effective 1 October 2017.  Dr John Clarkson, current founding CEO, will become Executive Chairman and current chairman, Neil Butler, will remain with the Company as a non-executive director of the Board.  Mr. Luber joins the Board of Atlas Genetics with broad experience in the life sciences industry, including having held multiple leadership roles in both public and private companies."
EXAS,EXAS:US,BBG000CWL0F5,Can Exact Sciences (EXAS) Keep the Earnings Streak Alive This Quarter?,2017-10-02 12:59:12 +0000,https://finance.yahoo.com/news/exact-sciences-exas-keep-earnings-125912465.html?.tsrc=rss,Exact Sciences (EXAS) can be a harbinger of out performance and a signal for a strong earnings profile on the back of its favorable Zacks rank and earnings ESP in the positive territory.
EXAS,EXAS:US,BBG000CWL0F5,See what the IHS Markit Score report has to say about Exact Sciences Corp.,2017-10-02 12:02:50 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120402377.html?.tsrc=rss,Exact Sciences Corp NASDAQ:EXAS
EXAS,EXAS:US,BBG000CWL0F5,7 ‘Strong Buy’ Stocks Wall Street Is 100% Sure Of,2017-09-22 19:49:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FIV8gZSQX6M/7-strong-buy-stocks-wall-street-is-100-sure-of-cm849829,InvestorPlace Stock Market News Stock Advice amp Trading Tips Which hot stocks are Wall Street analysts the most bullish on Stocks with no hold or sell ratings and a pure strong buy analyst consensus rating These are the stocks that make the most compelling investing
EXAS,EXAS:US,BBG000CWL0F5,EXACT Sciences Reaches Analyst Target Price,2017-09-22 14:37:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_9yrXYhq2kY/exact-sciences-reaches-analyst-target-price-cm849514,In recent trading shares of EXACT Sciences Corp Symbol EXAS have crossed above the average analyst 12 month target price of 43 82 changing hands for 45 00 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on valuation
EXAS,EXAS:US,BBG000CWL0F5,Today's Research Reports on Trending Tickers: Exact Sciences and Inovio Pharmaceuticals,2017-09-22 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000082.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 22, 2017 / U.S. markets retreated from record highs a day after the Federal Reserve announced that it would begin unwinding its $4.5 trillion balance sheet in October ..."
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences Corporation (EXAS) Could Be A Buy,2017-09-21 14:45:09 +0000,https://finance.yahoo.com/news/why-exact-sciences-corporation-exas-144509419.html?.tsrc=rss,"Exact Sciences Corporation (NASDAQ:EXAS), a pharmaceuticals, biotechnology and life sciences company based in United States, saw a significant share price rise of over 20% in the past couple of monthsRead More..."
EXAS,EXAS:US,BBG000CWL0F5,"IWO, CTLT, AZPN, EXAS: Large Outflows Detected at ETF",2017-09-12 16:36:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xaOVd8cAnp0/iwo-ctlt-azpn-exas-large-outflows-detected-at-etf-cm844404,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 2000 Growth ETF Symbol IWO where we have detected an approximate 42 8 million dollar outflow that s a 0 5 decrease week over week
EXAS,EXAS:US,BBG000CWL0F5,See what the IHS Markit Score report has to say about Exact Sciences Corp.,2017-09-12 12:07:07 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120707525.html?.tsrc=rss,Exact Sciences Corp NASDAQ:EXAS
EXAS,EXAS:US,BBG000CWL0F5,See what the IHS Markit Score report has to say about Exact Sciences Corp.,2017-09-11 12:02:22 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120222495.html?.tsrc=rss,Exact Sciences Corp NASDAQ:EXAS
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences Shares Rallied 10.2% in August,2017-09-05 20:52:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e-jGOj1C5lc/why-exact-sciences-shares-rallied-102-in-august-cm841222,What happened After the company reported better than expected 160 top and bottom line second quarter results in late July and updated investors on its strategy at Cannacord s 160 37th annual growth conference on Aug 9 shares of Exact Sciences NASDAQ EXAS jumped 10 2
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences Shares Rallied 10.2% in August,2017-09-05 19:30:00 +0000,http://finance.yahoo.com/r/ce3db20d-feca-3b2e-8e8a-92b503e24c36/why-exact-sciences-shares-rallied-102-in-august.aspx?yptr=yahoo&.tsrc=rss,"Following better-than-expected second-quarter financials and an investor conference early in the month, Exact Sciences&apos; stock posted double-digit gains in August."
EXAS,EXAS:US,BBG000CWL0F5,These 3 'Strong Buy' Healthcare Stocks Are Seeing Big Insider Buying,2017-09-05 15:18:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6LWO5TNswVA/these-3-strong-buy-healthcare-stocks-are-seeing-big-insider-buying-cm840873,Which hot healthcare stocks are corporate insiders snapping up right now? Tracking informative insider transactions is a great way of finding compelling investment opportunities from those who know the company best. But be aware that uninformative transactions indicate that an insider is buying/selling shares for
EXAS,EXAS:US,BBG000CWL0F5,"IWO, CTLT, EXAS, PRXL: Large Outflows Detected at ETF",2017-08-30 16:48:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iqXqjuuz-LY/iwo-ctlt-exas-prxl-large-outflows-detected-at-etf-cm839202,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 2000 Growth ETF Symbol IWO where we have detected an approximate 66 7 million dollar outflow that s a 0 8 decrease week over week
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences to participate in Baird Global Healthcare Conference,2017-08-30 10:00:00 +0000,https://finance.yahoo.com/news/exact-sciences-participate-baird-global-100000633.html?.tsrc=rss,"MADISON, Wis., Aug. 30, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that the company will participate in the Baird Global Healthcare Conference on Wednesday, Sept. 6.  Kevin Conroy, Exact Sciences' chairman and CEO, and Jeff Elliott, the company's chief financial officer, will participate in a fireside chat at 10:15 a.m. ET in New York.  Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer."
EXAS,EXAS:US,BBG000CWL0F5,Surging Earnings Estimates Signal Good News for Exact Sciences Corporation (EXAS),2017-08-29 13:54:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c0OHZPs3ylk/surging-earnings-estimates-signal-good-news-for-exact-sciences-corporation-exas-cm838546,Exact Sciences Corporation EXAS is a molecular diagnostics company focusing on developing products for the early detection and prevention of various cancers that could be an interesting play for investors That is because not only does the stock have decent short term momentum but it is
EXAS,EXAS:US,BBG000CWL0F5,Surging Earnings Estimates Signal Good News for Exact Sciences Corporation (EXAS),2017-08-29 12:30:12 +0000,https://finance.yahoo.com/news/surging-earnings-estimates-signal-good-123012508.html?.tsrc=rss,Exact Sciences Corporation (EXAS) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision in addition to having decent short-term momentum.
EXAS,EXAS:US,BBG000CWL0F5,These 3 Stocks Are Priced for Perfection. Can They Deliver?,2017-08-27 13:49:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8LbvHONnspk/these-3-stocks-are-priced-for-perfection-can-they-deliver-cm837622,Even great companies can turn into poor investments if you buy them at the wrong time That s why it is important to take a hard look at a company s valuation before pulling the trigger Shares of Exact Sciences NASDAQ EXAS Illumina NASDAQ ILMN and Intuitive
EXAS,EXAS:US,BBG000CWL0F5,These 3 Stocks Are Priced for Perfection. Can They Deliver?,2017-08-27 12:02:00 +0000,http://finance.yahoo.com/r/f5c6da59-a7db-3717-b089-43588c66f32a/these-3-stocks-are-priced-for-perfection-can-they.aspx?yptr=yahoo&.tsrc=rss,"Exact Sciences, Illumina, and Intuitive Surgical all sport premium valuations. Should investors be worried?"
EXAS,EXAS:US,BBG000CWL0F5,3 Reasons Exact Sciences Is a Better Growth Stock Than Illumina,2017-08-25 20:38:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XWjwW-KDBYg/3-reasons-exact-sciences-is-a-better-growth-stock-than-illumina-cm837397,Illumina NASDAQ ILMN has been and still is a leader in one of the most important scientific advances in human history The company s technology helped usher in widespread use of gene sequencing which has led to greater understanding of many genetic diseases As a
EXAS,EXAS:US,BBG000CWL0F5,3 Reasons Exact Sciences Is a Better Growth Stock Than Illumina,2017-08-25 18:43:00 +0000,http://finance.yahoo.com/r/27baef51-d665-313a-b0f2-e15141766e74/3-reasons-exact-sciences-is-a-better-growth-stock.aspx?yptr=yahoo&.tsrc=rss,"Illumina is a solid growth stock, but Exact Sciences is even better."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences: On the Way to 24 Million Tests?,2017-08-24 17:56:00 +0000,http://finance.yahoo.com/r/4d844ca4-d33f-3556-94ff-4710c7e2a4ec/exact-sciences-on-the-way-to-24-million-tests-1503597401?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Exact Sciences (EXAS) have tripled this year as investors came around to the idea that its colorectal cancer test might actually be gaining traction.  The big gains made Barron's  Andrew Bary  more cautious on its shares back in June, when he argued that the stock looked ""fully priced.""  Leerink's Puneet Souda and Kai Wang explain why they remain optimistic: We remain Outperform on EXAS given that the adoption of its Colorectal Cancer screening test Cologuard in the 80M target U.S. population remains highly underpenetrated at just ~2% today with expectations to reach 30% or even more longer-term.  Shares of Exact Sciences have risen 0.6% to $$40.65."
EXAS,EXAS:US,BBG000CWL0F5,See what the IHS Markit Score report has to say about Exact Sciences Corp.,2017-08-23 12:01:46 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120146227.html?.tsrc=rss,Exact Sciences Corp NASDAQ:EXAS
EXAS,EXAS:US,BBG000CWL0F5,Today's Research Reports on Trending Tickers: Ionis Pharmaceuticals Inc. and Exact Sciences Corporation,2017-08-23 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000145.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 23, 2017 / U.S. markets surged Tuesday, with the Dow Jones Industrial Average posting its best daily gain since April, on renewed hopes for tax reform. The Dow Jones ..."
EXAS,EXAS:US,BBG000CWL0F5,"Up 187% in 2017, Is Exact Sciences Corp. Stock Still a Buy?",2017-08-19 17:37:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VK7kS0ZpoYo/up-187-in-2017-is-exact-sciences-corp-stock-still-a-buy-cm834329,Exact Sciences NASDAQ EXAS 160 investors are having a year to remember Shares of the colon cancer detection company have been on an absolute tear in 2017 rising more than 187 But after the stock has booked such a big gain in such a short period can buy and hold
EXAS,EXAS:US,BBG000CWL0F5,"Up 187% in 2017, Is Exact Sciences Corp. Stock Still a Buy?",2017-08-19 15:48:00 +0000,http://finance.yahoo.com/r/3eda07b0-f3b3-343b-becf-0a00ded88b3a/exact-sciences-stock-still-a-buy.aspx?yptr=yahoo&.tsrc=rss,"The maker of the innovative Cologuard colon cancer detection test has momentum on its side, but how much upside is there from here?"
EXAS,EXAS:US,BBG000CWL0F5,See what the IHS Markit Score report has to say about Exact Sciences Corp.,2017-08-16 12:02:32 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120232420.html?.tsrc=rss,Exact Sciences Corp NASDAQ:EXAS
EXAS,EXAS:US,BBG000CWL0F5,3 Game-Changing Small-Cap Healthcare Stocks,2017-08-16 04:35:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0E6Py_f3AwM/3-game-changing-small-cap-healthcare-stocks-cm832541,The ability to shake up patient treatment could mean big bucks for Tetraphase Pharmaceuticals NASDAQ TTPH NovoCure NASDAQ NVCR and Exact Sciences NASDAQ EXAS Should you be buying shares in these companies Read on to learn if they re right for your
EXAS,EXAS:US,BBG000CWL0F5,3 Game-Changing Small-Cap Healthcare Stocks,2017-08-16 01:01:00 +0000,http://finance.yahoo.com/r/88b64a48-0951-3990-8dab-6da21f68dc01/3-game-changing-small-cap-healthcare-stocks.aspx?yptr=yahoo&.tsrc=rss,"Tetraphase Pharmaceuticals, NovoCure, and Exact Sciences could reshape patient treatment."
EXAS,EXAS:US,BBG000CWL0F5,See what the IHS Markit Score report has to say about Exact Sciences Corp.,2017-08-14 12:02:41 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120241009.html?.tsrc=rss,Exact Sciences Corp NASDAQ:EXAS
EXAS,EXAS:US,BBG000CWL0F5,Edited Transcript of EXAS earnings conference call or presentation 25-Jul-17 9:00pm GMT,2017-08-12 13:40:57 +0000,https://finance.yahoo.com/news/edited-transcript-exas-earnings-conference-011945716.html?.tsrc=rss,Q2 2017 Exact Sciences Corp Earnings Call
EXAS,EXAS:US,BBG000CWL0F5,Better Buy: Exact Sciences Corporation vs. Opko Health,2017-08-11 13:38:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-Cn8aM51W3E/better-buy-exact-sciences-corporation-vs-opko-health-cm830775,It was the best of times it was the worst of times Charles Dickens wasn t referring to Exact Sciences NASDAQ EXAS and Opko Health NASDAQ OPK when he wrote those words but they re certainly applicable for the two healthcare stocks 2017 has been a great year so far
EXAS,EXAS:US,BBG000CWL0F5,Better Buy: Exact Sciences Corporation vs. Opko Health,2017-08-11 12:04:00 +0000,http://finance.yahoo.com/r/738cd2ad-80b5-3c61-ae80-13a0ff01d48e/better-buy-exact-sciences-corporation-vs-opko-heal.aspx?yptr=yahoo&.tsrc=rss,Which stock is the better long-term pick in a head-to-head matchup between Exact Sciences and Opko Health?
EXAS,EXAS:US,BBG000CWL0F5,"ETFs with exposure to EXACT Sciences Corp. : August 8, 2017",2017-08-08 20:25:26 +0000,http://finance.yahoo.com/r/27caa2c2-3567-3d9a-9132-bbc9374e4adf/etfs-with-exposure-to-exact-sciences-corp-august-8-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to EXACT Sciences Corp. Here are 5 ETFs with the largest exposure to EXAS-US. Comparing the performance and risk of EXACT Sciences Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences CEO Sees Steady Uptick in Cologuard Orders,2017-08-04 19:09:53 +0000,https://finance.yahoo.com/video/exact-sciences-ceo-sees-steady-190953389.html?.tsrc=rss,"Aug.04 -- Kevin Conroy, Exact Sciences Corp. chairman and chief executive officer, discusses the company's earnings and demand for Cologuard colon-cancer tests with Bloomberg's Julia Chatterley on &quot;Bloomberg Markets.&quot;"
EXAS,EXAS:US,BBG000CWL0F5,Earnings Review and Free Research Report: Thermo Fisher’s Revenue Jumped 10%; EPS Climbed 20%,2017-08-03 11:10:00 +0000,https://finance.yahoo.com/news/earnings-review-free-research-report-111000312.html?.tsrc=rss,"Research Desk Line-up: Exact Sciences Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 3, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on Thermo Fisher Scientific Inc. ..."
EXAS,EXAS:US,BBG000CWL0F5,Here's Why the Best Is Yet to Come for Exact Sciences,2017-08-02 02:54:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-XpPbn0LYfc/heres-why-the-best-is-yet-to-come-for-exact-sciences-cm825403,Millions of Americans forego getting tested for colon cancer however a new colon cancer test from Exact Sciences NASDAQ EXAS is changing that and as a result patients are catching their cancer sooner The simple test is resonating with aging baby boomers who might otherwise
EXAS,EXAS:US,BBG000CWL0F5,Here&apos;s Why the Best Is Yet to Come for Exact Sciences,2017-08-02 01:00:00 +0000,http://finance.yahoo.com/r/05793fc4-1191-341c-9a26-e62c1182553a/heres-why-the-best-is-yet-to-come-for-exact-scienc.aspx?yptr=yahoo&.tsrc=rss,"The company has only begun tapping into the large, unmet need for better colon cancer screening."
EXAS,EXAS:US,BBG000CWL0F5,"VNRX: Large U.S. Study Comes Cheap, Could Support Asymptomatic FDA Filing",2017-08-01 13:00:00 +0000,https://finance.yahoo.com/news/vnrx-large-u-study-comes-130000675.html?.tsrc=rss,"VNRX is required to contribute just $3M (paid in equal quarterly installments over 3 years), with most of the funding borne by the study's main sponsor, the U.S. National Cancer Institute's (NCI) Early Detection Network (EDRN), which is the leading cancer research organization in the U.S.  The Great Lakes New England Clinical Validation Center and the University of Michigan are also major participants and, along with EDRN, focused on the pursuit of technologies for the early detection of cancer.  • will include ~13.5k asymptomatic screening samples from subjects > 50 years of age who have not previously undergone colonoscopy or CRC screening."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences to participate in Canaccord Genuity Growth Conference,2017-08-01 10:00:00 +0000,https://finance.yahoo.com/news/exact-sciences-participate-canaccord-genuity-100000832.html?.tsrc=rss,"MADISON, Wis., Aug. 1, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that the company will participate in the 37th Annual Canaccord Genuity Growth Conference on Wednesday, Aug. 9.  Jeff Elliott, Exact Sciences' chief financial officer, will make the company's presentation at the conference at 12 p.m. ET in Boston.  Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer."
EXAS,EXAS:US,BBG000CWL0F5,"Commit To Buy EXACT Sciences Corp. At $27, Earn 12.6% Using Options",2017-07-31 15:56:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/arI63OlF-X8/commit-to-buy-exact-sciences-corp-at-27-earn-126-using-options-cm824327,Investors considering a purchase of EXACT Sciences Corp Symbol EXAS shares but tentative about paying the going market price of 39 25 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Corporation (EXAS) Jumps: Stock Rises 6.2%,2017-07-27 14:02:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PuA2QNke-Og/exact-sciences-corporation-exas-jumps-stock-rises-62-cm822422,Exact Sciences Corporation EXAS was a big mover last session as the company saw its shares rise nearly 6 on the day The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is now up 16 3
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Corporation (EXAS) Jumps: Stock Rises 6.2%,2017-07-27 12:44:12 +0000,https://finance.yahoo.com/news/exact-sciences-corporation-exas-jumps-124412990.html?.tsrc=rss,"Exact Sciences Corporation (EXAS) was a big mover last session, as the company saw its shares rise nearly 6% on the day after the company delivered yet another quarter of greater than 100% top-line growth."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Continues to Surprise to the Upside,2017-07-27 01:57:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G5BH8rBnRjQ/exact-sciences-continues-to-surprise-to-the-upside-cm822133,Exact Sciences NASDAQ EXAS reported second quarter financial results today that exceeded industry watchers forecasts continuing a string of successes that has frustrated short sellers and caused shares to more than double in the past year Can this company continue its
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Continues to Surprise to the Upside,2017-07-27 00:46:00 +0000,http://finance.yahoo.com/r/2a6aabc9-5c24-3b71-a88a-f9ce8e23c604/exact-sciences-continues-to-surprise-to-the-upside.aspx?yptr=yahoo&.tsrc=rss,Exact Sciences delivered yet another quarter of greater than 100% top-line growth.
EXAS,EXAS:US,BBG000CWL0F5,Pacira Pharmaceuticals Inc (PCRX) and EXACT Sciences Corporation (EXAS) Are Shaking Up the Market,2017-07-26 18:34:36 +0000,https://finance.yahoo.com/news/pacira-pharmaceuticals-inc-pcrx-exact-183436880.html?.tsrc=rss,"Pacira Pharmaceuticals Inc (NASDAQ:PCRX) shares were falling 12% yesterday after the drug maker's pain medicine failed to meet a primary efficacy endpoint in one of its two Phase 3 femoral nerve block trial.  As far as Davis sees it, Pacira is still ""moving on to the finals,"" having just the right data to deliver a response to the FDA's Complete Response Letter (CRL) from back in March 2015.  In other words, the drug maker will soon be re-filing its sNDA in the indication of nerve block."
EXAS,EXAS:US,BBG000CWL0F5,"Risk-Reward Still Suggests Exact Sciences Is A Buy, But Be Cautious",2017-07-26 18:01:11 +0000,https://finance.yahoo.com/news/risk-reward-still-suggests-exact-180111714.html?.tsrc=rss,"Following EXACT Sciences Corporation (NASDAQ: EXAS )'s beat-and-raise quarter, Bank of America Merrill Lynch said risk/reward still suggests the stock is a Buy, although suggesting to proceed with caution ..."
EXAS,EXAS:US,BBG000CWL0F5,Why EXACT Sciences Corporation Is Rising Today,2017-07-26 18:00:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NkKEHniV82A/why-exact-sciences-corporation-is-rising-today-cm821883,What happened Shares of EXACT Sciences NASDAQ EXAS a company focused on colon cancer detection rose as much as 13 in early morning trading on Wednesday in response to reporting better than expected second quarter results So what Here s a review of the
EXAS,EXAS:US,BBG000CWL0F5,"Noteworthy Wednesday Option Activity: CAB, SSNC, EXAS",2017-07-26 16:58:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-SyhfuN75FA/noteworthy-wednesday-option-activity-cab-ssnc-exas-cm821799,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Cabela s Inc Symbol CAB where a total volume of 4 359 contracts has been traded thus far today a contract volume which is representative of approximately 435 900
EXAS,EXAS:US,BBG000CWL0F5,Why EXACT Sciences Corporation Is Rising Today,2017-07-26 16:23:00 +0000,http://finance.yahoo.com/r/13a2a56c-e595-3888-a788-ec2c4242fa85/why-exact-sciences-corporation-is-soaring-today.aspx?yptr=yahoo&.tsrc=rss,Shares jump after the company reports blowout quarterly results.
EXAS,EXAS:US,BBG000CWL0F5,"EXACT Sciences Corp. :EXAS-US: Earnings Analysis: Q2, 2017 By the Numbers : July 26, 2017",2017-07-26 15:41:13 +0000,http://finance.yahoo.com/r/6f78dae0-585c-39f4-8349-bb1d3a8ec295/exact-sciences-corp-exas-us-earnings-analysis-q2-2017-by-the-numbers-july-26-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis EXACT Sciences Corp. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 57.65 million, Net Earnings of USD -30.79 million. Gross margins widened from 52.34% to 68.79% compared to the same period last year, operating (EBITDA) margins now -48.07% from -199.53%. Change in operating ... Read more
<b>(Read more...)</b>"
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences: Blowout!,2017-07-26 14:26:00 +0000,http://finance.yahoo.com/r/4c86d836-b69e-3d7b-807b-b5600ff35151/exact-sciences-blowout-1501079193?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Exact Sciences reported a loss of 27 cents a share, beating forecasts for a 35 cent loss, on sales of $57.6 million, ahead of expectations for $49.8 million.  Canaccord Genuity analyst Mark Massaro calls it a ""blowout quarter"" for Exact Sciences: EXAS delivered another terrific quarter and is executing on all cylinders, reporting a major beat-and-raise above the ""blowout"" case we previewed."
EXAS,EXAS:US,BBG000CWL0F5,"Positive Data IGNITEs TTPH, MDCO Makes A Good TANGO, Wait Continues For EGRX",2017-07-26 02:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2TRAnoGhx_E/positive-data-ignites-ttph-mdco-makes-a-good-tango-wait-continues-for-egrx-20170726-00106,"Positive Data IGNITEs TTPH, MDCO Makes A Good TANGO, Wait Continues For EGRX"
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences reports 2Q loss,2017-07-26 02:19:08 +0000,https://finance.yahoo.com/news/exact-sciences-reports-2q-loss-211904325.html?.tsrc=rss,"On a per-share basis, the Madison, Wisconsin-based company said it had a loss of 27 cents. The results surpassed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment ..."
EXAS,EXAS:US,BBG000CWL0F5,"Cologuard® revenue increased to $57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests",2017-07-25 20:05:00 +0000,https://finance.yahoo.com/news/cologuard-revenue-increased-57-6-200500321.html?.tsrc=rss,"- Revenue guidance raised to $230-240 million for 2017, from $195-205 million - Guidance for Cologuard tests to be completed during 2017 increased to at least 550,000 tests, from at least 470,000 - 11,000 ..."
EXAS,EXAS:US,BBG000CWL0F5,Investor Network: Exact Sciences Corporation to Host Earnings Call,2017-07-25 16:00:00 +0000,https://finance.yahoo.com/news/investor-network-exact-sciences-corporation-160000590.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / July 25, 2017 / Exact Sciences Corporation (NASDAQ: EXAS ) will be discussing their earnings results in their Q2 Earnings Call to be held on Tuesday, July 25, 2017 at 5:00 PM ..."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Earnings OutLook: Not An Easy Task,2017-07-25 15:52:00 +0000,http://finance.yahoo.com/r/16d3f3ba-6fcb-3884-9920-7f2810571953/exact-sciences-earnings-outlook-not-easy-task?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Exact Sciences has been on a tear, thanks to the success of its colorectal cancer test. But can the momentum continue?"
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Grants Inducement Restricted Stock Unit Awards to Recently Hired Employees,2017-07-21 20:05:00 +0000,https://finance.yahoo.com/news/exact-sciences-grants-inducement-restricted-200500205.html?.tsrc=rss,"MADISON, Wis., July 21, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that, in support of the Company's continued growth plans, it granted restricted stock units covering a total of 145,348 shares of common stock to 167 recently hired non-executive employees under its previously announced inducement grant program.  The restricted stock unit awards vest in four equal annual installments beginning on the first anniversary of the grant date.  The awards were granted as an inducement material to the recently hired employees entering into employment with the Company in accordance with NASDAQ Marketplace Rule 5635(c)(4).  The Company is making this announcement as required by NASDAQ rules.  Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer."
EXAS,EXAS:US,BBG000CWL0F5,Is a Beat in the Cards for ImmunoGen (IMGN) in Q2 Earnings?,2017-07-21 18:07:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D5BFGB8tMNg/is-a-beat-in-the-cards-for-immunogen-imgn-in-q2-earnings-cm819476,We expect ImmunoGen Inc IMGN to beat expectations when it reports second quarter 2017 results on Jul 28 before the market opens Last quarter the company delivered a positive earnings surprise of 44 44 ImmunoGen s shares significantly outperformed the industry by gaining 189 2 so far
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences (EXAS) Might Surprise This Earnings Season,2017-07-21 14:10:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6DRKeAsgNiY/why-exact-sciences-exas-might-surprise-this-earnings-season-cm819287,Investors are always looking for stocks that are poised to beat at earnings season and Exact Sciences Corporation EXAS may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because Exact Sciences is seeing
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences (EXAS) Might Surprise This Earnings Season,2017-07-21 12:49:12 +0000,https://finance.yahoo.com/news/why-exact-sciences-exas-might-124912910.html?.tsrc=rss,Exact Sciences (EXAS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
EXAS,EXAS:US,BBG000CWL0F5,What To Expect From Exact Sciences' Pending Q2 Release,2017-07-20 17:24:34 +0000,https://finance.yahoo.com/news/expect-exact-sciences-pending-q2-172434158.html?.tsrc=rss,"Previewing EXACT Sciences Corporation (NASDAQ: EXAS )'s second-quarter results, Canaccord Genuity said it expects the company to deliver another strong quarter, extending its strong commercial momentum. ..."
EXAS,EXAS:US,BBG000CWL0F5,"PGX, PTH: Big ETF Inflows",2017-07-20 17:06:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K5uuwuWW06Q/pgx-pth-big-etf-inflows-cm818805,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the PowerShares Preferred Portfolio PGX which added 4 500 000 units or a 1 3 increase week over week And on a percentage change basis the ETF with
EXAS,EXAS:US,BBG000CWL0F5,New Strong Buy Stocks for July 19th,2017-07-19 17:06:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Nst6-MO4bXw/new-strong-buy-stocks-for-july-19th-cm818233,Here are 5 stocks added to the Zacks Rank 1 Strong Buy List today Agilent Technologies Inc A This provider of application focused solutions has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0 1 over the last 30 days Agilent Technologies
EXAS,EXAS:US,BBG000CWL0F5,New Strong Buy Stocks for July 19th,2017-07-19 14:11:02 +0000,https://finance.yahoo.com/news/strong-buy-stocks-july-19th-141102115.html?.tsrc=rss,New Strong Buy Stocks for July 19th
EXAS,EXAS:US,BBG000CWL0F5,New Strong Buy Stocks for July 17th,2017-07-17 15:55:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E_ruIOTaBfs/new-strong-buy-stocks-for-july-17th-cm817012,Here are 5 stocks added to the Zacks Rank 1 Strong Buy List today BancFirst Corporation BANF This financial holding company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0 2 over the last 30 days BancFirst Corporation Price and
EXAS,EXAS:US,BBG000CWL0F5,New Strong Buy Stocks for July 17th,2017-07-17 13:15:01 +0000,https://finance.yahoo.com/news/strong-buy-stocks-july-17th-131501646.html?.tsrc=rss,New Strong Buy Stocks for July 17th
EXAS,EXAS:US,BBG000CWL0F5,"The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Alimera Sciences, Enzo Biochem, Sarepta Therapeutics and EXACT Sciences",2017-07-12 15:51:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yA2sXL6d-20/the-zacks-analyst-blog-highlights-vertex-pharmaceuticals-alimera-sciences-enzo-biochem-sarepta-therapeutics-and-exact-sciences-cm815145,For Immediate Release Chicago IL July 12 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog include
EXAS,EXAS:US,BBG000CWL0F5,EXAS Crosses Above Average Analyst Target,2017-07-12 14:46:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rRLV050xTWg/exas-crosses-above-average-analyst-target-cm814958,In recent trading shares of EXACT Sciences Corp Symbol EXAS have crossed above the average analyst 12 month target price of 37 55 changing hands for 37 93 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on valuation
EXAS,EXAS:US,BBG000CWL0F5,"The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Alimera Sciences, Enzo Biochem, Sarepta Therapeutics and EXACT Sciences",2017-07-12 13:30:01 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-vertex-133001974.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Alimera Sciences, Enzo Biochem, Sarepta Therapeutics and EXACT Sciences"
EXAS,EXAS:US,BBG000CWL0F5,"Exact Sciences to host second-quarter 2017 results, annual meeting webcasts and calls",2017-07-10 10:00:00 +0000,https://finance.yahoo.com/news/exact-sciences-host-second-quarter-100000574.html?.tsrc=rss,"MADISON, Wis. , July 10, 2017 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will host webcasts and conference calls to discuss its second-quarter 2017 financial results ..."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences: Lifting Sales Estimates,2017-07-07 14:53:00 +0000,http://finance.yahoo.com/r/14c5140c-f70a-34a5-a7e6-f313d3adf9a2/exact-sciences-lifting-sales-estimates-1499439217?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Exact Sciences (EXAS) is trading higher Friday, thanks to a bullish note from Benchmark.  Analyst Raymond Myers reiterated a Buy rating and $50 price target on the stock, as he’s also raising his estimates ..."
EXAS,EXAS:US,BBG000CWL0F5,Today's Research Reports on Stocks to Watch: BioCryst Pharmaceuticals and Exact Sciences,2017-07-07 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000569.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / July 7, 2017 / U.S. markets continued to be dragged down by a selloff in technology stocks. The Dow Jones Industrial Average declined 0.74 percent to close at 21,320.04, while ..."
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences Corp. Fell 7.5% In June,2017-07-07 02:43:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ikyJkMZNJqM/why-exact-sciences-corp-fell-75-in-june-cm812793,What happened A big run up in Exact Sciences NASDAQ EXAS shares in May led to management tapping investors for more funding in June and that caused shares to slide 7 5 according to S amp P Global Market Intelligence So what Exact Sciences is growing rapidly
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences Corp. Fell 7.5% In June,2017-07-07 01:31:00 +0000,http://finance.yahoo.com/r/99d27705-7d6b-3d59-ae10-e1a4308980b8/why-exact-sciences-corp-fell-75-in-june.aspx?yptr=yahoo&.tsrc=rss,A stock offering in early June diluted investors and led to a dip in its share price.
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences (EXAS) Could Beat Earnings Estimates Again,2017-06-28 14:07:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3XRxwx90SD0/why-exact-sciences-exas-could-beat-earnings-estimates-again-cm809338,Looking for a stock that might be in a good position to beat earnings at its next report Consider Exact Sciences Corporation EXAS a firm in the Medical Biomedical and Genetics industry which could be a great candidate for another beat This company has seen a nice streak of
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences (EXAS) Could Beat Earnings Estimates Again,2017-06-28 12:33:12 +0000,https://finance.yahoo.com/news/why-exact-sciences-exas-could-123312600.html?.tsrc=rss,"Exact Sciences (EXAS) boasts a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat."
EXAS,EXAS:US,BBG000CWL0F5,Jerry Kelly and Exact Sciences Team Up to Promote Colon Cancer Screening,2017-06-22 20:05:00 +0000,https://finance.yahoo.com/news/jerry-kelly-exact-sciences-team-200500207.html?.tsrc=rss,"MADISON, Wis., June 22, 2017 /PRNewswire/ -- Exact Sciences today announced it is teaming up with Madison professional golfer Jerry Kelly to help drive home the importance of colorectal cancer screening.  Beginning at this week's American Family Insurance Championship, Kelly will wear a Cologuard-branded hat for the next two years at tournaments around the country to help raise awareness of colon cancer and the importance of regular screening beginning at age 50 for individuals at average risk.  ""We're joining with Jerry to remind people that turning 50 isn't just a milestone, it's a time to take control of your health,"" said Kevin Conroy, chairman and chief executive officer of Exact Sciences."
EXAS,EXAS:US,BBG000CWL0F5,3 Hot Plays in the Resurgent Biotech Sector,2017-06-22 16:19:00 +0000,http://finance.yahoo.com/r/1c5e6a19-fa65-3701-948a-3cc6aad275a7/3-hot-plays-resurgent-biotech-sector-kite-espr?partner=YahooSA&yptr=yahoo&.tsrc=rss,Biotech stocks and funds have broken out to 52-week highs and should attract steady buying interest in coming weeks.
EXAS,EXAS:US,BBG000CWL0F5,Today's Research Reports on Stocks to Watch: Exact Sciences and Immunogen,2017-06-22 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000072.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / June 22, 2017 / Exact Sciences Corporation saw gains of over 5% yesterday despite any big news. The company has been on a rally in the last month with shares seeing gains of ..."
EXAS,EXAS:US,BBG000CWL0F5,Seeking Alpha Interviews: Bret Jensen,2017-06-12 13:28:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XLry0Q1hdq4/seeking-alpha-interviews-bret-jensen-cm801975,By LilaMax Media ByLilaMax Media In the tenth episode of Seeking Alpha Interviews LilaMax s Jane King sits down with Bret Jensen of The Biotech Forum and The Insiders Forum to discuss the general state of the biotech sector the narrow range it s been trading in for the past five months
EXAS,EXAS:US,BBG000CWL0F5,"Exact Sciences Taps Markets, Bolsters Balance Sheet",2017-06-11 12:27:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w62piqgbjHc/exact-sciences-taps-markets-bolsters-balance-sheet-cm801663,Exact Sciences NASDAQ EXAS 160 announced on Wednesday that it s using the recent increase in its stock price to raise additional money from investors Specifically the company is offering 7 million shares at a price of 35 per share plus an overallotment option for another 1
EXAS,EXAS:US,BBG000CWL0F5,"Exact Sciences Taps Markets, Bolsters Balance Sheet",2017-06-11 11:00:00 +0000,http://finance.yahoo.com/r/5da5da23-dba4-3918-92f6-7c73520a46a1/exact-sciences-taps-markets-bolsters-balance-sheet.aspx?yptr=yahoo&.tsrc=rss,"Following a big run-up in the company&apos;s share price, management is pricing a secondary stock offering to raise more cash."
EXAS,EXAS:US,BBG000CWL0F5,[$$] It's Time to Lighten Up on Exact Sciences,2017-06-10 04:01:00 +0000,http://finance.yahoo.com/r/97286c19-b3b8-304a-abc0-b8b459fc1a77/its-time-to-lighten-up-on-exact-sciences-shares-1497070721?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Follow Up: Regeneron | Review | Preview  After a big run, Exact Sciences looks fully priced amid optimism about its colon-cancer screening test, Cologuard.  The shares (EXAS), now near $33, have more than doubled this year, as sales have beaten expectations and UnitedHealth Group (UNH) became the final major insurer to cover the test’s costs.  CEO Kevin Conway sees a “multibillion-dollar opportunity,” with more than 80 million Americans over age 50—the normal threshold for colon cancer screening."
EXAS,EXAS:US,BBG000CWL0F5,What Caused Exact Sciences Corp. to Rocket 16% Higher in May,2017-06-08 20:28:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nW8m-l-A9bo/what-caused-exact-sciences-corp-to-rocket-16-higher-in-may-cm800824,What happened Despite high profile criticism of its market valuation from short sellers last month Exact Sciences NASDAQ EXAS share price catapulted 16 higher in May according to S amp P Global Market Intelligence So what Exact Sciences has long been a target
EXAS,EXAS:US,BBG000CWL0F5,What Caused Exact Sciences Corp. to Rocket 16% Higher in May,2017-06-08 19:20:00 +0000,http://finance.yahoo.com/r/a336135c-fb02-3353-a50f-b89b5febebb6/what-caused-exact-sciences-corp-to-rocket-16-highe.aspx?yptr=yahoo&.tsrc=rss,Investors looked past bearish reports from short sellers last month and focused instead on the potential upside of more insurers agreeing to cover the Cologuard test.
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences: Good Timing?,2017-06-08 16:38:00 +0000,http://finance.yahoo.com/r/b0a66571-8f5e-3ae7-9876-8bf83e9b8aef/exact-sciences-good-timing-1496939881?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Yesterday, Exact Sciences (EXAS) fell 5.2% after the company sold seven million shares of stock at $35 a share.  Canaccord Genuity, however, thinks the big money raise makes a lot of sense.  Canaccord Genuity analyst Mark Massaro, however, says he is positive on ""both [the] size and timing] of the offering."
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences' Shares Lose Their Luster,2017-06-08 10:00:00 +0000,http://finance.yahoo.com/r/2d9fcde1-a21a-35e4-b833-759d42348d21/why-exact-sciences-shares-lose-their-luster-exas?partner=YahooSA&yptr=yahoo&.tsrc=rss,The market is underwhelmed by Exact Sciences Corporation's latest secondary offering.
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Corporation: The Bear Case From a Bull,2017-06-07 21:28:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/He5pDrpAESI/exact-sciences-corporation-the-bear-case-from-a-bull-cm800277,I ve been quite bullish on Exact Sciences NASDAQ EXAS stock for a while now In January I pointed out some reasons the molecular diagnostics stock should go much higher Since I wrote that article Exact Sciences share price indeed has gone much higher almost
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Corporation: The Bear Case From a Bull,2017-06-07 19:43:00 +0000,http://finance.yahoo.com/r/fcb545ee-b12b-3e73-8b80-efd0e76cc785/exact-sciences-corporation-the-bear-case-from-a-bu.aspx?yptr=yahoo&.tsrc=rss,A pessimistic look at red-hot Exact Sciences stock from an unabashed optimist.
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Drops 6%; Here's Why,2017-06-07 16:19:00 +0000,http://finance.yahoo.com/r/0a85bef1-7d5c-365d-b3e0-14f206ce14a4/exact-sciences-drops-6-heres-why-1496852346?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Wall Street is not happy about the latest public offering from Exact Sciences (EXAS).  The stock price dropped 6% today to $34.38 after the medical products company set a price of $35 a share for a previously announced underwritten public offering, in which it is selling 7 million shares of common stock to Jefferies, Bank of America-Merrill Lynch (BAC) and Robert W. Baird & Co. That offering price is below Tuesday’s closing price of $36.59 a share.  The company’s test for colorectal cancer has gained traction, and the stock price has responded by climbing more than 400% over the past 12 months."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Stock Falls on Secondary Stock Sale,2017-06-07 15:35:00 +0000,http://finance.yahoo.com/r/1ec6600b-dd7a-34db-9154-c1b9ffc1f359/exact-sciences-stock-falls-on-secondary-stock-sale.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The secondary offering, to be underwritten by Jefferies, Bank of America/Merrill Lynch and Robert W. Baird, would offer 7 million shares."
EXAS,EXAS:US,BBG000CWL0F5,"Morning Movers: Exact Sciences Slumps, Navistar Tumbles, U.S. Steel Gains",2017-06-07 12:35:00 +0000,http://finance.yahoo.com/r/e76f7f78-3b67-32f6-b1d9-5022170a6f2f/morning-movers-exact-sciences-slumps-navistar-tumbles-u-s-steel-gains-1496838902?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks are ticking up this morning ahead of a Thursday that includes a UK election, an ECB rates decision, and former FBI Director James Comey's testimony to the U.S. Senate. S&P 500 futures have ticked ..."
EXAS,EXAS:US,BBG000CWL0F5,Today's Research Reports on Stocks to Watch: EXACT Sciences and GNC Holdings,2017-06-07 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000974.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / June 7, 2017 / U.S. markets fell for the second consecutive day on geopolitical concerns. Inventors appear to be cautious ahead of upcoming events such as the U.K. general election, ..."
EXAS,EXAS:US,BBG000CWL0F5,InPlay from Briefing.com,2017-06-07 11:54:41 +0000,https://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss,InPlay from Briefing.com
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Announces Pricing of Public Offering of Common Stock,2017-06-07 11:46:00 +0000,https://finance.yahoo.com/news/exact-sciences-announces-pricing-public-114600277.html?.tsrc=rss,"MADISON, Wis., June 7, 2017 /PRNewswire/ -- Exact Sciences Corporation (EXAS) today announced the pricing of its previously announced underwritten public offering of common stock.  The Company is selling 7,000,000 shares of common stock through the underwriters at a public offering price of $35.00 per share.  The Company has also granted the underwriters an option to purchase up to 1,050,000 additional shares. The offering is being underwritten by Jefferies LLC, BofA Merrill Lynch and Robert W. Baird & Co. Incorporated, as joint book-running managers of the offering, William Blair & Company, L.L.C. and Cowen and Company, LLC, as lead-managers of the offering, and BTIG, LLC and Craig-Hallum Capital Group LLC, as co-managers of the offering, and is expected to close on or about June 12, 2017, subject to customary closing conditions."
EXAS,EXAS:US,BBG000CWL0F5,"FDA Panel To Review PTCT's Translarna, CTIC Plunges On Offering, NNVC Abuzz",2017-06-07 02:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Hlrrl-5thOA/fda-panel-to-review-ptcts-translarna-ctic-plunges-on-offering-nnvc-abuzz-20170607-00044,"FDA Panel To Review PTCT's Translarna, CTIC Plunges On Offering, NNVC Abuzz"
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences stock falls after share offering,2017-06-06 20:11:51 +0000,http://finance.yahoo.com/r/04d115ba-4641-34ab-8da1-fd0dbfd40100/Story.aspx?guid=A91166F0-8CD1-456B-BB48-FFBF4762BC3E&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Shares of Exact Sciences Corp. fell more than 3% Tuesday after the company said it entered an agreement with Jefferies LLC, Bank of America Merrill Lynch, and Robert W. Baird & Co. to sell 7 million shares ..."
EXAS,EXAS:US,BBG000CWL0F5,"Exact Sciences Announces Agreement to Sell 7,000,000 Common Shares",2017-06-06 20:02:00 +0000,https://finance.yahoo.com/news/exact-sciences-announces-agreement-sell-200200116.html?.tsrc=rss,"MADISON, Wis., June 6, 2017 /PRNewswire/ -- Exact Sciences Corporation (EXAS) today announced an agreement to sell 7,000,000 shares of its common stock to Jefferies LLC, BofA Merrill Lynch and Robert W. Baird & Co. Incorporated as underwriters in an underwritten public offering pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission (the ""SEC"") on Form S-3.  The Company has also granted the underwriters an option to purchase up to 1,050,000 additional shares.  The Company intends to use the net proceeds of this offering to fund expansion of our Cologuard commercialization activities including to increase our laboratory, manufacturing and customer service capacity, to fund our product development efforts, and for general corporate and working capital purposes."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences: Cramer's Top Takeaways,2017-06-03 10:42:00 +0000,http://finance.yahoo.com/r/60590b17-dfd5-3eb6-979c-260514f89ffe/exact-sciences-cramer-s-top-takeaways.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Kevin Conroy, chairman, president and CEO at Exact Sciences, tells Jim Cramer about his company's non-invasive test for colon cancer."
EXAS,EXAS:US,BBG000CWL0F5,"Cramer Remix: Yes, fidget spinners can help you understan...",2017-06-02 23:37:00 +0000,https://finance.yahoo.com/video/cramer-remix-yes-fidget-spinners-233700342.html?.tsrc=rss,Jim Cramer's not playing games when he relates main street’s hottest toy to the biggest stocks on Wall Street.
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Receives Vetr Downgrade After Insurer Covers Cancer Screening,2017-06-02 13:10:29 +0000,https://finance.yahoo.com/news/exact-sciences-receives-vetr-downgrade-131029040.html?.tsrc=rss,"The Vetr crowd downgraded its rating for EXACT Sciences Corporation (NASDAQ: EXAS ) Thursday from the stock's previous rating of 4.5 stars (Strong Buy), issued two days ago, to three stars (Hold). Crowd ..."
EXAS,EXAS:US,BBG000CWL0F5,"Noteworthy Thursday Option Activity: ACIA, EXAS, GM",2017-06-01 21:32:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Iw8NwP4vVFE/noteworthy-thursday-option-activity-acia-exas-gm-cm797688,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Acacia Communications Inc Symbol ACIA where a total volume of 7 021 contracts has been traded thus far today a contract volume which is representative of
EXAS,EXAS:US,BBG000CWL0F5,[$$] Exact Sciences CEO Shares Market Projections,2017-06-01 18:05:00 +0000,http://finance.yahoo.com/r/d730fe14-23ca-3573-ae9f-cd0bbb38582b/exact-sciences-ceo-shares-market-projections-1496340307?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Exact Sciences CEO Kevin Conroy sees a large addressable market for his company’s colon cancer screening test, as the company’s shares hit a new record today, gaining another 4%, to 37.81, following yesterday’s 12% advance.  “This is a multi-billion dollar opportunity,” Conroy told Barron’s. There are more than 80 million Americans over age 50 – the threshold for colon cancer screening.  With the company’s Cologuard test recommended for usage every three years, there could be $4 billion to $6 billion in annual revenue if Cologuard gets 30% to 40% market penetration of the patient population, Conroy said."
EXAS,EXAS:US,BBG000CWL0F5,"Noteworthy ETF Outflows: XBI, VRTX, EXAS, REGN",2017-06-01 16:34:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o_aTvkd__7I/noteworthy-etf-outflows-xbi-vrtx-exas-regn-cm797497,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 108 4 million dollar outflow that s a 3 5 decrease week over week from 45 150 000
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences (EXAS) Shows Strength: Stock Gains 11.7%,2017-06-01 13:34:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wgBBQvWuRZI/exact-sciences-exas-shows-strength-stock-gains-117-cm797362,Exact Sciences Corp EXAS was a big mover last session as the company saw its shares jump almost 12 on the day The upside was driven by the news from UnitedHealth that it would fund the Exact Sciences Cologuard test expenses for colon cancer Also this led to far more shares changing
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences (EXAS) Shows Strength: Stock Gains 11.7%,2017-06-01 12:20:12 +0000,https://finance.yahoo.com/news/exact-sciences-exas-shows-strength-122012448.html?.tsrc=rss,Exact Sciences Corp. (EXAS) shares jumped almost 12% in the last trading session.
EXAS,EXAS:US,BBG000CWL0F5,Today's Research Reports on Stocks to Watch: NeuroDerm and Exact Sciences,2017-06-01 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000886.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / June 1, 2017 / NeuroDerm was one of the biggest winners on the NASDAQ despite any significant news, aside from traders perhaps anticipating next week's 21 st International Congress ..."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences to participate in June investor conferences,2017-06-01 10:00:00 +0000,https://finance.yahoo.com/news/exact-sciences-participate-june-investor-100000811.html?.tsrc=rss,"MADISON, Wis., June 1, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that the company will participate in three investor conferences during June.  Kevin Conroy, Exact Sciences' chairman and CEO, will make the company's presentation at the Jefferies 2017 Global Healthcare Conference at 1:30 p.m. ET on Wednesday, June 7 in New York.  Mr. Conroy will make the company's presentation at the William Blair 37th Annual Growth Stock Conference at 12:40 p.m. CT on Wednesday, June 14 in Chicago."
EXAS,EXAS:US,BBG000CWL0F5,"Why Hertz Global Holdings, Exact Sciences, and J. Jill Jumped Today",2017-05-31 23:33:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zdiI32HMBSg/why-hertz-global-holdings-exact-sciences-and-j-jill-jumped-today-cm797161,Wednesday was another quiet day on Wall Street and major benchmarks finished with small losses at the end of the trading session With relatively little in the way of significant news market participants paid closer attention to the Federal Reserve s Beige Book reports from
EXAS,EXAS:US,BBG000CWL0F5,Mid-Afternoon Market Update: Vera Bradley Surges On Narrower-Than-Expected Loss; EnerSys Shares Slide,2017-05-31 20:45:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/05ILDXH0Mws/mid-afternoon-market-update-vera-bradley-surges-on-narrower-than-expected-loss-enersys-shares-slide-cm797115,Toward the end of trading Wednesday the Dow traded down 0 21 percent to 20 985 26 while the NASDAQ declined 0 25 percent to 6 187 97 The S amp P also fell dropping 0 21 percent to 2 407 81 Leading and Lagging Sectors Healthcare sector was the top gainer in the US market
EXAS,EXAS:US,BBG000CWL0F5,"Why Hertz Global Holdings, Exact Sciences, and J. Jill Jumped Today",2017-05-31 20:38:00 +0000,http://finance.yahoo.com/r/80e24156-d074-39b9-9714-9505f1cb78ec/why-hertz-global-holdings-exact-sciences-and-j-jil.aspx?yptr=yahoo&.tsrc=rss,These stocks rose despite a slight decline for the broader market. Find out why.
EXAS,EXAS:US,BBG000CWL0F5,Breaking Down Exact Sciences: What the Market Says,2017-05-31 19:24:00 +0000,http://finance.yahoo.com/r/2a8f9738-c616-3c26-8aa8-49d06ed81f75/breaking-down-exact-sciences-what-market-says-exas?partner=YahooSA&yptr=yahoo&.tsrc=rss,Exact Sciences stock soared after United Healthcare said it will cover its colon cancer screening test.
EXAS,EXAS:US,BBG000CWL0F5,Here's Why Exact Sciences Corp. Jumped Today,2017-05-31 17:34:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KwRFuARoJCw/heres-why-exact-sciences-corp-jumped-today-cm796956,What happened After news broke that a major health insurance company will start covering Cologuard shares of Exact Sciences NASDAQ EXAS a company focused on non invasive cancer testing surged 10 higher as of 11 15 a m EDT on Wednesday So what UnitedHealth
EXAS,EXAS:US,BBG000CWL0F5,Biotech And Pharma Industry And Stock News,2017-05-31 16:51:44 +0000,http://finance.yahoo.com/r/d95a9140-bcb4-38ab-b942-e0c45662051a/biotech-and-pharma-industry-and-stock-news-merk-bristol-myers-amgn-gilead?src=A00220&yptr=yahoo&.tsrc=rss,Track the latest trends and leading stocks in the biotech and pharmaceutical industries.
EXAS,EXAS:US,BBG000CWL0F5,"Top Gainers in the Healthcare Sector: May 22–26, 2017",2017-05-31 16:01:33 +0000,http://finance.yahoo.com/r/c545af3c-e484-35a8-81a4-38a8c1e58953/top-gainers-in-the-healthcare-sector-may-22-26-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"From May 19–May 26, 2017, pharmaceutical company Puma Biotechnology (PBYI) witnessed a rise of 111% in its stock price."
EXAS,EXAS:US,BBG000CWL0F5,Here&apos;s Why Exact Sciences Corp. Jumped Today,2017-05-31 15:48:00 +0000,http://finance.yahoo.com/r/25956154-2079-3359-ba27-d9ddcaed9d4e/heres-why-exact-sciences-corp-jumped-today.aspx?yptr=yahoo&.tsrc=rss,Investors cheered the news that yet another major insurer has decided to cover the Cologuard test.
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences: Heading for a Triple?,2017-05-31 13:58:00 +0000,http://finance.yahoo.com/r/1774d561-9c1f-3c98-b7a4-e49bbe63999b/exact-sciences-heading-for-a-triple-1496239132?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Exact Sciences (EXAS) have more than doubled so far this year.  With news like the announcement that UnitedHealth Group (UNH) has decided to pay for its Cologuard test, why not?  Canaccord Genuity's Mark Massaro explains why the news is a big deal: UnitedHealthcare updated its commercial coverage determination guidelines and included EXAS's Cologuard test on a test interval of once every three years, to go in effect on July 1, 2017."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences stock surges 9.5% after UnitedHealth says it will cover test,2017-05-31 13:08:14 +0000,http://finance.yahoo.com/r/ab923b7d-9bd2-346d-8c5a-a495106d1ca9/Story.aspx?guid=E01E12E2-25A4-40BF-A97D-D63B64FEE8E7&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Exact Sciences Corp. stock surged 9.5% in premarket trade after UnitedHealth Group Inc. said it plans to cover the company's colon cancer test starting on July 1. Exact Sciences Corp. was targeted by short-seller ...
EXAS,EXAS:US,BBG000CWL0F5,"Morning Movers: Kors Crumbles on Guidance, Exact Sciences Climbs",2017-05-31 12:52:00 +0000,http://finance.yahoo.com/r/038801c0-4a61-32c0-b89e-797826bd4af3/morning-movers-kors-crumbles-on-emorning-movers-kors-crumbles-on-guidance-exact-sciences-climbsarnings-exact-sciences-climbs-1496235151?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"The S&P 500 looks set for a higher open today after its seven-day winning streak ended yesterday. S&P 500 futures have risen 0.2%, while Dow Jones Industrial Average futures have advanced 0.2%. Nasdaq ..."
EXAS,EXAS:US,BBG000CWL0F5,EXACT Sciences Corp. (EXAS) Is Challenging The Highs Of The Year,2017-05-31 09:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ktvrYalas8E/exact-sciences-corp-exas-is-challenging-the-highs-of-the-year-20170531-00773,EXACT Sciences Corp. (EXAS) Is Challenging The Highs Of The Year
EXAS,EXAS:US,BBG000CWL0F5,These Stocks Have Doubled in 2017,2017-05-23 15:14:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zGB1QM1fUXs/these-stocks-have-doubled-in-2017-cm793194,The stock market has done reasonably well so far in 2017 with the S amp P 500 SNPINDEX GSPC enjoying total returns of about 7 and remaining close to all time record levels But some stocks have done a lot better than the overall market and shareholders in those companies
EXAS,EXAS:US,BBG000CWL0F5,These Stocks Have Doubled in 2017,2017-05-23 13:55:00 +0000,http://finance.yahoo.com/r/0e525166-0891-37d7-96e2-995ef707f2cf/these-stocks-have-doubled-in-2017.aspx?yptr=yahoo&.tsrc=rss,Find out why these stocks have done so well.
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Grants Inducement Restricted Stock Unit Awards to Recently Hired Employees,2017-05-19 20:05:00 +0000,https://finance.yahoo.com/news/exact-sciences-grants-inducement-restricted-200500563.html?.tsrc=rss,"MADISON, Wis., May 19, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that, in support of the Company's continued growth plans, it granted restricted stock units covering a total of 86,098 shares of common stock to 89 recently hired non-executive employees under its previously announced inducement grant program.  The restricted stock unit awards vest in four equal annual installments beginning on the first anniversary of the grant date.  The awards were granted as an inducement material to the recently hired employees entering into employment with the Company in accordance with NASDAQ Marketplace Rule 5635(c)(4).  The Company is making this announcement as required by NASDAQ rules."
EXAS,EXAS:US,BBG000CWL0F5,"ETFs with exposure to EXACT Sciences Corp. : May 19, 2017",2017-05-19 17:52:20 +0000,http://finance.yahoo.com/r/16a0633c-7612-3af6-8340-209a0067cd81/etfs-with-exposure-to-exact-sciences-corp-may-19-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to EXACT Sciences Corp. Here are 5 ETFs with the largest exposure to EXAS-US. Comparing the performance and risk of EXACT Sciences Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
EXAS,EXAS:US,BBG000CWL0F5,"XBI, VRTX, REGN, EXAS: Large Inflows Detected at ETF",2017-05-19 16:12:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wk70ZAil9Fs/xbi-vrtx-regn-exas-large-inflows-detected-at-etf-cm791931,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 126 1 million dollar inflow that s a 4 2 increase week over week in outstanding
EXAS,EXAS:US,BBG000CWL0F5,Meridian Funds Comments on Exact Sciences Corp,2017-05-19 13:11:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Xrco-EDhBvI/meridian-funds-comments-on-exact-sciences-corp-cm791760,Exact Sciences Corp NASDAQ EXAS develops noninvasive molecular screening tests for the early detection and prevention of colorectal cancer We originally invested in the company because Cologuard its revolutionary product exhibited low market penetration and significant opportunity
EXAS,EXAS:US,BBG000CWL0F5,Is Exact Sciences on Borrowed Time?,2017-05-16 23:15:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M6iNtO8C_NY/is-exact-sciences-on-borrowed-time-cm790271,Short sellers think Exact Sciences NASDAQ EXAS colon cancer screening test Cologuard will get further away from turning a profit when rules kick in next year that require Medicare to pay less for the test They also argue that Cologuard s advantages over competing
EXAS,EXAS:US,BBG000CWL0F5,Is Exact Sciences on Borrowed Time?,2017-05-16 21:40:00 +0000,http://finance.yahoo.com/r/0076e59e-70ae-3229-9a02-5602b6d7d493/is-exact-sciences-on-borrowed-time.aspx?yptr=yahoo&.tsrc=rss,Short-sellers are taking aim at this colon cancer screening company.
EXAS,EXAS:US,BBG000CWL0F5,Analyst Leaves Exact Sciences CEO Meeting With 'Fortified Confidence' Despite Recent Controversy,2017-05-16 19:23:33 +0000,https://finance.yahoo.com/news/analyst-leaves-exact-sciences-ceo-192333034.html?.tsrc=rss,"Following a series of investor meetings with EXACT Sciences Corporation's (NASDAQ: EXAS ) CEO and chief financial officer, Cowen said it has come back with fortified confidence in the outlook for upside ..."
EXAS,EXAS:US,BBG000CWL0F5,Why One Analyst Says Citron Got Exact Sciences Wrong,2017-05-16 15:19:00 +0000,http://finance.yahoo.com/r/47d1f893-e763-3b88-9e90-ffb52a3b619a/why-one-analyst-says-citron-got-exact-sciences-wrong-1494947967?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Another bull has weighed in on Exact Sciences (EXAS) following the recent bearish call by Citron Research . It wasn’t enough to lift the company's stock price. At a recent $32.06, the shares are down 1.1% ..."
EXAS,EXAS:US,BBG000CWL0F5,The Market In 5 Minutes,2017-05-16 13:02:32 +0000,https://finance.yahoo.com/news/market-5-minutes-130232039.html?.tsrc=rss,IN THE NEWS BENZINGA EXACT Sciences Corporation (NASDAQ: EXAS ) shares initially plunged more than 7 percent Monday after Citron Research released a new bearish report on the company. According to Citron’s ...
EXAS,EXAS:US,BBG000CWL0F5,Today's Research Reports on Stocks to Watch: Ionis Pharmaceuticals and Exact Sciences Corporation,2017-05-16 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000227.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 16, 2017 / Exact Sciences saw a drop on Monday after a Citron Research note had said the company's colon cancer test was a ""disastrous business model."" It took ..."
EXAS,EXAS:US,BBG000CWL0F5,Top Market News: What Happened In Investing Today,2017-05-15 23:16:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MZ5JTISMXD0/top-market-news-what-happened-in-investing-today-cm789557,By SA Editor Mike Taylor CFA BySA Editor Mike Taylor CFA AIG Under New Management AIG Under New ManagementAIG Under New Management Wikipedia Wikipedia Running AIG AIG has never struck me as easy It seemed especially hard in 2008 2009 when it was one of the
EXAS,EXAS:US,BBG000CWL0F5,IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Exact Sciences Corporation and Advises Investors with Losses to Contact the Firm,2017-05-15 22:03:00 +0000,https://finance.yahoo.com/news/important-shareholder-alert-lundin-law-220300861.html?.tsrc=rss,"Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Exact Sciences Corporation concerning possible violations of federal securities laws."
EXAS,EXAS:US,BBG000CWL0F5,Analyst refutes ‘flawed’ Citron Research report on Exact Sciences,2017-05-15 20:55:53 +0000,http://finance.yahoo.com/r/f80d255b-a8e3-342a-9ec6-1cf0d56e1dd6/Story.aspx?guid=44A5EF40-39A5-11E7-AF96-BC838FB78E6B&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"The bulk of Citron’s criticism centers around a colon cancer test, though the firm refrained from making poop jokes."
EXAS,EXAS:US,BBG000CWL0F5,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Exact Sciences Corporation (EXAS)",2017-05-15 20:49:00 +0000,https://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-204900909.html?.tsrc=rss,"NEW YORK, May 15, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Exact Sciences Corporation (""Exact"" or the ""Company"") (EXAS).  Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/exas.  The investigation concerns whether Exact and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934."
EXAS,EXAS:US,BBG000CWL0F5,The short seller who uncovered Valeant has found his next target in health care,2017-05-15 20:05:39 +0000,http://finance.yahoo.com/r/c565a40c-c666-3a9d-bf28-da176c852951/104470576?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104470576&yptr=yahoo&.tsrc=rss,"Citron Research's Andrew Left, who gained notoriety for successful bets against companies such as Valeant, posted a bearish report on Exact Sciences."
EXAS,EXAS:US,BBG000CWL0F5,The short seller who uncovered Valeant has found his next target in health care,2017-05-15 20:05:39 +0000,https://finance.yahoo.com/news/short-seller-uncovered-valeant-found-200539600.html?.tsrc=rss,"Citron Research&apos;s Andrew Left, who gained notoriety for successful bets against companies such as Valeant, posted a bearish report on Exact Sciences."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences: Nothing to See Here?,2017-05-15 19:09:00 +0000,http://finance.yahoo.com/r/1958f4b3-da59-3961-a39f-b3a925dd0ddc/exact-sciences-nothing-to-see-here-1494875360?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Exact Sciences (EXAS) are tumbling today after Citron Research released a report that claimed the company could drop to $20 in the short-term, and eventually hit $0.  From Citron's report: Anyone who follows the landscape of diagnostic cancer testing knows that everything is moving towards blood based DNA testing.  While they have an early-stage pipeline of other tests, Exact Sciences in not nearly as funded or dedicated as the many private and public companies that are advancing cancer testing."
EXAS,EXAS:US,BBG000CWL0F5,INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Exact Sciences Corporation,2017-05-15 19:08:00 +0000,https://finance.yahoo.com/news/investor-alert-goldberg-law-pc-190800787.html?.tsrc=rss,"Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Exact Sciences Corporation ."
EXAS,EXAS:US,BBG000CWL0F5,UPDATE: Exact Sciences Corp. stock drops 3% after short-seller Citron Research targets its colon cancer test,2017-05-15 18:04:08 +0000,http://finance.yahoo.com/r/cfe4b9bc-fa58-341f-9aab-5e77d9870998/Story.aspx?guid=03D2B4F9-6C70-4365-A96E-55BAA90D9E84&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Exact Sciences Corp. shares dropped 3.2% to $32.71 on Monday morning after short-seller Citron Research released a report about the company that called its colon cancer test ""a seriously inferior ..."
EXAS,EXAS:US,BBG000CWL0F5,EXACT (EXAS) ALERT: J&W Investigates Exact Sciences; Encourages Investors to Contact the Firm,2017-05-15 16:59:00 +0000,https://finance.yahoo.com/news/exact-exas-alert-j-w-165900812.html?.tsrc=rss,"SAN DIEGO, May 15, 2017 /PRNewswire/ -- Shareholder rights law firm Johnson & Weaver, LLP has commenced an investigation into whether certain officers and directors of Exact Sciences (EXAS) violated federal laws.  On May 15, 2017, Citron Research issued a report on Exact Sciences.  In this article, Citron stated that ""Exact Sciences pushes a cancer test (Cologuard) to the public, inferior by its own admission, and loses money doing it."" Cologuard is a branded laboratory based scan for DNA traces in stool samples indicating colorectal cancer."
EXAS,EXAS:US,BBG000CWL0F5,"Exact Sciences CEO and short-seller go mano-a-mano on CNBC, stock pares losses",2017-05-15 16:51:58 +0000,https://finance.yahoo.com/news/exact-sciences-ceo-short-seller-165158167.html?.tsrc=rss,"Shares of Exact Sciences Corp. bounced off earlier lows Monday, after Chief Executive Kevin Conroy went mano-a-mano with famed short-seller Andrew Left on CNBC, with Conroy saying Left's bearish comments ..."
EXAS,EXAS:US,BBG000CWL0F5,"Exact Sciences CEO and short-seller go mano-a-mano on CNBC, stock pares losses",2017-05-15 16:51:58 +0000,http://finance.yahoo.com/r/1a116958-495a-3d54-b2a4-9424063781ac/Story.aspx?guid=E4392BF2-477A-4C83-9700-0897ECEFB99A&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Shares of Exact Sciences Corp. bounced off earlier lows Monday, after Chief Executive Kevin Conroy went mano-a-mano with famed short-seller Andrew Left on CNBC, with Conroy saying Left's bearish comments ..."
EXAS,EXAS:US,BBG000CWL0F5,Famed short-seller Andrew Left battles the CEO of his lat...,2017-05-15 16:20:00 +0000,https://finance.yahoo.com/video/watch-short-seller-andrew-left-162000142.html?.tsrc=rss,"Andrew Left, short seller, and Kevin Conroy, Exact Sciences CEO debate a study about Exact Sciences colonoscopy tests."
EXAS,EXAS:US,BBG000CWL0F5,Short-seller's bear debate on Exact Sciences,2017-05-15 16:17:00 +0000,https://finance.yahoo.com/video/short-sellers-bear-debate-exact-161700091.html?.tsrc=rss,"Andrew Left, activist short seller, discusses the bear debate on Exact Sciences with Kevin Conroy, Exact Sciences CEO."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences: Signs Say…Sticky?,2017-05-15 15:16:00 +0000,http://finance.yahoo.com/r/9830a206-3826-3089-9ccc-9c1adf7f05ba/exact-sciences-signs-saysticky-1494861399?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"What do you do when a stock has quintupled over the last 12 months? That's the question with Exact Sciences (EXAS), which has surged as its test for colorectal cancer has started to gain traction among ..."
EXAS,EXAS:US,BBG000CWL0F5,3 Best Stocks in Personalized Medicine,2017-05-14 17:14:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mHgvdgPaZxQ/3-best-stocks-in-personalized-medicine-cm789008,Personalized medicine also known as precision medicine or genomic medicine is one of the most revolutionary trends shaping the future of healthcare What is personalized medicine The simple definition is that it s the customization of care to an individual s genetic profile
EXAS,EXAS:US,BBG000CWL0F5,3 Best Stocks in Personalized Medicine,2017-05-14 16:03:00 +0000,http://finance.yahoo.com/r/b14f4c8d-660b-33c1-9ff1-30023cfdc327/3-best-stocks-in-personalized-medicine.aspx?yptr=yahoo&.tsrc=rss,"Why Exact Sciences, Illumina, and Vertex Pharmaceuticals are the best stocks in personalized medicine right now."
EXAS,EXAS:US,BBG000CWL0F5,Short Covering Could Fuel More Gains For EXACT Sciences Stock,2017-05-12 20:51:00 +0000,http://finance.yahoo.com/r/37f840c8-1b5d-311c-bb1e-1a72a98dcd6c/short-covering-could-fuel-more-gains-for-exact-sciences-stock?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"EXACT Sciences has made a huge move on the charts over the past year, which could pressure short sellers to cover"
EXAS,EXAS:US,BBG000CWL0F5,"Notable ETF Outflow Detected - XBI, EXAS, VRTX, IONS",2017-05-11 16:01:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XPq-RtKfBIs/notable-etf-outflow-detected-xbi-exas-vrtx-ions-cm787841,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 149 2 million dollar outflow that s a 4 8 decrease week over week from 44 900 000
EXAS,EXAS:US,BBG000CWL0F5,3 Top Stocks With Lots of Room Left to Grow,2017-05-11 14:05:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YUFRVFO4UlY/3-top-stocks-with-lots-of-room-left-to-grow-cm787723,Exact Sciences NASDAQ EXAS LendingTree NASDAQ TREE and Shopify NYSE SHOP operate in different markets but all three have only begun to tap into growth opportunities that could drive these companies share prices to new highs A new approach to finding
EXAS,EXAS:US,BBG000CWL0F5,3 Top Stocks With Lots of Room Left to Grow,2017-05-11 12:03:00 +0000,http://finance.yahoo.com/r/8966208c-d512-34e3-b5ae-09541ef27c5a/3-stocks-with-a-lot-of-room-to-grow.aspx?yptr=yahoo&.tsrc=rss,"Exact Sciences, LendingTree, and Shopify are disrupting their respective markets, and they&apos;re only starting to reap the benefits."
EXAS,EXAS:US,BBG000CWL0F5,"ETFs with exposure to EXACT Sciences Corp. : May 8, 2017",2017-05-08 20:30:20 +0000,http://finance.yahoo.com/r/9391def3-7da1-31b3-a1f3-21bd3b9017d6/etfs-with-exposure-to-exact-sciences-corp-may-8-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to EXACT Sciences Corp. Here are 5 ETFs with the largest exposure to EXAS-US. Comparing the performance and risk of EXACT Sciences Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Is Rocketing Higher By as Much as 12% -- Here's Why,2017-05-05 21:27:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/plKNYKQrDFY/exact-sciences-is-rocketing-higher-by-as-much-as-12-heres-why-cm785277,What happened Shares of Exact Sciences NASDAQ EXAS a molecular diagnostics company with a lead product that helps physicians diagnose colorectal cancer and advanced adenomas surged as much as 12 on Friday after receiving a welcome price target upgrade from a Wall Street
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Is Rocketing Higher By as Much as 12% -- Here&apos;s Why,2017-05-05 19:52:00 +0000,http://finance.yahoo.com/r/e0e3c139-50e7-3d12-a5ef-5f0af597a87d/exact-sciences-is-rocketing-higher-by-as-much-as-1.aspx?yptr=yahoo&.tsrc=rss,"A timely price target hike lifts Exact Sciences, but do its recent earnings results support this optimism?"
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences is Soaring,2017-05-05 17:05:00 +0000,http://finance.yahoo.com/r/e70de077-897a-3428-9fed-207e66affab0/why-exact-sciences-is-soaring-1494003941?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Exact Sciences (EXAS) have soared to a new all-time high today after analysts at Cowen surveyed doctors and concluded that the company can post revenue of close to $700 million in 2019.  Exact Sciences makes Cologuard, which uses feces to test for colon cancer.  The big fear is that the test won't be used by doctors, something that appears unfounded given Cowen's survey results."
EXAS,EXAS:US,BBG000CWL0F5,One Tiny Number Hints At How Big Exact Sciences' Opportunity Is,2017-05-05 13:24:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3R5SKa00_Wg/one-tiny-number-hints-at-how-big-exact-sciences-opportunity-is-cm784760,Investors tend to concentrate on revenue and earnings growth when evaluating stocks for portfolios and Exact Sciences NASDAQ EXAS is unquestionably making progress on both those fronts but long term investors might want to base their decision to buy on the company s tiny 2
EXAS,EXAS:US,BBG000CWL0F5,One Tiny Number Hints At How Big Exact Sciences&apos; Opportunity Is,2017-05-05 11:21:00 +0000,http://finance.yahoo.com/r/135cf063-a567-32bf-93c0-a2a33d276860/one-tiny-number-hints-at-how-big-exact-sciences-op.aspx?yptr=yahoo&.tsrc=rss,Investors might want to focus on how small the company&apos;s market share is.
EXAS,EXAS:US,BBG000CWL0F5,Cramer's lightning round: Slow and steady wins the race in pharma,2017-05-03 22:52:39 +0000,http://finance.yahoo.com/r/22a9ddf1-3802-3be6-8c4f-2e19fb4cd191/104445486?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104445486&yptr=yahoo&.tsrc=rss,"Jim Cramer rattled off his take on caller favorite stocks, including this drugmaker."
EXAS,EXAS:US,BBG000CWL0F5,Cramer&apos;s lightning round: Slow and steady wins the race in pharma,2017-05-03 22:52:39 +0000,http://finance.yahoo.com/news/cramer-apos-lightning-round-slow-225239704.html?.tsrc=rss,"Jim Cramer rattled off his take on caller favorite stocks, including this drugmaker."
EXAS,EXAS:US,BBG000CWL0F5,What's Behind Exact Sciences Corp. Soaring 27.1% in April?,2017-05-02 21:29:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GSw--7PXi4M/whats-behind-exact-sciences-corp-soaring-271-in-april-cm783044,What happened Exact Sciences NASDAQ EXAS shares skyrocketed 27 1 in April following impressive first quarter financial results according to S amp P Global Market Intelligence So what Since its launch Exact Sciences Cologuard has helped 450 000 patients
EXAS,EXAS:US,BBG000CWL0F5,What&apos;s Behind Exact Sciences Corp. Soaring 27.1% in April?,2017-05-02 19:43:00 +0000,http://finance.yahoo.com/r/7191072e-fb65-30a0-97c4-0f55364eaa89/whats-behind-exact-sciences-corp-soaring-271-in-ap.aspx?yptr=yahoo&.tsrc=rss,"Demand for the company&apos;s Cologuard test continues to accelerate, and that puts this company firmly on a pathway to profitability."
EXAS,EXAS:US,BBG000CWL0F5,"Thompson Investment Management, Inc. Buys Lamb Weston Holdings, Alliance Data Systems, JM ...",2017-05-02 14:25:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jDDj9BgGX7w/thompson-investment-management-inc-buys-lamb-weston-holdings-alliance-data-systems-jm-cm782617,Thompson Investment Management Inc New Purchases LW EFII ADI OKS ATR HON TTWO Added Positions ADS SJM CVS EBAY TGT QCOM BBBY XOM JCI KSS Reduced Positions ROK RMD BAC EXAS ABB VZ JPM MO MSFT RBC Sold Out ALSN LLTC ADNT
EXAS,EXAS:US,BBG000CWL0F5,Edited Transcript of EXAS earnings conference call or presentation 27-Apr-17 2:00pm GMT,2017-05-01 12:25:55 +0000,http://finance.yahoo.com/news/edited-transcript-exas-earnings-conference-014530931.html?.tsrc=rss,Q1 2017 Exact Sciences Corp Earnings Call
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences to participate in Bank of America Merrill Lynch Healthcare Conference,2017-05-01 10:00:00 +0000,http://finance.yahoo.com/news/exact-sciences-participate-bank-america-100000082.html?.tsrc=rss,"MADISON, Wis., May 1, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that the company will participate in the Bank of America Merrill Lynch 2017 Healthcare Conference in Las Vegas.  Kevin Conroy, Exact Sciences' chairman and CEO, and Jeff Elliott, the company's chief financial officer, will participate in a fireside chat at the conference on Tuesday, May 16 at 11:20 a.m. PT.  Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer."
EXAS,EXAS:US,BBG000CWL0F5,"EXACT Sciences Corp. :EXAS-US: Earnings Analysis: Q1, 2017 By the Numbers : April 28, 2017",2017-04-28 15:09:22 +0000,http://finance.yahoo.com/r/6f34875c-5c24-34be-b189-f284cf33a865/exact-sciences-corp-exas-us-earnings-analysis-q1-2017-by-the-numbers-april-28-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis EXACT Sciences Corp. reports financial results for the quarter ended March 31, 2017. Highlights Summary numbers: Revenues of USD 48.36 million, Net Earnings of USD -34.95 million. Gross margins widened from 38.93% to 64.89% compared to the same period last year, operating (EBITDA) margins now -66.57% from -305.78%. Change in operating ... Read more
<b>(Read more...)</b>"
EXAS,EXAS:US,BBG000CWL0F5,EXAS Crosses Above Average Analyst Target,2017-04-28 14:26:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OJUDIHI9MpA/exas-crosses-above-average-analyst-target-cm781011,In recent trading shares of EXACT Sciences Corp Symbol EXAS have crossed above the average analyst 12 month target price of 25 10 changing hands for 30 14 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on valuation
EXAS,EXAS:US,BBG000CWL0F5,Today's Research Reports on Stocks to Watch: EXACT Sciences and Celgene,2017-04-28 11:30:00 +0000,http://finance.yahoo.com/news/todays-research-reports-stocks-watch-113000706.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / April 28, 2017 / Strong corporate earnings outweighed losses by the energy sector Thursday as U.S. crude futures slipped on growing output concerns. The Dow Jones Industrial ..."
EXAS,EXAS:US,BBG000CWL0F5,"Why PayPal Holdings, Nokia, and Exact Sciences Jumped Today",2017-04-27 22:28:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xif9yWcwxEA/why-paypal-holdings-nokia-and-exact-sciences-jumped-today-cm780738,The stock market essentially moved sideways Thursday consolidating its gains from earlier in the week as investors tried to parse large quantities of 160 news concerning federal policy making and corporate earnings results Most major benchmarks finished close to flat on the day
EXAS,EXAS:US,BBG000CWL0F5,Mid-Afternoon Market Update: LeMaitre Vascular Rises After Strong Q1 Results; Synchronoss Technologies Shares Plunge,2017-04-27 21:10:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yDuM09R35gk/mid-afternoon-market-update-lemaitre-vascular-rises-after-strong-q1-results-synchronoss-technologies-shares-plunge-cm780718,Toward the end of trading Thursday the Dow traded up 0 07 percent to 20 989 38 while the NASDAQ climbed 0 39 percent to 6 048 40 The S amp P also rose gaining 0 08 percent to 2 389 43 Leading and Lagging Sectors Thursday afternoon the technology sector proved to be a source
EXAS,EXAS:US,BBG000CWL0F5,"Why PayPal Holdings, Nokia, and Exact Sciences Jumped Today",2017-04-27 20:34:00 +0000,http://finance.yahoo.com/r/d87fa260-de7e-301e-987e-412a406327e5/why-paypal-holdings-nokia-and-exact-sciences-jumpe.aspx?yptr=yahoo&.tsrc=rss,"The market was roughly flat, but these stocks climbed. Find out why."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences: $40 is the New $30,2017-04-27 20:22:00 +0000,http://finance.yahoo.com/r/525d1e31-1941-3131-bac5-a756b329cdb1/exact-sciences-30-will-soon-look-conservative-1493304669?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Exact Sciences (EXAS) are soaring today after the maker of a colon cancer test reported financial results that beat across the board.  Exact Sciences reported a loss of 32 cents a share, beating forecasts for a loss of 41 cents, on sales of $8.4 million, ahead of estimates for $37.29 million.  Cowen's Doug Schenkel and team explain: Q1 revenue was >$10MM ahead of expectations, and the beat was driven by every metric exceeding expectations."
EXAS,EXAS:US,BBG000CWL0F5,"Thursday's ETF Movers: XBI, OIH",2017-04-27 19:26:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QqX20SNajbg/thursdays-etf-movers-xbi-oih-cm780593,In trading on Thursday the SPDR S amp P Biotech ETF XBI is outperforming other ETFs up about 1 4 on the day Components of that ETF showing particular strength include shares of Exact Sciences EXAS up about 25 9 and shares of Alexion Pharmaceuticals ALXN up about 5 8 on
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences Corp. Shares Are Soaring 25.6% Today,2017-04-27 18:28:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GAKOYSs6oJ4/why-exact-sciences-corp-shares-are-soaring-256-today-cm780547,What happened Following first quarter financial results that were better than expected Exact Sciences NASDAQ EXAS shares are rocketing 25 6 higher at 12 00 p m EST today So what Exact Sciences Cologuard is the company s only commercial product but sales of it
EXAS,EXAS:US,BBG000CWL0F5,"Health Care Sector Update for 04/27/2017: CDXC,EXAS,PACB",2017-04-27 17:45:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/spp2qhKTVtk/health-care-sector-update-for-04272017-cdxcexaspacb-cm780538,Top Health Care StocksTop Health Care Stocks JNJ 0 38 JNJ 0 38 PFE 0 38 PFE 0 38 MRK 0 15 MRK 0 15 ABT 0 11 ABT 0 11 AMGN 0 86 AMGN 0 86 Health care stocks were helping limit broader market declines during Thursday trading with the NYSE Health Care Index rising nearly 0 7
EXAS,EXAS:US,BBG000CWL0F5,Mid-Day Market Update: Crude Oil Down 2%; GrubHub Shares Surge On Earnings Beat,2017-04-27 17:40:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0CUUfNrDLPw/mid-day-market-update-crude-oil-down-2-grubhub-shares-surge-on-earnings-beat-cm780567,Midway through trading Thursday the Dow traded down 0 03 percent to 20 969 70 while the NASDAQ climbed 0 28 percent to 6 042 32 The S amp P also fell dropping 0 07 percent to 2 385 79 Leading and Lagging Sectors On Thursday the technology sector proved to be a source of
EXAS,EXAS:US,BBG000CWL0F5,"Notable Thursday Option Activity: EXAS, MAR, CSV",2017-04-27 17:30:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PPdwhUdTuds/notable-thursday-option-activity-exas-mar-csv-cm780497,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in EXACT Sciences Corp Symbol EXAS where a total of 30 741 contracts have traded so far representing approximately 3 1 million underlying shares That amounts to about 161 9 of EXAS
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences Corp. Shares Are Soaring 25.6% Today,2017-04-27 16:55:00 +0000,http://finance.yahoo.com/r/c5858b15-8133-3eb4-8bc3-2c3687cb09eb/why-exact-sciences-corp-shares-are-soaring-223-tod.aspx?yptr=yahoo&.tsrc=rss,Strong sales growth in the first quarter have investors increasingly bullish on the rest of the year.
EXAS,EXAS:US,BBG000CWL0F5,Story Stocks from Briefing.com,2017-04-27 15:56:42 +0000,http://finance.yahoo.com/news/story-stocks-briefing-com-175403381.html?.tsrc=rss,Story Stocks from Briefing.com
EXAS,EXAS:US,BBG000CWL0F5,Mid-Morning Market Update: Markets Open Higher; Ford Tops Q1 Expectations,2017-04-27 15:10:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2U1sKWR8LTg/mid-morning-market-update-markets-open-higher-ford-tops-q1-expectations-cm780331,Following the market opening Thursday the Dow traded up 0 08 percent to 20 991 12 while the NASDAQ climbed 0 30 percent to 6 043 52 The S amp P also rose gaining 0 11 percent to 2 389 97 Leading and Lagging Sectors Thursday morning the telecommunications services sector proved
EXAS,EXAS:US,BBG000CWL0F5,Biotech Earnings Roundup: Exact Sciences Flying Higher,2017-04-27 12:51:00 +0000,http://finance.yahoo.com/r/4cb6bc0e-10a5-33c2-a9e2-dc71625c4a4a/biotech-earnings-roundup-exact-sciences-flying-higher?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Shares of Exact Sciences are flying higher after earnings; Amgen, Alkermes and Celgene are sinking lower."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences reports 1Q loss,2017-04-27 10:30:53 +0000,http://finance.yahoo.com/news/exact-sciences-reports-1q-loss-103053996.html?.tsrc=rss,"The Madison, Wisconsin-based company said it had a loss of 32 cents per share. The results surpassed Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research ..."
EXAS,EXAS:US,BBG000CWL0F5,"Cologuard growth accelerates to $48.4 million in revenue during first quarter; volume grows 150 percent year over year to 100,000 completed tests",2017-04-27 10:00:00 +0000,http://finance.yahoo.com/news/cologuard-growth-accelerates-48-4-100000968.html?.tsrc=rss,"MADISON, Wis., April 27, 2017 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenues of $48.4 million and completed approximately 100,000 Cologuard tests ..."
EXAS,EXAS:US,BBG000CWL0F5,InPlay from Briefing.com,2017-04-27 09:57:20 +0000,http://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss,InPlay from Briefing.com
EXAS,EXAS:US,BBG000CWL0F5,MDxHealth and Exact Sciences Sign Collaboration Agreement,2017-04-27 05:02:02 +0000,http://finance.yahoo.com/news/mdxhealth-exact-sciences-sign-collaboration-050202825.html?.tsrc=rss,"Exact Sciences also to acquire biomarker and technology patents NEWS RELEASE / REGULATED INFORMATION /  INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, April 27, 2017 - MDxHealth SA (Euronext: ..."
EXAS,EXAS:US,BBG000CWL0F5,"ETFs with exposure to EXACT Sciences Corp. : April 26, 2017",2017-04-26 19:17:41 +0000,http://finance.yahoo.com/r/89adae68-f5fb-3283-ac6a-1dc90f4ad070/etfs-with-exposure-to-exact-sciences-corp-april-26-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to EXACT Sciences Corp. Here are 5 ETFs with the largest exposure to EXAS-US. Comparing the performance and risk of EXACT Sciences Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
EXAS,EXAS:US,BBG000CWL0F5,3 Stocks the Market Is Wrong About,2017-04-17 12:44:00 +0000,http://finance.yahoo.com/r/d1192562-c3b3-3cc0-a3dd-014610793f3c/3-stocks-the-market-is-wrong-about.aspx?yptr=yahoo&.tsrc=rss,"We think the market has this diagnostic test company, credit card processor, and Canadian oil producer all wrong."
EXAS,EXAS:US,BBG000CWL0F5,"XLF, PTH: Big ETF Outflows",2017-04-11 15:55:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S5GWR7i6m8Y/xlf-pth-big-etf-outflows-cm772662,Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel the biggest outflow was seen in the Financial Select Sector SPDR Fund XLF where 24 800 000 units were destroyed or a 2 5 decrease week over week Among the largest underlying components
EXAS,EXAS:US,BBG000CWL0F5,CMS includes Cologuard in updated Medicare Advantage Star Ratings,2017-04-04 10:00:00 +0000,http://finance.yahoo.com/news/cms-includes-cologuard-updated-medicare-100000323.html?.tsrc=rss,"MADISON, Wis., April 4, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that the Centers for Medicare and Medicaid Services (CMS) included Cologuard® in its updated Medicare Advantage Star Ratings program. Medicare Advantage plans now can help increase their Star Ratings when their beneficiaries complete Cologuard, Exact Sciences' non-invasive colon cancer screening test."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences to host first-quarter 2017 results webcast and call,2017-03-31 10:00:00 +0000,http://finance.yahoo.com/news/exact-sciences-host-first-quarter-100000463.html?.tsrc=rss,"MADISON, Wis., March 31, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that the company will host a webcast and conference call on April 27, 2017, to discuss its first-quarter 2017 financial results and commercial accomplishments.  For more information, please follow us on Twitter @ExactSciences or find us on Facebook."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences to host first-quarter 2017 results webcast and call,2017-03-31 10:00:00 +0000,http://finance.yahoo.com/news/exact-sciences-host-first-quarter-100000463.html,"[PR Newswire] - MADISON, Wis., March 31, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that the company will host a webcast and conference call on April 27, 2017, to discuss its first-quarter 2017 financial results and commercial accomplishments. For more information, please follow us on Twitter @ExactSciences or find us on Facebook."
EXAS,EXAS:US,BBG000CWL0F5,Potential Stock Market Winners of the 2020s,2017-03-30 18:00:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OdyACBhXwy8/potential-stock-market-winners-of-the-2020s-cm767889,No one can definitively tell you which stocks will be the biggest winners a decade from now But we can certainly make educated picks based on a long term view of current technological and industry trends So we asked three top Motley Fool contributors to each discuss a stock that
EXAS,EXAS:US,BBG000CWL0F5,Potential Stock Market Winners of the 2020s,2017-03-30 16:00:00 +0000,http://finance.yahoo.com/r/901cd99e-b103-3112-9497-92a38f8316ca/potential-stock-market-winners-of-the-2020s.aspx?yptr=yahoo&.tsrc=rss,You don't need a crystal ball to realize these businesses should reward investors in the coming years.
EXAS,EXAS:US,BBG000CWL0F5,Potential Stock Market Winners of the 2020s,2017-03-30 16:00:00 +0000,https://www.fool.com/investing/2017/03/30/potential-stock-market-winners-of-the-2020s.aspx,Potential Stock Market Winners of the 2020s
EXAS,EXAS:US,BBG000CWL0F5,"Why Fitbit, Sears Holdings, and Exact Sciences Jumped Today",2017-03-27 22:59:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/adtqI5-4p4I/why-fitbit-sears-holdings-and-exact-sciences-jumped-today-cm766245,The stock market started the week in mixed territory on Monday as investors mulled the potential for legislative roadblocks on the Trump administration s promise for pro growth tax reform and infrastructure spending Late last week Republicans failed to gather enough support for
EXAS,EXAS:US,BBG000CWL0F5,"Why Fitbit, Sears Holdings, and Exact Sciences Jumped Today",2017-03-27 20:54:00 +0000,https://www.fool.com/investing/2017/03/27/why-fitbit-sears-holdings-and-exact-sciences-jumpe.aspx,"Why Fitbit, Sears Holdings, and Exact Sciences Jumped Today"
EXAS,EXAS:US,BBG000CWL0F5,"Why Fitbit, Sears Holdings, and Exact Sciences Jumped Today",2017-03-27 20:54:00 +0000,http://finance.yahoo.com/r/b0ad7d6a-b1df-322e-931a-10b9544485ee/why-fitbit-sears-holdings-and-exact-sciences-jumpe.aspx?yptr=yahoo&.tsrc=rss,These winners delivered outsized gains today. Here's what investors need to know.
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Stock Soaring on Aetna Cologuard Coverage,2017-03-27 16:34:00 +0000,https://www.thestreet.com/story/14060806/1/exact-sciences-stock-soaring-on-aetna-cologuard-coverage.html?puc=yahoo&cm_ven=YAHOO,Exact Sciences Stock Soaring on Aetna Cologuard Coverage
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Stock Soaring on Aetna Cologuard Coverage,2017-03-27 16:34:00 +0000,http://finance.yahoo.com/r/ca576bfb-4669-3bfd-a472-559106bb4a9e/exact-sciences-stock-soaring-on-aetna-cologuard-coverage.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Aetna now offers commercial coverage of Exact Sciences' Cologuard test.
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences is Soaring,2017-03-27 15:53:00 +0000,http://finance.yahoo.com/r/46bab5a5-af04-3283-9001-b3b87b968c22/why-exact-sciences-is-soaring?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Yes, the market is falling today, but that hasn't hurt Exact Sciences (EXAS), who received good news about coverage of its colon-cancer test.  Barron's  Andrew Bary has been writing about Exact Sciences since 2012, when it was still awaiting trial results from its test that is now known as Cologuard.  Exact Sciences gained 75% since that last story, more than double the S&P 500's 35% return, and today it's getting another boost thanks to Aetna's (AET) decision to add the drug to a list of covered tests."
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences is Soaring,2017-03-27 15:53:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/27/why-exact-sciences-is-soaring/?mod=yahoobarrons&ru=yahoo,Why Exact Sciences is Soaring
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Stock Jumps On Cowen Upgrade,2017-03-27 14:54:00 +0000,http://finance.yahoo.com/r/21767176-f8fb-3dce-acc4-147eeb29fa79/exact-sciences-jumps-cowen-upgrade-exas?partner=YahooSA&yptr=yahoo&.tsrc=rss,EXAS is up nearly 5% after Cowen upgrade.
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Stock Jumps On Cowen Upgrade,2017-03-27 14:54:00 +0000,http://www.investopedia.com/news/exact-sciences-jumps-cowen-upgrade-exas/?partner=YahooSA,Exact Sciences Stock Jumps On Cowen Upgrade
EXAS,EXAS:US,BBG000CWL0F5,Billionaires' Best Healthcare Stock Picks of 2017 (So Far),2017-03-21 19:02:00 +0000,https://www.fool.com/investing/2017/03/21/billionaires-best-healthcare-stock-picks-of-2017-s.aspx,Billionaires' Best Healthcare Stock Picks of 2017 (So Far)
EXAS,EXAS:US,BBG000CWL0F5,Billionaires' Best Healthcare Stock Picks of 2017 (So Far),2017-03-21 19:02:00 +0000,http://finance.yahoo.com/r/9f08b028-c429-393a-9ff5-1ffec2af0934/billionaires-best-healthcare-stock-picks-of-2017-s.aspx?yptr=yahoo&.tsrc=rss,"Why billionaire investors are loving Immunomedics, Achaogen, AveXis, Exact Sciences, and Clovis Oncology this year."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Grants Inducement Restricted Stock Unit Awards to Recently Hired Employees,2017-03-17 20:05:00 +0000,http://finance.yahoo.com/news/exact-sciences-grants-inducement-restricted-200500763.html?.tsrc=rss,"MADISON, Wis., March 17, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that, in support of the Company's continued growth plans, it granted restricted stock units covering a total of 85,421 shares of common stock to 77 recently hired non-executive employees under its previously announced inducement grant program.  The restricted stock unit awards vest in four equal annual installments beginning on the first anniversary of the grant date.  The awards were granted as an inducement material to the recently hired employees entering into employment with the Company in accordance with NASDAQ Marketplace Rule 5635(c)(4).  The Company is making this announcement as required by NASDAQ rules."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Grants Inducement Restricted Stock Unit Awards to Recently Hired Employees,2017-03-17 20:05:00 +0000,http://finance.yahoo.com/news/exact-sciences-grants-inducement-restricted-200500763.html,"[PR Newswire] - MADISON, Wis., March 17, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that, in support of the Company's continued growth plans, it granted restricted stock units covering a total of 85,421 shares of common stock to 77 recently hired non-executive employees under its previously announced inducement grant program. The restricted stock unit awards vest in four equal annual installments beginning on the first anniversary of the grant date. The awards were granted as an inducement material to the recently hired employees entering into employment with the Company in accordance with NASDAQ Marketplace Rule 5635(c)(4). The Company is making this announcement as required by NASDAQ rules."
EXAS,EXAS:US,BBG000CWL0F5,SPDR S&P Biotech ETF Experiences Big Inflow,2017-03-14 16:08:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xl2X0nxLMSY/spdr-sp-biotech-etf-experiences-big-inflow-cm760568,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 110 8 million dollar inflow that s a 3 6 increase week over week in outstanding
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences Shares Are Already Up 65% in 2017,2017-03-14 14:07:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0U54BM8Snoc/why-exact-sciences-shares-are-already-up-65-in-2017-cm760363,Exact Sciences NASDAQ EXAS thinks that its cheaper and less intrusive approach to colon cancer screening can allow it to tap into a massive market About 80 million Americans fall within the guidelines for regular colon cancer screening but only about half of them
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences Shares Are Already Up 65% in 2017,2017-03-14 12:24:00 +0000,http://www.fool.com/investing/2017/03/14/why-exact-sciences-shares-are-already-up-65-in-201.aspx,Why Exact Sciences Shares Are Already Up 65% in 2017
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences Shares Are Already Up 65% in 2017,2017-03-14 12:24:00 +0000,http://finance.yahoo.com/r/81dedf32-461e-37c4-8ddc-64a0102ded04/why-exact-sciences-shares-are-already-up-65-in-201.aspx?yptr=yahoo&.tsrc=rss,Growing demand for its new colon cancer screening test is fueling investors' excitement.
EXAS,EXAS:US,BBG000CWL0F5,Top Stocks That Are Already Crushing the Market in 2017,2017-03-13 16:10:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/un7WrfHTuq0/top-stocks-that-are-already-crushing-the-market-in-2017-cm760028,If you re looking for new stocks to buy for your portfolio you might want to consider digging deeper into the story behind Exelixis NASDAQ EXEL Pacira Pharmaceuticals NASDAQ PCRX Kite Pharma NASDAQ KITE Exact Sciences NASDAQ EXAS
EXAS,EXAS:US,BBG000CWL0F5,Top Stocks That Are Already Crushing the Market in 2017,2017-03-13 14:11:00 +0000,http://www.fool.com/investing/2017/03/13/top-stocks-that-are-already-crushing-the-market-in.aspx,Top Stocks That Are Already Crushing the Market in 2017
EXAS,EXAS:US,BBG000CWL0F5,Is Exact Sciences' Balance Sheet Safe?,2017-03-08 15:16:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q4A633TiGNw/is-exact-sciences-balance-sheet-safe-cm757787,Exact Sciences NASDAQ EXAS Cologuard colon cancer screening test is winning over doctors and patients but marketing costs are hampering the company s ability to strengthen its balance sheet A big league market opportunity Guidelines call for Americans between age 50 and age 75
EXAS,EXAS:US,BBG000CWL0F5,Is Exact Sciences' Balance Sheet Safe?,2017-03-08 13:21:00 +0000,http://finance.yahoo.com/r/a199dda0-5c38-347e-823e-ed12e184f795/is-exact-sciences-balance-sheet-safe.aspx?yptr=yahoo&.tsrc=rss,"Rapidly growing demand for its colon cancer screening test is on deck, but massive spending plans weigh on its financial health."
EXAS,EXAS:US,BBG000CWL0F5,Is Exact Sciences' Balance Sheet Safe?,2017-03-08 13:21:00 +0000,http://www.fool.com/investing/2017/03/08/is-exact-sciences-balance-sheet-safe.aspx,Is Exact Sciences' Balance Sheet Safe?
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences to participate in March investor conferences,2017-03-03 11:00:00 +0000,http://finance.yahoo.com/news/exact-sciences-participate-march-investor-110000119.html?.tsrc=rss,"MADISON, Wis., March 3, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that the company will participate in two investor conferences during March.  Kevin Conroy, the company's chairman and CEO, will participate in a fireside chat at the Cowen & Co. 37th Annual Healthcare Conference on March 7 at 12 p.m. ET in Boston.  Jeff Elliott, the company's CFO, will make Exact Sciences' presentation at the Roth Capital Partners 29th Annual Conference on March 13 at 8:30 a.m. PT in Dana Point, Calif."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences to participate in March investor conferences,2017-03-03 11:00:00 +0000,http://finance.yahoo.com/news/exact-sciences-participate-march-investor-110000119.html,"[PR Newswire] - MADISON, Wis., March 3, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that the company will participate in two investor conferences during March. Kevin Conroy, the company's chairman and CEO, will participate in a fireside chat at the Cowen & Co. 37th Annual Healthcare Conference on March 7 at 12 p.m. ET in Boston. Jeff Elliott, the company's CFO, will make Exact Sciences' presentation at the Roth Capital Partners 29th Annual Conference on March 13 at 8:30 a.m. PT in Dana Point, Calif."
EXAS,EXAS:US,BBG000CWL0F5,"FDA Approves Odactra, JUNO Abandons Rocket, VRML Abuzz, No Tremors For NDRM",2017-03-02 05:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AeyT2lhQlYg/fda-approves-odactra-juno-abandons-rocket-vrml-abuzz-no-tremors-for-ndrm-20170302-00244,"FDA Approves Odactra, JUNO Abandons Rocket, VRML Abuzz, No Tremors For NDRM"
EXAS,EXAS:US,BBG000CWL0F5,5:43 pm EXACT Sciences and Mayo Clinic study shows promise of new blood-based lung cancer test,2017-03-01 22:43:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#exas,5:43 pm EXACT Sciences and Mayo Clinic study shows promise of new blood-based lung cancer test
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences and Mayo Clinic study shows promise of new blood-based lung cancer test,2017-03-01 22:31:00 +0000,http://finance.yahoo.com/news/exact-sciences-mayo-clinic-study-223100285.html,"[PR Newswire] - MADISON, Wis., March 1, 2017 /PRNewswire/ -- A study from Exact Sciences Corp. (EXAS) and Mayo Clinic released today by the American Association of Cancer Research (AACR) shows promise for the development of a blood-based lung cancer test. Researchers conducted a multi-round study of nearly 400 patients, which demonstrated high accuracy for detecting lung cancer at all stages. ""These results reveal an opportunity to detect lung cancer from a simple blood draw,"" said Kevin Conroy, chairman and CEO of Exact Sciences."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences and Mayo Clinic study shows promise of new blood-based lung cancer test,2017-03-01 22:31:00 +0000,http://finance.yahoo.com/news/exact-sciences-mayo-clinic-study-223100285.html?.tsrc=rss,"MADISON, Wis., March 1, 2017 /PRNewswire/ -- A study from Exact Sciences Corp. (EXAS) and Mayo Clinic released today by the American Association of Cancer Research (AACR) shows promise for the development of a blood-based lung cancer test.  Researchers conducted a multi-round study of nearly 400 patients, which demonstrated high accuracy for detecting lung cancer at all stages.  ""These results reveal an opportunity to detect lung cancer from a simple blood draw,"" said Kevin Conroy, chairman and CEO of Exact Sciences."
EXAS,EXAS:US,BBG000CWL0F5,3 Winning Stocks You Never Saw Coming,2017-03-01 16:14:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KxNgGw8CF8E/3-winning-stocks-you-never-saw-coming-cm754792,Chesapeake Energy NYSE CHK Check Point Software Technologies NASDAQ CHKP and Exact Sciences NASDAQ EXAS are very different companies but one thing that they do share in common is market beating returns Here s why these stocks have produced envy inspiring gains
EXAS,EXAS:US,BBG000CWL0F5,3 Winning Stocks You Never Saw Coming,2017-03-01 14:23:00 +0000,http://www.fool.com/investing/2017/03/01/3-winning-stocks-you-never-saw-coming.aspx,3 Winning Stocks You Never Saw Coming
EXAS,EXAS:US,BBG000CWL0F5,3 Winning Stocks You Never Saw Coming,2017-03-01 14:23:00 +0000,http://finance.yahoo.com/r/b18ef29e-bb96-30f6-b74f-10502ac43476/3-winning-stocks-you-never-saw-coming.aspx?yptr=yahoo&.tsrc=rss,"Some of the best-performing stocks have been among the most surprising, including Chesapeake Energy, Check Point Software, and Exact Sciences."
EXAS,EXAS:US,BBG000CWL0F5,Investors Are Betting Big Against Exact Sciences Corporation -- Are They Right?,2017-02-28 22:51:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KaWBvitFUn0/investors-are-betting-big-against-exact-sciences-corporation-are-they-right-cm754501,Molecular diagnostics company Exact Sciences NASDAQ EXAS thinks there s a 4 billion U S market opportunity for its proprietary colorectal cancer test Cologuard Revenue from the self administered test is growing fast 160 and has a lot more room to run With sales and
EXAS,EXAS:US,BBG000CWL0F5,Investors Are Betting Big Against Exact Sciences Corporation -- Are They Right?,2017-02-28 21:37:00 +0000,http://finance.yahoo.com/r/fc764f24-bdfb-3f6c-864f-55e95c4b6020/investors-are-betting-big-against-exact-sciences-c.aspx?yptr=yahoo&.tsrc=rss,"Completed Cologuard tests are rising fast, so why are so many investors betting against Exact Sciences' stock?"
EXAS,EXAS:US,BBG000CWL0F5,Investors Are Betting Big Against Exact Sciences Corporation -- Are They Right?,2017-02-28 21:37:00 +0000,http://www.fool.com/investing/2017/02/28/investors-are-betting-big-against-exact-sciences-c.aspx,Investors Are Betting Big Against Exact Sciences Corporation -- Are They Right?
EXAS,EXAS:US,BBG000CWL0F5,Fight Colorectal Cancer and Exact Sciences Corp. (Nasdaq: EXAS) to Ring The Nasdaq Stock Market Closing Bell,2017-02-28 15:00:00 +0000,http://finance.yahoo.com/news/fight-colorectal-cancer-exact-sciences-150000037.html?.tsrc=rss,"What: Fight Colorectal Cancer, a leading national colorectal cancer nonprofit and Exact Sciences Corp., a molecular diagnostics company focused on the early detection and prevention of the deadliest forms ..."
EXAS,EXAS:US,BBG000CWL0F5,Fight Colorectal Cancer and Exact Sciences Corp. (Nasdaq: EXAS) to Ring The Nasdaq Stock Market Closing Bell,2017-02-28 15:00:00 +0000,http://finance.yahoo.com/news/fight-colorectal-cancer-exact-sciences-150000037.html,"[GlobeNewswire] - What: Fight Colorectal Cancer, a leading national colorectal cancer nonprofit and Exact Sciences Corp., a molecular diagnostics company focused on the early detection and prevention of the deadliest forms ..."
EXAS,EXAS:US,BBG000CWL0F5,EXACT SCIENCES CORP Financials,2017-02-25 18:04:11 +0000,http://finance.yahoo.com/q/is?s=exas,EXACT SCIENCES CORP Financials
EXAS,EXAS:US,BBG000CWL0F5,Pfizer's Leukemia Candidate Gets Priority Review in U.S.,2017-02-23 00:50:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M_MRKdPZ84s/pfizers-leukemia-candidate-gets-priority-review-in-us-cm751705,Pfizer Inc PFE announced that its Biologics License Application BLA for leukemia candidate inotuzumab ozogamicin has been accepted for priority review by the FDA Inotuzumab ozogamicin is being evaluated for the treatment of adult patients with relapsed or refractory B cell precursor
EXAS,EXAS:US,BBG000CWL0F5,Exelixis (EXEL) Q4 Earnings: Is Positive Surprise in Store?,2017-02-22 22:49:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DY5IzZNQ5QQ/exelixis-exel-q4-earnings-is-positive-surprise-in-store-cm751652,Exelixis Inc EXEL is scheduled to report fourth quarter 2016 results on Feb 27 after the market close Exelixis had a mixed track record over the last four quarters The company surpassed expectations thrice in the four trailing quarters and missed the same in the remaining with an
EXAS,EXAS:US,BBG000CWL0F5,Pfizer's Leukemia Candidate Gets Priority Review in U.S.,2017-02-22 22:08:10 +0000,http://finance.yahoo.com/news/pfizers-leukemia-candidate-gets-priority-220810266.html,Pfizer's Leukemia Candidate Gets Priority Review in U.S.
EXAS,EXAS:US,BBG000CWL0F5,Pfizer's Leukemia Candidate Gets Priority Review in U.S.,2017-02-22 22:08:10 +0000,http://finance.yahoo.com/news/pfizers-leukemia-candidate-gets-priority-220810266.html?.tsrc=rss,Pfizer Inc. (PFE) announced that its Biologics License Application (BLA) for leukemia candidate inotuzumab ozogamicin has been accepted for priority review by the FDA.
EXAS,EXAS:US,BBG000CWL0F5,Exelixis (EXEL) Q4 Earnings: Is Positive Surprise in Store?,2017-02-22 20:10:08 +0000,http://finance.yahoo.com/news/exelixis-exel-q4-earnings-positive-201008166.html,Exelixis (EXEL) Q4 Earnings: Is Positive Surprise in Store?
EXAS,EXAS:US,BBG000CWL0F5,Is EXAS Getting Ahead of Itself?,2017-02-22 18:05:00 +0000,http://www.investopedia.com/articles/investing/022217/exas-surges-quarterly-results-exas.asp?partner=YahooSA,Is EXAS Getting Ahead of Itself?
EXAS,EXAS:US,BBG000CWL0F5,Is EXAS Getting Ahead of Itself?,2017-02-22 18:05:00 +0000,http://finance.yahoo.com/r/42a804d8-a4b7-3dfd-9e60-c38b0d7fe1b7/exas-surges-quarterly-results-exas.asp?partner=YahooSA&yptr=yahoo&.tsrc=rss,"EXAS reported results for the fourth quarter and full year 2016, and gave upbeat guidance."
EXAS,EXAS:US,BBG000CWL0F5,"EXACT Sciences Corp. :EXAS-US: Earnings Analysis: Q4, 2016 By the Numbers : February 22, 2017",2017-02-22 14:53:53 +0000,http://www.capitalcube.com/blog/index.php/exact-sciences-corp-exas-us-earnings-analysis-q4-2016-by-the-numbers-february-22-2017/,"EXACT Sciences Corp. :EXAS-US: Earnings Analysis: Q4, 2016 By the Numbers : February 22, 2017"
EXAS,EXAS:US,BBG000CWL0F5,"EXACT Sciences Corp. :EXAS-US: Earnings Analysis: Q4, 2016 By the Numbers : February 22, 2017",2017-02-22 14:53:53 +0000,http://finance.yahoo.com/r/001556b9-89e3-3fb1-9e03-5701705db7fe/exact-sciences-corp-exas-us-earnings-analysis-q4-2016-by-the-numbers-february-22-2017?yptr=yahoo&.tsrc=rss,"Categories:   Yahoo Finance Get free summary analysis EXACT Sciences Corp. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of EXACT Sciences Corp. – Myriad Genetics, Inc., Genomic Health, Inc. and Invacare Corporation (MYGN-US, GHDX-US and IVC-US) that have also reported for this period. Highlights Summary numbers: Revenues ... Read more    
<b>(Read more...)</b>"
EXAS,EXAS:US,BBG000CWL0F5,[$$] Exact Sciences Is on Target for More Gains,2017-02-22 11:58:00 +0000,http://finance.yahoo.com/r/be5cba65-22a5-3e07-8e80-fa7ea30f43c1/exact-sciences-is-on-target-for-more-gains-1487764685?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Exact Sciences (EXAS:Nasdaq)  By The Benchmark Co. ($22.38, February 21, 2017) We are upgrading shares to Buy due to a change in analyst coverage and robust growth trajectory for Exact Sciences.  Fourth-quarter revenue rose 144% to $35.2 million and Cologuard coverage expanded to 72% of the addressable population by February 20.  The compliance rate held steady sequentially at 67%."
EXAS,EXAS:US,BBG000CWL0F5,[$$] Exact Sciences Is on Target for More Gains,2017-02-22 11:58:00 +0000,http://www.barrons.com/articles/exact-sciences-is-on-target-for-more-gains-1487764685?mod=yahoobarrons&ru=yahoo,[$$] Exact Sciences Is on Target for More Gains
EXAS,EXAS:US,BBG000CWL0F5,EXACT Sciences upgraded by ROTH Capital,2017-02-22 11:29:26 +0000,http://finance.yahoo.com/q/ud?s=EXAS,EXACT Sciences upgraded by ROTH Capital
EXAS,EXAS:US,BBG000CWL0F5,Ionis (IONS) Q4 Earnings: What's in the Cards for the Stock?,2017-02-22 01:06:53 +0000,,Ionis Pharmaceuticals Inc IONS is scheduled to report fourth quarter 2016 results on Feb 28 Last quarter the company recorded a negative earnings surprise of 14 29 Let s see how things are shaping up for this announcement Ionis share price decreased 1 9 year to date compared with
EXAS,EXAS:US,BBG000CWL0F5,Ionis (IONS) Q4 Earnings: What's in the Cards for the Stock?,2017-02-22 01:06:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OLMZz2LbYGI/ionis-ions-q4-earnings-whats-in-the-cards-for-the-stock-cm750955,Ionis Pharmaceuticals Inc IONS is scheduled to report fourth quarter 2016 results on Feb 28 Last quarter the company recorded a negative earnings surprise of 14 29 Let s see how things are shaping up for this announcement Ionis share price decreased 1 9 year to date compared with
EXAS,EXAS:US,BBG000CWL0F5,Edited Transcript of EXAS earnings conference call or presentation 21-Feb-17 3:00pm GMT,2017-02-21 22:12:44 +0000,http://finance.yahoo.com/news/edited-transcript-exas-earnings-conference-221244624.html,Edited Transcript of EXAS earnings conference call or presentation 21-Feb-17 3:00pm GMT
EXAS,EXAS:US,BBG000CWL0F5,"EXACT SCIENCES CORP Files SEC form 10-K, Annual Report",2017-02-21 21:29:16 +0000,http://biz.yahoo.com/e/170221/exas10-k.html,"EXACT SCIENCES CORP Files SEC form 10-K, Annual Report"
EXAS,EXAS:US,BBG000CWL0F5,Insiders Were Right: EXAS Makes New 52-Week High,2017-02-21 21:08:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Tf6cFYbMOWg/insiders-were-right-exas-makes-new-52-week-high-cm750884,In trading on Tuesday shares of EXACT Sciences Corp Symbol EXAS touched a new 52 week high of 23 68 share That s a 407 07 rise or 19 01 per share from the 52 week low of 4 67 set back on 03 01 2016 That means at today s intraday high any investor who purchased EXAS stock any time
EXAS,EXAS:US,BBG000CWL0F5,"Gainers & Losers Of The Day: EYEG, BLPH, VSAR, MNTA, AMPH...",2017-02-21 19:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Gda4OqtvtOg/gainers--losers-of-the-day-eyeg-blph-vsar-mnta-amph-20170221-01881,"Gainers & Losers Of The Day: EYEG, BLPH, VSAR, MNTA, AMPH..."
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences Corp. Is Jumping 12.9% Today,2017-02-21 19:09:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wUj451wSe8g/why-exact-sciences-corp-is-jumping-129-today-cm750783,What happened Following the release of fourth quarter and full year 2016 financial results Exact Sciences NASDAQ EXAS shares are climbing 12 9 at 12 p m EST So what A colonoscopy is the best way to determine a patient s risk of colon cancer but colonoscopies are
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences Corp. Is Jumping 12.9% Today,2017-02-21 17:33:21 +0000,http://www.fool.com/investing/2017/02/21/why-exact-sciences-corp-is-jumping-129-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Exact Sciences Corp. Is Jumping 12.9% Today
EXAS,EXAS:US,BBG000CWL0F5,​Exact Sciences revenue jumps 152% as Cologuard use soars,2017-02-21 16:45:08 +0000,http://www.bizjournals.com/milwaukee/news/2017/02/21/exact-sciences-revenue-jumps-152-as-cologuard-use.html?ana=yahoo,​Exact Sciences revenue jumps 152% as Cologuard use soars
EXAS,EXAS:US,BBG000CWL0F5,Q4 2016 Exact Sciences Corp Earnings Release - Before Market Open,2017-02-21 12:07:05 +0000,http://biz.yahoo.com/research/earncal/20170221.html?t=exas,Q4 2016 Exact Sciences Corp Earnings Release - Before Market Open
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences reports 4Q loss,2017-02-21 11:28:56 +0000,http://sg.finance.yahoo.com/news/exact-sciences-reports-4q-loss-111839668.html,Exact Sciences reports 4Q loss
EXAS,EXAS:US,BBG000CWL0F5,"Exact Sciences generated $99.4 million in revenues during 2016, a 152-percent increase",2017-02-21 11:00:00 +0000,http://finance.yahoo.com/news/exact-sciences-generated-99-4-110000913.html,"[PR Newswire] - MADISON, Wis., Feb. 21, 2017 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenues of $99.4 million and completed approximately 244,000 Cologuard tests ..."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Corp. (EXAS) Is Challenging The Highs After Q4 Loss Narrowed,2017-02-21 09:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8JknsKqTopM/exact-sciences-corp-exas-is-challenging-the-highs-after-q4-loss-narrowed-20170221-01023,Exact Sciences Corp. (EXAS) Is Challenging The Highs After Q4 Loss Narrowed
EXAS,EXAS:US,BBG000CWL0F5,"Drug Stocks Q4 Earnings Lineup for Feb 21: IRWD, MNTA, EXAS",2017-02-20 13:52:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HZDGy-X13Nw/drug-stocks-q4-earnings-lineup-for-feb-21-irwd-mnta-exas-cm750167,As the Q4 earnings season enters the last leg we believe this quarter is on track to witness the highest growth momentum in the last two years As of Feb 17 2017 411 S amp P 500 members accounting for 88 4 of the index s total market capitalization have reported results according to
EXAS,EXAS:US,BBG000CWL0F5,"Drug Stocks Q4 Earnings Lineup for Feb 21: IRWD, MNTA, EXAS",2017-02-20 11:52:11 +0000,http://finance.yahoo.com/news/drug-stocks-q4-earnings-lineup-115211830.html,"Drug Stocks Q4 Earnings Lineup for Feb 21: IRWD, MNTA, EXAS"
EXAS,EXAS:US,BBG000CWL0F5,"Noteworthy Friday Option Activity: SPGI, NLNK, EXAS",2017-02-17 21:52:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OPBB0mymTMw/noteworthy-friday-option-activity-spgi-nlnk-exas-cm749841,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in S amp P Global Inc Symbol SPGI where a total of 7 011 contracts have traded so far representing approximately 701 100 underlying shares That amounts to about 63 1 of SPGI s
EXAS,EXAS:US,BBG000CWL0F5,Merrimack (MACK): What Awaits the Stock in Q4 Earnings?,2017-02-17 21:51:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p6mayfa5Oa8/merrimack-mack-what-awaits-the-stock-in-q4-earnings-cm749823,Merrimack Pharmaceuticals Inc MACK is scheduled to report fourth quarter 2016 results in the next week Last quarter Merrimack delivered a positive earnings surprise of 23 33 Merrimack s share price decreased 21 9 year to date compared with the Zacks classified Medical Biomedical
EXAS,EXAS:US,BBG000CWL0F5,Geron (GERN) Q4 Earnings: What's in Store for the Stock?,2017-02-17 15:55:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QYFMwqfTFxQ/geron-gern-q4-earnings-whats-in-store-for-the-stock-cm749540,Geron Corporation GERN is expected to report fourth quarter 2016 results next week In the last reported quarter the company recorded a positive earnings surprise of 66 67 Let s see how things are shaping up for the upcoming announcement Geron s shares outperformed the
EXAS,EXAS:US,BBG000CWL0F5,Can Fitbit (FIT) Stock Surprise Investors Post Q4 Earnings?,2017-02-17 14:58:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aFcd0m4QgSI/can-fitbit-fit-stock-surprise-investors-post-q4-earnings-cm749442,Fitbit Inc FIT is set to report fourth quarter 2016 results on Feb 22 Last quarter the company posted a positive earnings surprise of 18 18 Over the past one year shares of Fitbit underperformed the Zacks categorized Electronic Measuring Instruments industry While the industry
EXAS,EXAS:US,BBG000CWL0F5,BioMarin (BMRN) Q4 Earnings: Will it Post a Beat Again?,2017-02-17 14:58:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qTP1yu0rxU4/biomarin-bmrn-q4-earnings-will-it-post-a-beat-again-cm749441,We expect BioMarin Pharmaceutical Inc BMRN to beat expectations when it reports fourth quarter and full year 2016 results on Feb 23 after the market closes BioMarin had delivered a positive earnings surprise of 66 67 in the last quarter BioMarin s shares are up 9 2 so far this
EXAS,EXAS:US,BBG000CWL0F5,Geron (GERN) Q4 Earnings: What's in Store for the Stock?,2017-02-17 14:10:02 +0000,http://finance.yahoo.com/news/geron-gern-q4-earnings-whats-141002066.html,Geron (GERN) Q4 Earnings: What's in Store for the Stock?
EXAS,EXAS:US,BBG000CWL0F5,"Alkermes (ALKS) Q4 Loss Narrower than Expectations, Sales Beat",2017-02-16 22:55:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l2kOwCDSJo8/alkermes-alks-q4-loss-narrower-than-expectations-sales-beat-cm749226,Alkermes plc ALKS reported loss of 4 cents per share including the impact of share based compensation expense in the fourth quarter of 2016 narrower than the Zacks Consensus Estimate of a loss of 19 cents The reported loss was however narrower than the year ago loss of 34 cents
EXAS,EXAS:US,BBG000CWL0F5,"Alexion (ALXN) Q4 Earnings In-Line, Sales Rise Y/Y",2017-02-16 22:54:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZD47EscK3gY/alexion-alxn-q4-earnings-in-line-sales-rise-yy-cm749218,Alexion Pharmaceuticals Inc s ALXN fourth quarter 2016 earnings including stock based compensation expense of 1 10 cents per share compared with the year ago earnings of 78 cents Earnings were in line with the Zacks Consensus Estimate of 1 10 Revenues on the other hand rose 19
EXAS,EXAS:US,BBG000CWL0F5,"Alexion (ALXN) Q4 Earnings In-Line, Sales Rise Y/Y",2017-02-16 21:19:09 +0000,http://finance.yahoo.com/news/alexion-alxn-q4-earnings-line-211909291.html,"Alexion (ALXN) Q4 Earnings In-Line, Sales Rise Y/Y"
EXAS,EXAS:US,BBG000CWL0F5,EXACT Sciences Reaches Analyst Target Price,2017-02-16 15:54:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hCk0R55kuLk/exact-sciences-reaches-analyst-target-price-cm748843,In recent trading shares of EXACT Sciences Corp Symbol EXAS have crossed above the average analyst 12 month target price of 19 00 changing hands for 19 69 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on valuation
EXAS,EXAS:US,BBG000CWL0F5,Ligand (LGND) Q4 Earnings: Will the Stock Pull a Surprise?,2017-02-16 14:58:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YTrr4g81MyA/ligand-lgnd-q4-earnings-will-the-stock-pull-a-surprise-cm748921,Ligand Pharmaceuticals Incorporated LGND is scheduled to report fourth quarter 2016 results on Feb 23 after the market closes Ligand s earnings history is mixed as it missed expectations in two of the last four quarters Overall the company had an average negative surprise of 5 01 in
EXAS,EXAS:US,BBG000CWL0F5,Key Presenters At Leerink's Healthcare Conference,2017-02-13 20:52:10 +0000,http://finance.yahoo.com/news/key-presenters-leerinks-healthcare-conference-205210539.html,Key Presenters At Leerink's Healthcare Conference
EXAS,EXAS:US,BBG000CWL0F5,What's in Store for ImmunoGen (IMGN) this Earnings Season?,2017-02-13 16:22:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/klYpW97IM3A/whats-in-store-for-immunogen-imgn-this-earnings-season-cm747000,ImmunoGen Inc IMGN is scheduled to report results for the three months ended Dec 31 2016 on Feb 17 before the opening bell ImmunoGen s track record has been disappointing with the company missing expectations in each of the last four reported quarters Overall the company has posted
EXAS,EXAS:US,BBG000CWL0F5,"The Zacks Analyst Blog Highlights: Celgene, Cellectis S.A., Exelixis, Exact Sciences and Sunesis Pharmaceuticals",2017-02-08 16:23:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZiWCvzzfUmo/the-zacks-analyst-blog-highlights-celgene-cellectis-sa-exelixis-exact-sciences-and-sunesis-pharmaceuticals-cm744838,For Immediate Release Chicago IL February 08 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
EXAS,EXAS:US,BBG000CWL0F5,"The Zacks Analyst Blog Highlights: Celgene, Cellectis S.A., Exelixis, Exact Sciences and Sunesis Pharmaceuticals",2017-02-08 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-celgene-143002432.html,"The Zacks Analyst Blog Highlights: Celgene, Cellectis S.A., Exelixis, Exact Sciences and Sunesis Pharmaceuticals"
EXAS,EXAS:US,BBG000CWL0F5,5 Great Biotech Stocks to Buy Now,2017-02-07 22:16:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jLjhvST47po/5-great-biotech-stocks-to-buy-now-cm744505,Through the second half of 2015 biotech stocks were the preferred choice of investors seeking aggressive growth options Even as the S amp P 500 gained around 50 from 2013 up to that point the likes of the iShares Nasdaq Biotechnology Index and the SPDR S amp P Biotech nearly tripled in
EXAS,EXAS:US,BBG000CWL0F5,5 Great Biotech Stocks to Buy Now,2017-02-07 20:26:08 +0000,http://finance.yahoo.com/news/5-great-biotech-stocks-buy-202608361.html,5 Great Biotech Stocks to Buy Now
EXAS,EXAS:US,BBG000CWL0F5,The Sole Reason Exact Sciences Corporation Skyrocketed 42% in January,2017-02-02 14:35:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DlCsBic4mQk/the-sole-reason-exact-sciences-corporation-skyrocketed-42-in-january-cm742009,Image source Exact Sciences What happened Shares of Exact Sciences NASDAQ EXAS a molecular diagnostics company focused on developing tests to detect and help prevent various types of cancer skyrocketed 42 in January according to data from S amp P Global
EXAS,EXAS:US,BBG000CWL0F5,The Sole Reason Exact Sciences Corporation Skyrocketed 42% in January,2017-02-02 12:52:05 +0000,http://www.fool.com/investing/2017/02/02/the-sole-reason-exact-sciences-corporation-skyrock.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Sole Reason Exact Sciences Corporation Skyrocketed 42% in January
EXAS,EXAS:US,BBG000CWL0F5,CMS Proposes Inclusion of Cologuard in Medicare Advantage Star Ratings,2017-02-02 11:00:00 +0000,http://finance.yahoo.com/news/cms-proposes-inclusion-cologuard-medicare-110000041.html,"[PR Newswire] - MADISON, Wis., Feb. 2, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that Cologuard® is included in the Medicare Advantage Advance Notice and Draft Call letter. Cologuard's inclusion in the final Star Ratings will allow Medicare Advantage plans to increase their Star Rating when patients complete Exact Sciences' non-invasive colon cancer screening test. The Centers for Medicare and Medicaid Services (CMS) Medicare Advantage Star Ratings are directly impacted by the Healthcare Effectiveness Data and Information Set (HEDIS)."
EXAS,EXAS:US,BBG000CWL0F5,Cara Therapeutics (CARA) Worth Watching: Stock Jumps 8%,2017-02-01 15:36:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/35jF0PZZFwI/cara-therapeutics-cara-worth-watching-stock-jumps-8-cm741499,Cara Therapeutics Inc CARA was a big mover last session as the company saw its shares climb over 8 on the day The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is now up 57 in
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences to participate in Leerink Partners Global Healthcare Conference,2017-02-01 11:00:00 +0000,http://finance.yahoo.com/news/exact-sciences-participate-leerink-partners-110000504.html,"[PR Newswire] - MADISON, Wis., Feb. 1, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that the company will participate in the 6th Annual Leerink Partners Global Healthcare Conference in New York. Kevin Conroy, Exact Sciences' chairman and CEO, will deliver the company's presentation on Thursday, Feb. 16 at 11 a.m. EST. Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer."
EXAS,EXAS:US,BBG000CWL0F5,Pfizer (PFE) C. Difficile Vaccine Positive in Phase II Study,2017-01-27 16:35:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6M_jyQpEsgk/pfizer-pfe-c-difficile-vaccine-positive-in-phase-ii-study-cm739355,Pfizer Inc PFE announced positive top line results from a phase II study on its investigational vaccine candidate PF 06425090 for the prevention of clostridium difficile infection which includes life threatening diarrhea and pseudomembranous colitis The phase II
EXAS,EXAS:US,BBG000CWL0F5,Pfizer (PFE) C. Difficile Vaccine Positive in Phase II Study,2017-01-27 14:35:02 +0000,http://finance.yahoo.com/news/pfizer-pfe-c-difficile-vaccine-143502685.html,Pfizer (PFE) C. Difficile Vaccine Positive in Phase II Study
EXAS,EXAS:US,BBG000CWL0F5,Vertex Pharma's (VRTX) Q4 Earnings & Sales Beat; Stock Up,2017-01-26 16:34:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TdoTuN4bIz8/vertex-pharmas-vrtx-q4-earnings-sales-beat-stock-up-cm738667,Vertex Pharmaceuticals Inc VRTX reported fourth quarter 2016 earnings of 11 cents per share including the impact of stock based compensation expenses The Zacks Consensus Estimate was of a loss of 1 cent per share Notably the company had posted breakeven results in the year ago
EXAS,EXAS:US,BBG000CWL0F5,Vertex Pharma's (VRTX) Q4 Earnings & Sales Beat; Stock Up,2017-01-26 14:36:02 +0000,http://finance.yahoo.com/news/vertex-pharmas-vrtx-q4-earnings-143602302.html,Vertex Pharma's (VRTX) Q4 Earnings & Sales Beat; Stock Up
EXAS,EXAS:US,BBG000CWL0F5,"Exact Sciences to host fourth-quarter, full-year 2016 results webcast and call",2017-01-26 11:00:00 +0000,http://finance.yahoo.com/news/exact-sciences-host-fourth-quarter-110000365.html,"[PR Newswire] - MADISON, Wis., Jan. 26, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that the company will host a webcast and conference call on Feb. 21, 2017, to discuss its fourth-quarter and full-year 2016 financial results and commercial accomplishments. Exact Sciences' management also will discuss the company's 2017 priorities, including its product pipeline."
EXAS,EXAS:US,BBG000CWL0F5,5 Healthcare Stocks Poised for Maximum Gains in 2017,2017-01-17 22:38:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XgjiyxvpJcg/5-healthcare-stocks-poised-for-maximum-gains-in-2017-cm734458,The healthcare sector s drop in the past year means that investors can buy many healthcare stocks on sale including these five stocks All five could experience explosive growth in 2017 and they are trading at share prices that are below 2016 s peak Read on to find out if now is
EXAS,EXAS:US,BBG000CWL0F5,5 Healthcare Stocks Poised for Maximum Gains in 2017,2017-01-17 21:20:06 +0000,http://www.fool.com/investing/2017/01/17/5-healthcare-stocks-poised-for-maximum-gains-in-20.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,5 Healthcare Stocks Poised for Maximum Gains in 2017
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences' Stock Could Go Much Higher,2017-01-14 17:10:07 +0000,http://www.fool.com/investing/2017/01/13/why-exact-sciences-stock-could-go-much-higher.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Exact Sciences' Stock Could Go Much Higher
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Grants Inducement Restricted Stock Unit Awards to Recently Hired Employees,2017-01-13 21:05:00 +0000,http://finance.yahoo.com/news/exact-sciences-grants-inducement-restricted-210500756.html,"[PR Newswire] - MADISON, Wis., Jan.13, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that, in support of the Company's continued growth plans, it granted restricted stock units covering a total of 53,275 shares of common stock to 45 recently hired non-executive employees under its previously announced inducement grant program. The restricted stock unit awards vest in four equal annual installments beginning on the first anniversary of the grant date. The awards were granted as an inducement material to the recently hired employees entering into employment with the Company in accordance with NASDAQ Marketplace Rule 5635(c)(4). The Company is making this announcement as required by NASDAQ rules. Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer."
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences' Stock Could Go Much Higher,2017-01-13 18:38:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6wTzln-cYKk/why-exact-sciences-stock-could-go-much-higher-cm733402,Exact Sciences NASDAQ EXAS announced preliminary fourth quarter and full year 2016 financial results on Sunday Those numbers were so impressive that the molecular diagnostics company s stock soared more than 20 On Thursday Exact Sciences CEO Kevin Conroy spoke at the J P
EXAS,EXAS:US,BBG000CWL0F5,"Why Ariad Pharmaceuticals, VCA, and Exact Sciences Jumped Today",2017-01-10 00:48:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3eY2Ln0PdpQ/why-ariad-pharmaceuticals-vca-and-exact-sciences-jumped-today-cm731362,The stock market started the new week on a sluggish note Monday and the broadest based market benchmarks gave up ground as the Dow fell further away from the 20 000 mark Even though the Nasdaq Composite climbed to new highs a 2 per barrel plunge in the price of oil to fall below
EXAS,EXAS:US,BBG000CWL0F5,"Why Ariad Pharmaceuticals, VCA, and Exact Sciences Jumped Today",2017-01-09 23:21:00 +0000,http://www.fool.com/investing/2017/01/09/why-ariad-pharmaceuticals-vca-and-exact-sciences-j.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,"Why Ariad Pharmaceuticals, VCA, and Exact Sciences Jumped Today"
EXAS,EXAS:US,BBG000CWL0F5,"Exact Sciences Q4 Sales Beat, Colon-Cancer Test Procedures Double",2017-01-09 21:15:26 +0000,http://www.investors.com/news/technology/exact-sciences-q4-sales-beat-colon-cancer-test-procedures-double/,"Exact Sciences Q4 Sales Beat, Colon-Cancer Test Procedures Double"
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences Corp. Is Surging 19.3% Today,2017-01-09 20:49:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Tmtis-HdzHA/why-exact-sciences-corp-is-surging-193-today-cm731270,Image source Getty Images What happened After the company announced preliminary fourth quarter figures that are better than what industry watchers were expecting shares in Exact Sciences NASDAQ EXAS 160 were soaring 19 3 higher today at 2 p m EST So
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences Corp. Is Surging 19.3% Today,2017-01-09 19:27:49 +0000,http://www.fool.com/investing/2017/01/09/why-exact-sciences-corp-is-surging-19-3-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Exact Sciences Corp. Is Surging 19.3% Today
EXAS,EXAS:US,BBG000CWL0F5,"ETFs with exposure to EXACT Sciences Corp. : January 9, 2017",2017-01-09 18:19:21 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-exact-sciences-corp-january-9-2017/,"ETFs with exposure to EXACT Sciences Corp. : January 9, 2017"
EXAS,EXAS:US,BBG000CWL0F5,"EXACT Sciences Corp. – Value Analysis (NASDAQ:EXAS) : January 9, 2017",2017-01-09 15:55:06 +0000,http://www.capitalcube.com/blog/index.php/exact-sciences-corp-value-analysis-nasdaqexas-january-9-2017/,"EXACT Sciences Corp. – Value Analysis (NASDAQ:EXAS) : January 9, 2017"
EXAS,EXAS:US,BBG000CWL0F5,Better Buy: Myriad Genetics vs. Exact Sciences,2017-01-09 15:52:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PiZIxbjHN78/better-buy-myriad-genetics-vs-exact-sciences-cm731000,Human understanding of genetics is changing the world and two companies in the forefront of that momentous change are Myriad Genetics NASDAQ MYGN and Exact Sciences NASDAQ EXAS However the molecular diagnostics companies stocks have taken quite different trajectories
EXAS,EXAS:US,BBG000CWL0F5,Better Buy: Myriad Genetics vs. Exact Sciences,2017-01-09 14:56:12 +0000,http://www.fool.com/investing/2017/01/09/better-buy-myriad-genetics-inc-vs-exact-sciences.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Myriad Genetics vs. Exact Sciences
EXAS,EXAS:US,BBG000CWL0F5,"Stocks Mixed, Nasdaq Up; Apple Breaks Out Past New Buy Point",2017-01-09 14:45:33 +0000,http://www.investors.com/market-trend/stock-market-today/stock-futures-global-markets-mixed-oil-drops-jd-com-gets-upgrade/,"Stocks Mixed, Nasdaq Up; Apple Breaks Out Past New Buy Point"
EXAS,EXAS:US,BBG000CWL0F5,"Health Care Sector Update for 01/09/2017: ARWR, EXAS, JNJ, PFE, ABT, MRK, AMGN",2017-01-09 14:29:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VSSQ8tsQet8/health-care-sector-update-for-01092017-arwr-exas-jnj-pfe-abt-mrk-amgn-cm730945,Top Health Care stocks Top Health Care stocks JNJ 0 1 JNJ 0 1 PFE 0 1 PFE 0 1 ABT 0 1 ABT 0 1 MRK 0 4 MRK 0 4 AMGN 0 5 AMGN 0 5 Health care shares were mostly higher in pre market trade Monday Health care shares were mostly higher in pre market trade Monday In health
EXAS,EXAS:US,BBG000CWL0F5,Diagnosing colon cancer in the privacy of your own home,2017-01-09 13:04:43 +0000,http://finance.yahoo.com/video/diagnosing-colon-cancer-privacy-own-130443242.html,Diagnosing colon cancer in the privacy of your own home
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Corp. (EXAS) Is Climbing On Revenue Forecast,2017-01-09 09:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a66q8BJ-z5A/exact-sciences-corp-exas-is-climbing-on-revenue-forecast-20170109-00648,Exact Sciences Corp. (EXAS) Is Climbing On Revenue Forecast
EXAS,EXAS:US,BBG000CWL0F5,"Exact Sciences to report $99 million in revenues, 150 percent growth for 2016",2017-01-08 23:00:00 +0000,http://finance.yahoo.com/news/exact-sciences-report-99-million-230000502.html,"[PR Newswire] - MADISON, Wis., Jan. 8, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) announced today that the company expects to report revenues between $34.9 million and $35.4 million for the fourth quarter ended Dec. 31, 2016, an increase of 142 percent from the same quarter of 2015. More than 9,500 health care providers ordered Cologuard for the first time during the fourth quarter ended Dec. 31, 2016. The number of providers who have ordered Cologuard since it was launched increased to nearly 60,000 during 2016, an increase of 122 percent from the prior year. Insurance coverage of Cologuard expanded by 67 percent during 2016."
EXAS,EXAS:US,BBG000CWL0F5,"EXAS Abuzz, MACK Makes Deal With Ipsen, XENE Awaits Data",2017-01-08 22:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WoouSJVRzBk/exas-abuzz-mack-makes-deal-with-ipsen-xene-awaits-data-20170108-00044,"EXAS Abuzz, MACK Makes Deal With Ipsen, XENE Awaits Data"
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Sees Higher Revenues In Q4,2017-01-08 19:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VkyGG_lOeB0/exact-sciences-sees-higher-revenues-in-q4-20170108-00024,Exact Sciences Sees Higher Revenues In Q4
EXAS,EXAS:US,BBG000CWL0F5,"EXACT Sciences Corp. breached its 50 day moving average in a Bullish Manner : EXAS-US : January 6, 2017",2017-01-06 12:40:05 +0000,http://www.capitalcube.com/blog/index.php/exact-sciences-corp-breached-its-50-day-moving-average-in-a-bullish-manner-exas-us-january-6-2017/,"EXACT Sciences Corp. breached its 50 day moving average in a Bullish Manner : EXAS-US : January 6, 2017"
EXAS,EXAS:US,BBG000CWL0F5,Cologuard Earns Positive Review from Blue Cross Blue Shield Association,2017-01-05 13:22:00 +0000,http://finance.yahoo.com/news/cologuard-earns-positive-review-blue-132200442.html,"[PR Newswire] - MADISON, Wis., Jan. 5, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that the Blue Cross Blue Shield Association's (BCBSA) Center for Clinical Effectiveness ""Evidence Street"" recently released a positive review of Cologuard to its members. BCBSA is a national federation of 36 Blue Cross and Blue Shield companies that insure one in three Americans. The BCBSA's Center for Clinical Effectiveness is an organization that assesses the effectiveness of medical devices, procedures, and biological products through comprehensive reviews and clinical evidence. The Evidence Street assessment follows other positive reviews of Cologuard, which is now included in the recommendations of the U.S. Preventive Services Task Force, and the colorectal cancer screening guidelines of the American Cancer Society and the National Comprehensive Cancer Network."
EXAS,EXAS:US,BBG000CWL0F5,"Wednesday's ETF Movers: XBI, XLE",2017-01-04 18:37:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sX3kPjb0BQU/wednesdays-etf-movers-xbi-xle-cm729441,In trading on Wednesday the SPDR S amp P Biotech ETF is outperforming other ETFs up about 4 5 on the day Components of that ETF showing particular strength include shares of Acadia Pharmaceuticals up about 10 1 and shares of Exact Sciences up about 10 on the day And
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences Corp. Shot 44.7% Higher in 2016,2017-01-04 14:39:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xYrNuuCuntY/why-exact-sciences-corp-shot-447-higher-in-2016-cm729103,IMAGE SOURCE GETTY IMAGES What happened Soaring sales following the launch of its colon cancer DNA test Cologuard led to Exact Sciences NASDAQ EXAS shares surging 44 7 higher in 2016 according to S amp P Global Market Intelligence So what Colonoscopies may be
EXAS,EXAS:US,BBG000CWL0F5,Biotech Stocks to Watch in 2017 Enanta Pharmaceuticals and EXACT Sciences,2017-01-04 14:15:00 +0000,http://finance.yahoo.com/news/biotech-stocks-watch-2017-enanta-141500697.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / January 4, 2017 / The Biotech Industry posted a sharp loss in 2016 as concerns over price gouging plagued the Industry. The iShares NASDAQ Biotechnology Index ETF (IBB) fell ..."
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences Corp. Shot 44.7% Higher in 2016,2017-01-04 13:21:10 +0000,http://www.fool.com/investing/2017/01/04/why-exact-sciences-corp-shot-447-higher-in-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Exact Sciences Corp. Shot 44.7% Higher in 2016
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences to participate in J.P. Morgan Healthcare Conference,2017-01-03 11:00:00 +0000,http://finance.yahoo.com/news/exact-sciences-participate-j-p-110000992.html,"[PR Newswire] - MADISON, Wis., Jan. 3, 2017 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will participate in the 35th Annual J.P. Morgan Healthcare Conference in San Francisco. Kevin Conroy, Exact Sciences' chairman and CEO, will present on Thursday, Jan. 12 at 7:30 a.m. PT. Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer."
EXAS,EXAS:US,BBG000CWL0F5,3 Under-the-Radar Biotech Stocks to Watch in 2017,2017-01-01 21:56:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wT6jay7pEiA/3-under-the-radar-biotech-stocks-to-watch-in-2017-cm728290,You read plenty about the biggest biotechs on the market But what about smaller biotechs that have a lot of potential Akebia Therapeutics NASDAQ AKBA Synergy Pharmaceuticals NASDAQ SGYP and Exact Sciences NASDAQ EXAS might not have huge market caps yet but they
EXAS,EXAS:US,BBG000CWL0F5,3 Under-the-Radar Biotech Stocks to Watch in 2017,2017-01-01 20:07:51 +0000,http://www.fool.com/investing/2017/01/01/3-under-the-radar-biotech-stocks-to-watch-in-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Under-the-Radar Biotech Stocks to Watch in 2017
EXAS,EXAS:US,BBG000CWL0F5,New Strong Buy Stocks for December 29th,2016-12-29 17:02:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e-29H2L5tEU/new-strong-buy-stocks-for-december-29th-cm727553,Here are 5 stocks added to the Zacks Rank 1 Strong Buy List today Ameren Corporation AEE This public utility holding company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0 1 over the last 30 days AMEREN CORP Price and
EXAS,EXAS:US,BBG000CWL0F5,New Strong Buy Stocks for December 29th,2016-12-29 13:51:01 +0000,http://finance.yahoo.com/news/strong-buy-stocks-december-29th-135101589.html,New Strong Buy Stocks for December 29th
EXAS,EXAS:US,BBG000CWL0F5,"Exact Sciences (EXAS): Strong Industry, Solid Earnings Estimate Revisions",2016-12-16 14:59:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MmKEluC9i3E/exact-sciences-exas-strong-industry-solid-earnings-estimate-revisions-cm722468,One stock that might be an intriguing choice for investors right now is Exact Sciences Corporation EXAS This is because this security in the Medical Biomedical Genetics space is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank
EXAS,EXAS:US,BBG000CWL0F5,"Exact Sciences (EXAS): Strong Industry, Solid Earnings Estimate Revisions",2016-12-16 13:31:01 +0000,http://finance.yahoo.com/news/exact-sciences-exas-strong-industry-133101154.html,"Exact Sciences (EXAS): Strong Industry, Solid Earnings Estimate Revisions"
EXAS,EXAS:US,BBG000CWL0F5,Cologuard Available to Humana Members as In-Network Colon Cancer Screening Option,2016-12-12 11:00:00 +0000,http://finance.yahoo.com/news/cologuard-available-humana-members-network-110000905.html,"[PR Newswire] - MADISON, Wis., Dec. 12, 2016 /PRNewswire/ -- Exact Sciences Corp. (EXAS) announced today that under a recently-signed contract, Humana Inc. agreed to cover Cologuard as an in-network service for its members, effective January 1, 2017. ""As demand for Cologuard grows, this contract marks an opportunity to increase access to colon cancer screening among Humana's beneficiaries who now can choose Cologuard and its wrap-around compliance service,"" said Kevin Conroy, chairman and CEO of Exact Sciences."
EXAS,EXAS:US,BBG000CWL0F5,"ETFs with exposure to EXACT Sciences Corp. : December 9, 2016",2016-12-09 18:23:47 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-exact-sciences-corp-december-9-2016/,"ETFs with exposure to EXACT Sciences Corp. : December 9, 2016"
EXAS,EXAS:US,BBG000CWL0F5,Is EXACT Sciences Corporation (EXAS) a Good Stock to Buy?,2016-12-08 14:00:54 +0000,http://www.insidermonkey.com/blog/is-exact-sciences-corporation-exas-a-good-stock-to-buy-500646/,Is EXACT Sciences Corporation (EXAS) a Good Stock to Buy?
EXAS,EXAS:US,BBG000CWL0F5,Hedge Funder Whitney Tilson’s Three Short and One Long Picks,2016-12-06 16:22:39 +0000,http://www.insidermonkey.com/blog/hedge-funder-whitney-tilsons-three-short-and-one-long-picks-495600/,Hedge Funder Whitney Tilson’s Three Short and One Long Picks
EXAS,EXAS:US,BBG000CWL0F5,Is GCP Applied Technologies Inc (GCP) Going to Burn These Hedge Funds?,2016-12-06 15:51:47 +0000,http://www.insidermonkey.com/blog/is-gcp-applied-technologies-inc-gcp-going-to-burn-these-hedge-funds-499630/,Is GCP Applied Technologies Inc (GCP) Going to Burn These Hedge Funds?
EXAS,EXAS:US,BBG000CWL0F5,Is Prothena Corporation PLC (PRTA) Going to Burn These Hedge Funds?,2016-12-05 07:08:37 +0000,http://www.insidermonkey.com/blog/is-prothena-corporation-plc-prta-going-to-burn-these-hedge-funds-498205/,Is Prothena Corporation PLC (PRTA) Going to Burn These Hedge Funds?
EXAS,EXAS:US,BBG000CWL0F5,Is Depomed Inc (DEPO) A Good Stock To Buy?,2016-12-02 13:40:48 +0000,http://www.insidermonkey.com/blog/is-depomed-inc-depo-a-good-stock-to-buy-496689/,Is Depomed Inc (DEPO) A Good Stock To Buy?
EXAS,EXAS:US,BBG000CWL0F5,EXACT Sciences is Now Oversold (EXAS),2016-12-01 22:33:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q6RdmakTQBs/exact-sciences-is-now-oversold-exas-cm716640,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
EXAS,EXAS:US,BBG000CWL0F5,"ETFs with exposure to EXACT Sciences Corp. : November 28, 2016",2016-11-28 17:07:20 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-exact-sciences-corp-november-28-2016/,"ETFs with exposure to EXACT Sciences Corp. : November 28, 2016"
EXAS,EXAS:US,BBG000CWL0F5,3 Charts That Point to a Great Future for Exact Sciences,2016-11-28 14:33:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KowX3ZpWKck/3-charts-that-point-to-a-great-future-for-exact-sciences-cm714389,What a difference a year makes Exact Sciences NASDAQ EXAS shares got clobbered in 2015 but the stock has been on a roll in 2016 up nearly 60 year to date What s next for the molecular diagnostics company Here are three charts that could point to a great future for
EXAS,EXAS:US,BBG000CWL0F5,3 Charts That Point to a Great Future for Exact Sciences,2016-11-28 13:32:29 +0000,http://www.fool.com/investing/2016/11/28/3-charts-that-point-to-a-great-future-for-exact-sc.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Charts That Point to a Great Future for Exact Sciences
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Grants Inducement Restricted Stock Unit Awards to Recently Hired Employees,2016-11-18 21:05:00 +0000,http://finance.yahoo.com/news/exact-sciences-grants-inducement-restricted-210500949.html,"[PR Newswire] - MADISON, Wis., Nov. 18, 2016 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that, in support of the Company's continued growth plans, it granted restricted stock units covering a total of 47,704 shares of common stock to 40 recently hired non-executive employees under its previously announced inducement grant program. The awards were granted as an inducement material to the recently hired employees entering into employment with the Company in accordance with NASDAQ Marketplace Rule 5635(c)(4). The Company is making this announcement as required by NASDAQ rules. Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer."
EXAS,EXAS:US,BBG000CWL0F5,"ETFs with exposure to EXACT Sciences Corp. : November 16, 2016",2016-11-16 18:06:07 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-exact-sciences-corp-november-16-2016/,"ETFs with exposure to EXACT Sciences Corp. : November 16, 2016"
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Corp (EXAS) President and CEO Kevin T Conroy Sold $10.5 million of Shares,2016-11-16 06:15:10 +0000,http://finance.yahoo.com/news/exact-sciences-corp-exas-president-061510990.html,Exact Sciences Corp (EXAS) President and CEO Kevin T Conroy Sold $10.5 million of Shares
EXAS,EXAS:US,BBG000CWL0F5,"EXACT Sciences Corp. :EXAS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016",2016-11-14 15:42:36 +0000,http://www.capitalcube.com/blog/index.php/exact-sciences-corp-exas-us-earnings-analysis-q3-2016-by-the-numbers-november-14-2016/,"EXACT Sciences Corp. :EXAS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016"
EXAS,EXAS:US,BBG000CWL0F5,"EXACT SCIENCES CORP Files SEC form 8-K, Change in Directors or Principal Officers",2016-11-10 21:18:07 +0000,http://biz.yahoo.com/e/161110/exas8-k.html,"EXACT SCIENCES CORP Files SEC form 8-K, Change in Directors or Principal Officers"
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Appoints Jeff Elliott Chief Financial Officer,2016-11-08 21:05:00 +0000,http://finance.yahoo.com/news/exact-sciences-appoints-jeff-elliott-210500665.html,"[PR Newswire] - ""Demand for Cologuard is accelerating and an enormous market opportunity lies ahead to achieve our mission of eradicating colon cancer,"" said Kevin Conroy, Exact Sciences' chairman and CEO. Mr. Elliott's experience includes nearly nine years at Baird, most recently as the senior research analyst who covered diagnostics and life science tools companies. Previously in his career, Mr. Elliott worked in various positions at Walgreens and Cap Gemini Ernst & Young. He earned a Bachelor of Science in Business Administration from the University of Illinois at Urbana-Champaign and a Master of Business Administration from the University of Chicago Booth School of Business."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences to participate in November investor conferences,2016-11-08 20:05:00 +0000,http://finance.yahoo.com/news/exact-sciences-participate-november-investor-200500918.html,"[PR Newswire] - MADISON, Wis., Nov. 8, 2016 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that the company will participate in three investor conferences during November. Kevin Conroy, the company's chairman and CEO, will participate in a fireside chat at the Stephens Fall Investment Conference on Wednesday, Nov. 9 at 2 p.m. ET in New York. Mr. Conroy also will make the company's presentation at the Craig-Hallum Alpha Select Conference on Wednesday, Nov. 16 at 10:40 a.m. ET in New York."
EXAS,EXAS:US,BBG000CWL0F5,1 Sentence in Exact Sciences Corporation's Q3 Report Cost It 16% in October,2016-11-08 18:59:00 +0000,http://www.fool.com/investing/2016/11/07/1-sentence-in-exact-sciences-corporations-q3-repor.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,1 Sentence in Exact Sciences Corporation's Q3 Report Cost It 16% in October
EXAS,EXAS:US,BBG000CWL0F5,1 Sentence in Exact Sciences Corporation's Q3 Report Cost It 16% in October,2016-11-07 19:54:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0xfydg7I8Ec/1-sentence-in-exact-sciences-corporations-q3-report-cost-it-16-in-october-cm705188,Cologuard collection kit Image source Exact Sciences What happened Shares of Exact Sciences NASDAQ EXAS a molecular diagnostics company focused on the development of diagnostic tools to detect and prevent cancer lost 16 of their value in October according to data
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Corp. Gets a Better Balance Sheet,2016-11-03 19:08:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3JAntOk-GfU/exact-sciences-corp-gets-a-better-balance-sheet-cm703562,Investors are avoiding Exact Sciences NASDAQ EXAS 160 shares because spending in support of the launch of its Cologuard colon cancer screening test is taxing its balance sheet However increasing Cologuard sales stable costs and a 144 2 million follow on offering
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Corp. Gets a Better Balance Sheet,2016-11-03 17:29:37 +0000,http://www.fool.com/investing/2016/11/03/exact-sciences-balance-sheet-takes-steps-forward.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Exact Sciences Corp. Gets a Better Balance Sheet
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences’ Cologuard product wins a top honor for innovation,2016-10-28 18:50:12 +0000,http://www.bizjournals.com/milwaukee/news/2016/10/28/exact-sciences-cologuard-productwins-a-top-honor.html?ana=yahoo,Exact Sciences’ Cologuard product wins a top honor for innovation
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences' Cologuard Wins Prestigious Prix Galien Award for Best Medical Technology Product,2016-10-28 10:00:00 +0000,http://finance.yahoo.com/news/exact-sciences-cologuard-wins-prestigious-100000625.html,"[PR Newswire] - MADISON, Wis., Oct. 28, 2016 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that Cologuard, the first and only FDA-approved noninvasive, stool DNA-based colorectal cancer screening test, has won the 2016 10th Annual Prix Galien USA Award for best medical technology product. Awarded by the Galien Foundation, the Prix Galien USA awards are among the nation's highest honors recognizing biomedical and technology product achievement associated with improving the human condition. ""It's an extraordinary honor for Cologuard and the Exact Sciences team to be recognized in such a distinguished forum,"" said Graham Lidgard, Ph.D., chief science officer of Exact Sciences."
EXAS,EXAS:US,BBG000CWL0F5,Is This the Most Important Take-Away From Exact Sciences Third Quarter Results?,2016-10-27 13:44:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HFPzAB_xQ5k/is-this-the-most-important-take-away-from-exact-sciences-third-quarter-results-cm699141,Image source Getty Images Exact Sciences NASDAQ EXAS reported third quarter earnings results yesterday and while shares are dropping because management lowered the top end of its full year sales guidance investors might want to focus less on that number and more on
EXAS,EXAS:US,BBG000CWL0F5,"EXACT Sciences Corp. breached its 50 day moving average in a Bearish Manner : EXAS-US : October 27, 2016",2016-10-27 12:29:43 +0000,http://www.capitalcube.com/blog/index.php/exact-sciences-corp-breached-its-50-day-moving-average-in-a-bearish-manner-exas-us-october-27-2016/,"EXACT Sciences Corp. breached its 50 day moving average in a Bearish Manner : EXAS-US : October 27, 2016"
EXAS,EXAS:US,BBG000CWL0F5,Is This the Most Important Take-Away From Exact Sciences Third Quarter Results?,2016-10-27 12:14:58 +0000,http://www.fool.com/investing/2016/10/27/is-this-the-most-important-take-away-from-exact-sc.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is This the Most Important Take-Away From Exact Sciences Third Quarter Results?
EXAS,EXAS:US,BBG000CWL0F5,Edited Transcript of EXAS earnings conference call or presentation 26-Oct-16 2:00pm GMT,2016-10-27 02:36:24 +0000,http://finance.yahoo.com/news/edited-transcript-exas-earnings-conference-023624108.html,Edited Transcript of EXAS earnings conference call or presentation 26-Oct-16 2:00pm GMT
EXAS,EXAS:US,BBG000CWL0F5,Marketplace Roundtable: Diving Into Dividend Investing,2016-10-26 22:51:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pqve5Y3NS9Q/marketplace-roundtable-diving-into-dividend-investing-cm693785,By SA Marketplace BySA Marketplace 2016 has sent investors on the quest for holy yield Interest rates remain at barely positive levels despite Fed murmurings and that has forced income seeking investors towards dividend paying stocks Which leads to its own questions about whether
EXAS,EXAS:US,BBG000CWL0F5,Mid-Afternoon Market Update: Crude Oil Down Over 1.5%; NCR Shares Spike Higher,2016-10-26 21:29:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rVGcSFpwU2g/mid-afternoon-market-update-crude-oil-down-over-15-ncr-shares-spike-higher-cm698981,Toward the end of trading Wednesday the Dow traded up 0 23 percent to 18 211 80 while the NASDAQ declined 0 56 percent to 5 253 87 The S amp P also fell dropping 0 11 percent to 2 140 77 Leading and Lagging Sectors Wednesday afternoon industrials shares gained by 0 16
EXAS,EXAS:US,BBG000CWL0F5,"EXACT SCIENCES CORP Files SEC form 10-Q, Quarterly Report",2016-10-26 20:15:32 +0000,http://biz.yahoo.com/e/161026/exas10-q.html,"EXACT SCIENCES CORP Files SEC form 10-Q, Quarterly Report"
EXAS,EXAS:US,BBG000CWL0F5,Here's Why Exact Sciences Corporation's Stock Is Dropping Today,2016-10-26 18:52:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mpWgiTD3pHk/heres-why-exact-sciences-corporations-stock-is-dropping-today-cm698826,Image source Exact Sciences What happened Shares of Exact Sciences NASDAQ EXAS a 160 diagnostics company focused on colon cancer 160 dropped by 12 as of 12 30 p m EDT after the company announced its third quarter earnings So what Exact Sciences
EXAS,EXAS:US,BBG000CWL0F5,Here's Why Exact Sciences Corporation's Stock Is Dropping Today,2016-10-26 16:58:48 +0000,http://www.fool.com/investing/2016/10/26/heres-why-exact-sciences-corporation-is-dropping-t.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's Why Exact Sciences Corporation's Stock Is Dropping Today
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences' 3Q loss narrows as product use soars,2016-10-26 14:40:12 +0000,http://www.bizjournals.com/milwaukee/news/2016/10/26/exact-sciences-3q-loss-narrows-as-product-use.html?ana=yahoo,Exact Sciences' 3Q loss narrows as product use soars
EXAS,EXAS:US,BBG000CWL0F5,Q3 2016 Exact Sciences Corp Earnings Release - Before Market Open,2016-10-26 11:07:02 +0000,http://biz.yahoo.com/research/earncal/20161026.html?t=exas,Q3 2016 Exact Sciences Corp Earnings Release - Before Market Open
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences reports 3Q loss,2016-10-26 10:06:37 +0000,http://sg.finance.yahoo.com/news/exact-sciences-reports-3q-loss-100637368.html,Exact Sciences reports 3Q loss
EXAS,EXAS:US,BBG000CWL0F5,"Exact Sciences Completes 68,000 Cologuard Tests During the Third Quarter",2016-10-26 10:00:00 +0000,http://finance.yahoo.com/news/exact-sciences-completes-68-000-100000979.html,"[PR Newswire] - MADISON, Wis., Oct. 26, 2016 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenues of $28.1 million during the third quarter ended Sept. 30, 2016, an increase ..."
EXAS,EXAS:US,BBG000CWL0F5,"Drug Stock Earnings to Watch on Oct 26: BIIB, MDCO & More",2016-10-25 12:27:12 +0000,http://finance.yahoo.com/news/drug-stock-earnings-watch-oct-122712297.html,"Drug Stock Earnings to Watch on Oct 26: BIIB, MDCO & More"
EXAS,EXAS:US,BBG000CWL0F5,4 stocks to watch,2016-10-18 16:54:11 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=83132823-814D-42DE-8A5F-13300E84296A&siteid=yhoof2,4 stocks to watch
EXAS,EXAS:US,BBG000CWL0F5,Advance Auto Parts Breaks Down,2016-10-18 15:38:00 +0000,http://www.forbes.com/sites/greatspeculations/2016/10/18/advance-auto-parts-breaks-down/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Advance Auto Parts Breaks Down
EXAS,EXAS:US,BBG000CWL0F5,"2 Longs And 2 Shorts to Watch: Week Of October 18, 2016",2016-10-18 15:23:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t-40pbm_4Ng/2-longs-and-2-shorts-to-watch-week-of-october-18-2016-cm694780,"After another sloppy day on Wall Street Monday, we're going to feature shorts as well as longs for traders to consider in this choppy market.  On the short side, Advance Auto Parts Inc. ( AAP ) broke down from a wedge pattern on Monday, dropping 3.37 to 143.27 on 800,000 shares. Next support for the stock is in the"
EXAS,EXAS:US,BBG000CWL0F5,"Commit To Purchase EXACT Sciences Corp. At $13, Earn 12.3% Using Options",2016-10-17 15:41:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZgFQxL0qsYo/commit-to-purchase-exact-sciences-corp-at-13-earn-123-using-options-cm694206,Investors considering a purchase of EXACT Sciences Corp Symbol EXAS stock but cautious about paying the going market price of 18 94 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the
EXAS,EXAS:US,BBG000CWL0F5,Cologuard® Covered for TRICARE Beneficiaries,2016-10-17 10:00:00 +0000,http://finance.yahoo.com/news/cologuard-covered-tricare-beneficiaries-100000512.html,"[PR Newswire] - MADISON, Wis., Oct. 17, 2016 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that Cologuard® is now covered under TRICARE's preventive services policies for use every three years without patient coinsurance, copayments or deductibles. The update was made after TRICARE's review of its screening coverage policies to align them with the preventive services coverage mandate of the Affordable Care Act. TRICARE is the health care program of the U.S. Department of Defense, providing benefits to 9.4 million active-duty, reserve and National Guard personnel, veterans and their dependents. ""Cologuard is the ideal patient-friendly colon cancer screening option for America's active military and veterans to use at-home, ensuring they can efficiently be screened for the most preventable form of cancer,"" said Kevin Conroy, chairman and CEO of Exact Sciences."
EXAS,EXAS:US,BBG000CWL0F5,"ETF’s with exposure to EXACT Sciences Corp. : October 14, 2016",2016-10-14 14:43:07 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-exact-sciences-corp-october-14-2016/,"ETF’s with exposure to EXACT Sciences Corp. : October 14, 2016"
EXAS,EXAS:US,BBG000CWL0F5,Daily Wrap: The Biggest Hedge Fund Moves of the Day,2016-10-12 12:53:17 +0000,http://www.insidermonkey.com/blog/daily-wrap-the-biggest-hedge-fund-moves-of-the-day-480780/,Daily Wrap: The Biggest Hedge Fund Moves of the Day
EXAS,EXAS:US,BBG000CWL0F5,"EXACT Sciences Corp. breached its 50 day moving average in a Bullish Manner : EXAS-US : October 11, 2016",2016-10-11 12:18:01 +0000,http://www.capitalcube.com/blog/index.php/exact-sciences-corp-breached-its-50-day-moving-average-in-a-bullish-manner-exas-us-october-11-2016/,"EXACT Sciences Corp. breached its 50 day moving average in a Bullish Manner : EXAS-US : October 11, 2016"
EXAS,EXAS:US,BBG000CWL0F5,6 Healthcare Stocks Investors Can't Miss in Q3 Earnings,2016-10-07 16:22:04 +0000,http://finance.yahoo.com/news/6-healthcare-stocks-investors-cant-162204234.html,6 Healthcare Stocks Investors Can't Miss in Q3 Earnings
EXAS,EXAS:US,BBG000CWL0F5,"Zacks.com featured highlights: Anika Therapeutics, Advanced Micro Devices, Edwards Lifesciences, Exact and Legacy Texas Financial Group",2016-10-05 15:48:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/agfWCR_LlNI/zackscom-featured-highlights-anika-therapeutics-advanced-micro-devices-edwards-lifesciences-exact-and-legacy-texas-financial-group-cm689116,For Immediate Release Chicago IL October 05 2016 Stocks in this week s article include Anika Therapeutics NASDAQ ANIK Free Report Advanced Micro Devices AMD Free Report Edwards Lifesciences Corp NYSE EW Free Report Exact Sciences Corp NASDAQ
EXAS,EXAS:US,BBG000CWL0F5,"Zacks.com featured highlights: Anika Therapeutics, Advanced Micro Devices, Edwards Lifesciences, Exact and Legacy Texas Financial Group",2016-10-05 13:30:01 +0000,http://finance.yahoo.com/news/zacks-com-featured-highlights-anika-133001932.html,"Zacks.com featured highlights: Anika Therapeutics, Advanced Micro Devices, Edwards Lifesciences, Exact and Legacy Texas Financial Group"
EXAS,EXAS:US,BBG000CWL0F5,Get Ready To Be Surprised This Earnings Season,2016-10-04 21:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3VaZR4wJH7M/get-ready-to-be-surprised-this-earnings-season-cm688818,With earnings season officially set to begin next week Tuesday 10 11 16 with Alcoa reporting earnings before the opening bell this is a good screen to use both before and after a company reports Like any earnings season we re going to see both positive surprises and negative
EXAS,EXAS:US,BBG000CWL0F5,Get Ready To Be Surprised This Earnings Season,2016-10-04 18:07:06 +0000,http://finance.yahoo.com/news/ready-surprised-earnings-season-180706656.html,[Zacks] - Get Ready To Be Surprised This Earnings Season
EXAS,EXAS:US,BBG000CWL0F5,"Exact Sciences (EXAS) Stock Climbs, Colorectal Cancer Screening Guidelines Updated",2016-10-03 17:15:00 +0000,https://www.thestreet.com/story/13839229/1/exact-sciences-exas-stock-climbs-colorectal-cancer-screening-guidelines-updated.html?puc=yahoo&cm_ven=YAHOO,"Exact Sciences (EXAS) Stock Climbs, Colorectal Cancer Screening Guidelines Updated"
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Announces Inclusion of Cologuard® in HEDIS Quality Measures,2016-10-03 16:33:00 +0000,http://finance.yahoo.com/news/exact-sciences-announces-inclusion-cologuard-163300977.html,"[PR Newswire] - MADISON, Wis., Oct. 3, 2016 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that Cologuard® is now included in the 2017 Healthcare Effectiveness Data and Information Set (HEDIS) quality measures for colorectal cancer screening. The new quality measures were published by the National Committee for Quality Assurance (NCQA). ""Cologuard's inclusion in the preeminent quality measures and its standing as an A-graded service in a leading screening guideline are critical steps toward becoming a standard of care for colon cancer screening,"" said Kevin Conroy, chairman and CEO of Exact Sciences."
EXAS,EXAS:US,BBG000CWL0F5,"EXACT Sciences Corp. – Value Analysis (NASDAQ:EXAS) : October 3, 2016",2016-10-03 16:16:58 +0000,http://www.capitalcube.com/blog/index.php/exact-sciences-corp-value-analysis-nasdaqexas-october-3-2016/,"EXACT Sciences Corp. – Value Analysis (NASDAQ:EXAS) : October 3, 2016"
EXAS,EXAS:US,BBG000CWL0F5,"EXACT Sciences Corp. breached its 50 day moving average in a Bearish Manner : EXAS-US : September 30, 2016",2016-09-30 12:28:16 +0000,http://www.capitalcube.com/blog/index.php/exact-sciences-corp-breached-its-50-day-moving-average-in-a-bearish-manner-exas-us-september-30-2016/,"EXACT Sciences Corp. breached its 50 day moving average in a Bearish Manner : EXAS-US : September 30, 2016"
EXAS,EXAS:US,BBG000CWL0F5,"ETF’s with exposure to EXACT Sciences Corp. : September 29, 2016",2016-09-29 13:38:02 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-exact-sciences-corp-september-29-2016/,"ETF’s with exposure to EXACT Sciences Corp. : September 29, 2016"
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences to host third-quarter 2016 results webcast and call,2016-09-28 10:00:00 +0000,http://finance.yahoo.com/news/exact-sciences-host-third-quarter-100000733.html,"[PR Newswire] - Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer. The company has exclusive intellectual property protecting its noninvasive, molecular screening technology for the detection of colorectal cancer. Cologuard is included in the colorectal cancer screening guidelines of the American Cancer Society and stool DNA is included in the guidelines of the U.S. Multi-Society Task Force on Colorectal Cancer."
EXAS,EXAS:US,BBG000CWL0F5,"EXACT Sciences (EXAS) Shares March Higher, Can It Continue?",2016-09-23 16:24:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lUX9BAido7M/exact-sciences-exas-shares-march-higher-can-it-continue-cm683813,As of late it has definitely been a great time to be an investor in EXACT Sciences Corporation EXAS The stock has moved higher by 12 6 in the past month while it is also above its 20 Day SMA too This combination of strong price performance and favorable technical could suggest that
EXAS,EXAS:US,BBG000CWL0F5,"EXACT Sciences (EXAS) Shares March Higher, Can It Continue?",2016-09-23 14:34:02 +0000,http://finance.yahoo.com/news/exact-sciences-exas-shares-march-143402479.html,"EXACT Sciences (EXAS) Shares March Higher, Can It Continue?"
EXAS,EXAS:US,BBG000CWL0F5,4 health-care stocks to watch,2016-09-21 19:38:44 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=CCF56263-1AE7-4530-9EE1-DE0ED3FFB8FB&siteid=yhoof2,4 health-care stocks to watch
EXAS,EXAS:US,BBG000CWL0F5,3 Longs And 1 Short to Watch,2016-09-20 16:58:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pkoNH223dKo/3-longs-and-1-short-to-watch-cm682153,"Here are three stocks with strong technical momentum and one that appears to be headed lower.  Avon Products Inc. ( AVP ) is in a bullish consolidation after breaking out in early August.  The stock bounced off lateral support on Monday, closing up 27 cents to $5.54 on 5 million shares.  As long as the stock remains"
EXAS,EXAS:US,BBG000CWL0F5,2 Bullish Stock Picks and 2 Stocks to Sell Short,2016-09-20 15:59:00 +0000,https://www.thestreet.com/story/13746034/1/2-bullish-stock-picks-and-2-stocks-to-sell-short.html?puc=yahoo&cm_ven=YAHOO,2 Bullish Stock Picks and 2 Stocks to Sell Short
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Grants Inducement Restricted Stock Unit Awards to Recently Hired Employees,2016-09-16 20:15:00 +0000,http://finance.yahoo.com/news/exact-sciences-grants-inducement-restricted-201500324.html,"[PR Newswire] - MADISON, Wis., Sept. 16, 2016 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced that, in support of the Company's continued growth plans, it granted restricted stock units covering a ..."
EXAS,EXAS:US,BBG000CWL0F5,4 stocks to watch,2016-09-14 13:34:33 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=C0CFD741-F9D3-4FAC-8CD0-AB43DD606B57&siteid=yhoof2,4 stocks to watch
EXAS,EXAS:US,BBG000CWL0F5,4 Breakout Stocks to Watch,2016-09-08 15:57:00 +0000,https://www.thestreet.com/story/13698739/1/4-breakout-stocks-to-watch.html?puc=yahoo&cm_ven=YAHOO,4 Breakout Stocks to Watch
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences to participate in the Baird 2016 Global Healthcare Conference,2016-08-30 10:00:00 +0000,http://finance.yahoo.com/news/exact-sciences-participate-baird-2016-100000181.html,"[PR Newswire] - MADISON, Wis., Aug. 30, 2016 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that the company will participate in Baird's 2016 Global Healthcare Conference. Kevin Conroy, the company's chairman and chief executive, will participate in a fireside chat at the conference on Wednesday, Sept. 7 at 10:15 a.m. ET in New York. A live webcast of the fireside chat will be available through the company's website at www.exactsciences.com. An archived webcast will be available following the conclusion of the fireside chat."
EXAS,EXAS:US,BBG000CWL0F5,"ETF’s with exposure to EXACT Sciences Corp. : August 29, 2016",2016-08-29 15:22:43 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-exact-sciences-corp-august-29-2016/,"ETF’s with exposure to EXACT Sciences Corp. : August 29, 2016"
EXAS,EXAS:US,BBG000CWL0F5,"Exact Sciences (EXAS): Strong Industry, Solid Earnings Estimate Revisions",2016-08-29 14:14:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gZ_EITOha2I/exact-sciences-exas-strong-industry-solid-earnings-estimate-revisions-cm671619,"One stock that might be an intriguing choice for investors right now is Exact Sciences CorporationEXAS .This is because this security in the Medical Biomedical Genetics space is seeing solid earnings estimate revision activity, and is in"
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Corp (EXAS): Billionaire David E. Shaw’s D E Shaw Ups Its Stake,2016-08-26 16:53:02 +0000,http://www.insidermonkey.com/blog/exact-sciences-corp-exas-billionaire-david-e-shaws-d-e-shaw-ups-its-stake-470599/,Exact Sciences Corp (EXAS): Billionaire David E. Shaw’s D E Shaw Ups Its Stake
EXAS,EXAS:US,BBG000CWL0F5,Smaller Biotechs Surging to New Highs,2016-08-23 16:24:00 +0000,http://www.investopedia.com/stock-analysis/cotd/082316/smaller-biotechs-surging-new-highs-nktr-exas-nktr-exas-supn.aspx?partner=YahooSA,Smaller Biotechs Surging to New Highs
EXAS,EXAS:US,BBG000CWL0F5,"The Zacks Analyst Blog Highlights: Apple, Exact Sciences, Amkor Technology, Puma Biotechnology and Chemours",2016-08-19 15:50:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VEpkuzv5nv4/the-zacks-analyst-blog-highlights-apple-exact-sciences-amkor-technology-puma-biotechnology-and-chemours-cm667750,"For Immediate Release  Chicago, IL   August 19, 2016   Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events"
EXAS,EXAS:US,BBG000CWL0F5,"The Zacks Analyst Blog Highlights: Apple, Exact Sciences, Amkor Technology, Puma Biotechnology and Chemours",2016-08-19 13:30:01 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-apple-133001103.html,"The Zacks Analyst Blog Highlights: Apple, Exact Sciences, Amkor Technology, Puma Biotechnology and Chemours"
EXAS,EXAS:US,BBG000CWL0F5,"ETF’s with exposure to EXACT Sciences Corp. : August 18, 2016",2016-08-18 22:24:29 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-exact-sciences-corp-august-18-2016/,"ETF’s with exposure to EXACT Sciences Corp. : August 18, 2016"
EXAS,EXAS:US,BBG000CWL0F5,4 Biggest Winners from This Earnings Season,2016-08-18 20:45:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XgpT7w1CQKg/4-biggest-winners-from-this-earnings-season-cm667322,"As the earnings season nears its end and we begin adding up the numbers, things seem to be improving for corporate results as a whole. Though both earnings and revenues continue to decline year over year, results"
EXAS,EXAS:US,BBG000CWL0F5,4 Biggest Winners from This Earnings Season,2016-08-18 18:39:06 +0000,http://finance.yahoo.com/news/4-biggest-winners-earnings-season-183906439.html,4 Biggest Winners from This Earnings Season
EXAS,EXAS:US,BBG000CWL0F5,Better Buy: Exact Sciences Corporation vs. Myriad Genetics,2016-08-15 15:35:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MIgvzrOdgsY/better-buy-exact-sciences-corporation-vs-myriad-genetics-cm665298,Image source  Getty Images.  Two molecular diagnostics companies  One is profitable. The other isn't. One saw its bottom line grow year over year in the most recent quarter. The other saw a
EXAS,EXAS:US,BBG000CWL0F5,Better Buy: Exact Sciences Corporation vs. Myriad Genetics,2016-08-15 14:07:00 +0000,http://www.fool.com/investing/2016/08/15/better-buy-exact-sciences-corporation-vs-myriad-ge.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Exact Sciences Corporation vs. Myriad Genetics
EXAS,EXAS:US,BBG000CWL0F5,CMS Affirms Cologuard® Covered Every Three Years for Medicare Advantage Beneficiaries without Cost Sharing,2016-08-15 10:00:00 +0000,http://finance.yahoo.com/news/cms-affirms-cologuard-covered-every-100000725.html,"[PR Newswire] - MADISON, Wis., Aug. 15, 2016 /PRNewswire/ -- Exact Sciences Corp. (EXAS) announced that the Centers for Medicare and Medicaid Services (CMS) issued an updated Evidence of Coverage notice for Medicare Advantage plans that affirms such plans must include coverage of Cologuard every three years without patient coinsurance, copayments or deductibles. ""The CMS update assures patients and physicians that Cologuard is covered by Medicare Advantage plans without any out-of-pocket costs,"" said Kevin Conroy, chairman and CEO of Exact Sciences."
EXAS,EXAS:US,BBG000CWL0F5,3 Under-the-Radar Healthcare Stocks You've Never Heard of,2016-08-13 14:37:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iWHlT7EFhno/3-under-the-radar-healthcare-stocks-youve-never-heard-of-cm665022,"When it comes to finding winning investments, it can pay off to travel the road less taken. Stocks that are household names are often priced at a premium  that means to find bargains in healthcare, you"
EXAS,EXAS:US,BBG000CWL0F5,3 Under-the-Radar Healthcare Stocks You've Never Heard of,2016-08-13 13:00:00 +0000,http://www.fool.com/investing/2016/08/13/3-under-the-radar-healthcare-stocks-youve-never-he.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Under-the-Radar Healthcare Stocks You've Never Heard of
EXAS,EXAS:US,BBG000CWL0F5,Cologuard® Coverage Expands with Updated Policies from HCSC and Florida Blue,2016-08-11 10:00:00 +0000,http://finance.yahoo.com/news/cologuard-coverage-expands-updated-policies-100000908.html,"[PR Newswire] - MADISON, Wis., Aug. 11, 2016 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that Health Care Service Corp. (HCSC), the nation's fourth largest health insurer, and Florida Blue recently updated their medical policies to cover Cologuard. Including Medicare, Cologuard is now covered for 62 percent of its total target population. ""We are pleased that Cologuard's commercial coverage continues to broaden following its inclusion in the recently-updated U.S. Preventive Services Task Force colorectal cancer screening recommendations,"" said Kevin Conroy, chairman and CEO of Exact Sciences."
EXAS,EXAS:US,BBG000CWL0F5,EXAS: A Biotech Stock Screening to Prevent Colorectal Cancer,2016-08-09 00:16:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lWZ0aRt9oNg/exas-a-biotech-stock-screening-to-prevent-colorectal-cancer-cm662169,"Exact Sciences Corporation EXAS is a biotechnology firm focused on using molecular diagnostics to screen for cancer and identify candidates who may be at a higher risk of getting cancer.  The company was founded in 1995, and it has"
EXAS,EXAS:US,BBG000CWL0F5,EXAS: A Biotech Stock Screening to Prevent Colorectal Cancer,2016-08-08 22:25:10 +0000,http://finance.yahoo.com/news/exas-biotech-stock-screening-prevent-222510817.html,EXAS: A Biotech Stock Screening to Prevent Colorectal Cancer
EXAS,EXAS:US,BBG000CWL0F5,"ETF’s with exposure to EXACT Sciences Corp. : August 8, 2016",2016-08-08 18:09:04 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-exact-sciences-corp-august-8-2016/,"ETF’s with exposure to EXACT Sciences Corp. : August 8, 2016"
EXAS,EXAS:US,BBG000CWL0F5,"Exact Sciences Director buys 3,380 shares",2016-08-08 16:28:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QW04sIukyr4/exact-sciences-director-buys-3380-shares-cm661961,"Katherine Zanotti, Director  at Exact Sciences ( EXAS ), bought 3,380  shares of the company's common stock on August 3.   Zanotti bought the shares at $17.93  for a total of  $60,603.40.     InvestorsKeyhole Trade AlertIK > The technicals"
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences to participate in Canaccord Genuity 36th Annual Growth Conference,2016-08-08 14:57:00 +0000,http://finance.yahoo.com/news/exact-sciences-participate-canaccord-genuity-145700138.html,"[PR Newswire] - MADISON, Wis., Aug. 8, 2016 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that the company will participate in the Canaccord Genuity 36th Annual Growth Conference. Kevin Conroy, the company's chairman and chief executive, will participate in a fireside chat on Wednesday, Aug. 10 at 10:30 a.m. ET. A live webcast of the fireside chat will be available through the company's website at www.exactsciences.com. Archived webcasts will be available following the conclusion of the presentation."
EXAS,EXAS:US,BBG000CWL0F5,Why Exact Sciences Shares Skyrocketed 41% in July,2016-08-02 22:56:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HFdJRhUiyMI/why-exact-sciences-shares-skyrocketed-41-in-july-cm659186,"Image source  Exact Sciences.  What  Following the inclusion of its Cologuard test on important treatment guidelines and ahead of strong second quarter results that included a record number of completed colon cancer tests,"
EXAS,EXAS:US,BBG000CWL0F5,"Humana sues urine analysis company, claiming fraudulent billing",2016-08-02 16:00:11 +0000,http://www.bizjournals.com/louisville/news/2016/08/02/humana-sues-urine-analysis-company-claiming.html?ana=yahoo,"Humana sues urine analysis company, claiming fraudulent billing"
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Corp (EXAS): D. E. Shaw Boosts Stake In High-Flying Stock,2016-08-02 13:55:11 +0000,http://www.insidermonkey.com/blog/exact-sciences-corp-exas-d-e-shaw-boosts-stake-in-high-flying-stock-467279/,Exact Sciences Corp (EXAS): D. E. Shaw Boosts Stake In High-Flying Stock
EXAS,EXAS:US,BBG000CWL0F5,3 Reasons This Little Stock Is One of the Market's Best Performers,2016-08-01 23:55:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hf7-iPsT9H8/3-reasons-this-little-stock-is-one-of-the-markets-best-performers-cm658464,"Image source  Exact Sciences.  Exact Sciences (NASDAQ  EXAS)  may have inflicted a lot of pain on shareholders last year, but a batch of good news since June has sent shares soaring. Can"
EXAS,EXAS:US,BBG000CWL0F5,"EXACT SCIENCES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits",2016-08-01 20:18:26 +0000,http://biz.yahoo.com/e/160801/exas8-k.html,"EXACT SCIENCES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits"
EXAS,EXAS:US,BBG000CWL0F5,"EXACT Sciences Corp. :EXAS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 1, 2016",2016-08-01 19:25:46 +0000,http://www.capitalcube.com/blog/index.php/exact-sciences-corp-exas-us-earnings-analysis-q2-2016-by-the-numbers-august-1-2016/,"EXACT Sciences Corp. :EXAS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 1, 2016"
EXAS,EXAS:US,BBG000CWL0F5,Mid-Morning Market Update: Markets Mostly Higher; Tesla To Acquire SolarCity,2016-08-01 15:38:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KmNCrOTQtDw/mid-morning-market-update-markets-mostly-higher-tesla-to-acquire-solarcity-cm658096,"Following the market opening Monday, the Dow traded down 0.01 percent to 18,431.25 while the NASDAQ gained 0.37 percent to 5,181.18. The S&P also rose, gaining 0.02 percent to 2,174.11.  Leading and Lagging Sectors"
EXAS,EXAS:US,BBG000CWL0F5,"EXACT SCIENCES CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of",2016-07-29 20:21:58 +0000,http://biz.yahoo.com/e/160729/exas8-k.html,"EXACT SCIENCES CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of"
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Grants Inducement Restricted Stock Unit Awards to Recently Hired Employees,2016-07-29 20:08:04 +0000,http://www.publicnow.com/view/5E9DCAA69F7F025746D6C5C307A87923A91DAA2A,[at noodls] - 06/01/2016 Cologuard Available In-Network for Anthem Blue Cross and Blue Shield Members in Five Additional Midwest States Exact Sciences Completes Contracting with Anthem Commercial and Medicare Advantage ...
EXAS,EXAS:US,BBG000CWL0F5,"ETF’s with exposure to EXACT Sciences Corp. : July 29, 2016",2016-07-29 17:28:50 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-exact-sciences-corp-july-29-2016/,"ETF’s with exposure to EXACT Sciences Corp. : July 29, 2016"
EXAS,EXAS:US,BBG000CWL0F5,3 Stocks That Could Double Your Money,2016-07-28 16:28:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1mamr9tZhD8/3-stocks-that-could-double-your-money-cm656509,"It's incredibly hard to guess when shares in any company may rise or fall, but long haul investors who are willing to take on risk in their portfolio may benefit from owning these three companies, each of"
EXAS,EXAS:US,BBG000CWL0F5,4 Tech and Biotech Stocks With Momentum to Watch,2016-07-28 16:21:00 +0000,https://www.thestreet.com/story/13656434/1/4-tech-and-biotech-stocks-with-momentum-to-watch.html?puc=yahoo&cm_ven=YAHOO,4 Tech and Biotech Stocks With Momentum to Watch
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences (EXAS) Stock Falling After Public Offering,2016-07-28 14:48:00 +0000,https://www.thestreet.com/story/13656195/1/exact-sciences-exas-stock-falling-after-public-offering.html?puc=yahoo&cm_ven=YAHOO,Exact Sciences (EXAS) Stock Falling After Public Offering
EXAS,EXAS:US,BBG000CWL0F5,3 Stocks That Could Double Your Money,2016-07-28 14:21:00 +0000,http://www.fool.com/investing/2016/07/28/3-stocks-that-could-double-your-money.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Stocks That Could Double Your Money
EXAS,EXAS:US,BBG000CWL0F5,6 stocks to watch,2016-07-28 13:26:04 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=5450758D-874A-4176-8DE3-8D8AEFBEDA2E&siteid=yhoof2,6 stocks to watch
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Announces Upsizing and Pricing of Public Offering of Common Stock,2016-07-28 12:08:11 +0000,http://www.publicnow.com/view/C52C7AEDFCF51B3ECCE52C932456F4B8CD35B57E,[at noodls] - 06/01/2016 Cologuard Available In-Network for Anthem Blue Cross and Blue Shield Members in Five Additional Midwest States Exact Sciences Completes Contracting with Anthem Commercial and Medicare Advantage ...
EXAS,EXAS:US,BBG000CWL0F5,"Exact Sciences Announces Agreement to Sell 7,000,000 Common Shares",2016-07-27 20:28:16 +0000,http://www.publicnow.com/view/1208579EB7FF52E700D5DC793176365323F29591,[at noodls] - 06/01/2016 Cologuard Available In-Network for Anthem Blue Cross and Blue Shield Members in Five Additional Midwest States Exact Sciences Completes Contracting with Anthem Commercial and Medicare Advantage ...
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences: Building Momentum?,2016-07-27 19:01:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/07/27/exact-sciences-building-momentum/?mod=yahoobarrons&ru=yahoo,Exact Sciences: Building Momentum?
EXAS,EXAS:US,BBG000CWL0F5,"Noteworthy Tuesday Option Activity: EXAS, MNKD, XLNX",2016-07-26 21:22:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QU0XssmJ65Q/noteworthy-tuesday-option-activity-exas-mnkd-xlnx-cm655187,"Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in EXACT Sciences Corp. (Symbol EXAS), where a total volume of 21,620 contracts has been traded thus far today, a contract volume"
EXAS,EXAS:US,BBG000CWL0F5,"Close Update: U.S. Stocks Fluctuate With Nasdaq Up, Dow Lower Ahead of FOMC",2016-07-26 20:38:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2EikSp6N90s/close-update-us-stocks-fluctuate-with-nasdaq-up-dow-lower-ahead-of-fomc-cm655173,"Stocks in the U.S. swung between gains and losses on Tuesday as oil prices weakened and investors readied for the Federal Open Market Committee's rate decision, where the Fed funds target range is expected to be kept unchanged amid"
EXAS,EXAS:US,BBG000CWL0F5,Mid-Afternoon Market Update: Crude Oil Drops Below $43; Linear Technology Shares Spike Higher,2016-07-26 20:38:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3-qYsJc4xvo/mid-afternoon-market-update-crude-oil-drops-below-43-linear-technology-shares-spike-higher-cm655200,"Toward the end of trading Tuesday, the Dow traded down 0.21 percent to 18,454.74 while the NASDAQ gained 0.22 percent to 5,108.70. The S&P also fell, dropping 0.04 percent to 2,167.58.  Leading and Lagging"
EXAS,EXAS:US,BBG000CWL0F5,"Health Care Sector Update for 07/26/2016: EXAS,ALIM,TKAI",2016-07-26 18:23:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xu0fET3nNPM/health-care-sector-update-for-07262016-exasalimtkai-cm655071,"Top Health Care Stocks JNJ 0.01% PFE 0.14% MRK +0.25% ABT 0.65% AMGN +0.27% Health care stocks have turned mostly lower in recent trade, with the NYSE Health Care Index dropping about 0.1% after earlier posting a small gain"
EXAS,EXAS:US,BBG000CWL0F5,Mid-Day Market Update: Dow Falls 0.5%; EXACT Sciences Shares Rise Following Strong Q2 Results,2016-07-26 17:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ibp1l-krjEA/mid-day-market-update-dow-falls-05-exact-sciences-shares-rise-following-strong-q2-results-cm655065,"Midway through trading Tuesday, the Dow traded down 0.50 percent to 18,401.53 while the NASDAQ declined 0.18 percent to 5,088.70. The S&P also fell, dropping 0.30 percent to 2,161.92.  Leading and Lagging Sectors"
EXAS,EXAS:US,BBG000CWL0F5,Mid-Morning Market Update: Markets Mostly Higher; Caterpillar Tops Q2 Views,2016-07-26 15:32:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l4mvBbMVlz0/mid-morning-market-update-markets-mostly-higher-caterpillar-tops-q2-views-cm654966,"Following the market opening Tuesday, the Dow traded up 0.02 percent to 18,495.90 while the NASDAQ climbed 0.35 percent to 5,115.67. The S&P also rose, gaining 0.13 percent to 2,171.22.  Leading and Lagging Sectors"
EXAS,EXAS:US,BBG000CWL0F5,"Exact Sciences Completes 54,000 Cologuard Tests during the Second Quarter",2016-07-26 09:08:01 +0000,http://www.publicnow.com/view/33922F86445142EF5362184CDF90BA90FA7BB0E6,[at noodls] - 06/01/2016 Cologuard Available In-Network for Anthem Blue Cross and Blue Shield Members in Five Additional Midwest States Exact Sciences Completes Contracting with Anthem Commercial and Medicare Advantage ...
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences reports 2Q loss,2016-07-26 09:07:26 +0000,http://sg.finance.yahoo.com/news/exact-sciences-reports-2q-loss-090726954.html,Exact Sciences reports 2Q loss
EXAS,EXAS:US,BBG000CWL0F5,Better Buy: Exact Sciences Corporation vs. Quest Diagnostics,2016-07-13 17:52:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2qjXBiLC0TQ/better-buy-exact-sciences-corporation-vs-quest-diagnostics-cm648741,"Image source  Getty Images.  Vague guidance for colorectal cancer screening recently boosted shares of Exact Sciences (NASDAQ  EXAS) , which gained about 78% over the past month. The past few weeks have"
EXAS,EXAS:US,BBG000CWL0F5,NCQA Proposes Inclusion of Cologuard in 2017 HEDIS Quality Measures,2016-07-13 17:48:09 +0000,http://www.publicnow.com/view/E7CCD97507E6B96C582D0E7B381EF78EACFC50FA,[at noodls] - 06/01/2016 Cologuard Available In-Network for Anthem Blue Cross and Blue Shield Members in Five Additional Midwest States Exact Sciences Completes Contracting with Anthem Commercial and Medicare Advantage ...
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences' Cologuard Included in Final USPSTF Colorectal Cancer Screening Recommendations,2016-06-15 18:59:01 +0000,http://www.publicnow.com/view/5FCF7C0261ABE212A4190860E3D9B35FE2ECE65E,[at noodls] - 06/01/2016 Cologuard Available In-Network for Anthem Blue Cross and Blue Shield Members in Five Additional Midwest States Exact Sciences Completes Contracting with Anthem Commercial and Medicare Advantage ...
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Statement Regarding Pending USPSTF Colorectal Cancer Screening Guidelines,2016-06-15 14:09:02 +0000,http://www.publicnow.com/view/AA6B86B432A0D0AAC9C47526AF1A3E16806947B7,[at noodls] - 06/01/2016 Cologuard Available In-Network for Anthem Blue Cross and Blue Shield Members in Five Additional Midwest States Exact Sciences Completes Contracting with Anthem Commercial and Medicare Advantage ...
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Appoints Jeff Elliott to Lead Business Development & Strategy,2016-06-03 10:25:03 +0000,http://www.publicnow.com/view/6FCFFD9DC0A9FBDA906AE3AF38BA2B4C11707A26,[at noodls] - 06/01/2016 Cologuard Available In-Network for Anthem Blue Cross and Blue Shield Members in Five Additional Midwest States Exact Sciences Completes Contracting with Anthem Commercial and Medicare Advantage ...
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences to participate in three investor conferences during June,2016-06-01 20:35:05 +0000,http://www.publicnow.com/view/C03B1215E08C492889D6A2CA9FBC29D2B8AC6CB7,[at noodls] - 06/01/2016 Cologuard Available In-Network for Anthem Blue Cross and Blue Shield Members in Five Additional Midwest States Exact Sciences Completes Contracting with Anthem Commercial and Medicare Advantage ...
EXAS,EXAS:US,BBG000CWL0F5,Cologuard Available In-Network for Anthem Blue Cross and Blue Shield Members in Five Additional Midwest States,2016-06-01 10:23:06 +0000,http://www.publicnow.com/view/7BCE05E054F0EAB778DC9C8799AF769FB1D0F5DB,"[at noodls] - 06/01/2016 Exact Sciences Completes Contracting with Anthem Commercial and Medicare Advantage Plans in Ind., Ohio, Ky., Mo. and Wis. Exact Sciences Corp. (Nasdaq: EXAS) announced today that under a recently-signed ..."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences to participate in two investor conferences during May,2016-05-05 10:21:09 +0000,http://www.publicnow.com/view/959FEABABDB8D30D8258C7E0A0FF377B7EE3EAA6,"[at noodls] - 04/12/2016 Exact Sciences to host first-quarter 2016 results webcast and call Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will host a webcast and conference call on May 3, 2016 ..."
EXAS,EXAS:US,BBG000CWL0F5,"Exact Sciences Completes 40,000 Cologuard Tests during First Quarter 2016",2016-05-03 09:10:08 +0000,http://www.publicnow.com/view/2F5B6AE0211849C5F7DBC6D9F5E66FA3BD6C72AB,"[at noodls] - 04/12/2016 Exact Sciences to host first-quarter 2016 results webcast and call Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will host a webcast and conference call on May 3, 2016 ..."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences reports 1Q loss,2016-05-03 09:05:37 +0000,http://sg.finance.yahoo.com/news/exact-sciences-reports-1q-loss-090537728.html,Exact Sciences reports 1Q loss
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences to host first-quarter 2016 results webcast and call,2016-04-12 09:43:15 +0000,http://www.publicnow.com/view/35BC92B679E7A8020254C6E46CE1A249B00F1E17,"[at noodls] - 01/11/2016 New Modeling Supports Using Cologuard® Every Three Years Archimedes model used to conduct screening study in a virtual population of 200,000 MADISON, Wis. , Jan. 11, 2016 /PRNewswire/ - Exact ..."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences reports 4Q loss,2016-02-24 11:19:26 +0000,http://sg.finance.yahoo.com/news/exact-sciences-reports-4q-loss-111926778.html,Exact Sciences reports 4Q loss
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences to participate in Leerink Partners Global Healthcare Conference,2016-02-01 11:10:02 +0000,http://www.publicnow.com/view/18FD51D0A8628E83BF2F052F9BB145537947BD9E,"[at noodls] - 01/11/2016 Exact Sciences Announces Preliminary Fourth Quarter and Full Year 2015 Results 104,000 Cologuard® tests completed with compliance rate exceeding 70 percent during launch year MADISON, Wis. , ..."
EXAS,EXAS:US,BBG000CWL0F5,"Exact Sciences announces appointment of John A. Fallon, M.D., to company's board of directors",2016-01-25 13:57:07 +0000,http://www.publicnow.com/view/212A0A58FAE4B15BD6D1E2FFD7154AAF1A30458C,"[at noodls] - 01/11/2016 Exact Sciences Announces Preliminary Fourth Quarter and Full Year 2015 Results 104,000 Cologuard® tests completed with compliance rate exceeding 70 percent during launch year MADISON, Wis. , ..."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Announces Preliminary Fourth Quarter and Full Year 2015 Results,2016-01-11 11:27:03 +0000,http://www.noodls.com/view/CBFF4031B49440FCFA8143D35DE5B25670ABF7DE,"[at noodls] - 10/29/2015 Cologuard® Growth Trajectory Increases to 34,000 Completed Tests, Generates $12.6M in Revenue in Third Quarter 2015 Exact Sciences Corp. (Nasdaq:EXAS) today announced that the company continued ..."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Announces Contract with Anthem BlueCross of California,2016-01-11 11:27:03 +0000,http://www.noodls.com/view/DA578FFD43888FD81A9E005861DC92B1FFD3667D,"[at noodls] - 10/29/2015 Cologuard® Growth Trajectory Increases to 34,000 Completed Tests, Generates $12.6M in Revenue in Third Quarter 2015 Exact Sciences Corp. (Nasdaq:EXAS) today announced that the company continued ..."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences to participate in J.P. Morgan 2016 Healthcare Conference,2015-12-30 20:13:20 +0000,http://www.noodls.com/view/7E1B96F0290D210483D8860CC1806D5DB2986A46,"[at noodls] - 10/29/2015 Cologuard® Growth Trajectory Increases to 34,000 Completed Tests, Generates $12.6M in Revenue in Third Quarter 2015 Exact Sciences Corp. (Nasdaq:EXAS) today announced that the company continued ..."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences Names John Bakewell Chief Financial Officer,2015-12-17 11:25:25 +0000,http://www.noodls.com/view/AAECA81CCAF11ED9CA08E24B344C5AF36B180A74,[at noodls] - Experienced health care executive brings more than 25 years of financial leadership to the company --(BUSINESS WIRE)-- (: EXAS) today announced the appointment of as chief financial officer. will begin ...
EXAS,EXAS:US,BBG000CWL0F5,CMS Corrects 2016 Reimbursement Rate for Cologuard®,2015-12-02 11:24:31 +0000,http://www.noodls.com/view/957B01C9F5E128D279DE0EDB4FB65FD74AE3A99B,"[at noodls] - Exact Sciences reimbursed $483.35 for Cologuard tests provided to Medicare beneficiaries MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS) announced that the Centers for Medicare and ..."
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences reports 3Q loss,2015-10-29 09:08:01 +0000,http://sg.finance.yahoo.com/news/exact-sciences-reports-3q-loss-090801708.html,Exact Sciences reports 3Q loss
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences misses 3Q profit forecasts,2014-10-27 11:36:50 +0000,http://sg.finance.yahoo.com/news/exact-sciences-misses-3q-profit-113650348--finance.html,Exact Sciences misses 3Q profit forecasts
EXAS,EXAS:US,BBG000CWL0F5,Exact Sciences soars on colon cancer test ruling,2014-10-10 21:11:17 +0000,http://sg.finance.yahoo.com/news/ahead-bell-exact-sciences-shares-120143289--finance.html,Exact Sciences soars on colon cancer test ruling
EXAS,EXAS:US,BBG000CWL0F5,FDA approves first DNA-based test for colon cancer,2014-08-11 22:43:37 +0000,http://sg.finance.yahoo.com/news/fda-approves-first-dna-based-211717711--finance.html,FDA approves first DNA-based test for colon cancer
